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ABSTRACT OF THESIS
Polymorphism of bovine MHC (BoLA) class I molecules has been characterised mainly by serology. The use of alloantisera has
led to the identification of 50 different serological specficities, most of which behave as alleles of a single highly polymorphic
locus. However, molecular biological and biochemical studies suggest that there are at least two class I genes expressed from any
one haplotype. The actual number of expressed MHC class I genes in cattle is as yet unknown. The aim of this study was to
isolate different functional class I genes from a heterozygous animal, class I typed as BoLA- A10/A11. In order to investigate
the expression and function of individual class I products, transfection and characterisation of a series of bovine class 1 genomic
and cDNA clones isolated from this animal were performed.
From a group of fifteen bovine class I genomic clones, five different clones (1.3, 4.2, 15.2, 17.3x and 19.1), characterised
by their exon 2 sequences and by restriction analysis of an amplified 3.2kb class I gene fragment, were transfected into mouse
L cells. Of the five clones transfected, only 19.1 and 4.2 showed expression at the L-cell surface by using a murine monoclonal
antibody specific for a non-polymorphic determinant on bovine MHC class I (IL-A88) in flow cytometry. The phage clone 19.1
which had been previously shown to express a bovine class I molecule with All specificity, served as a control in these
transfection experiments. The transfectants obtained from both expressing clones were characterised serologically, biochemically
and by cellular assays and both were found to encode All serological specificity. Interestingly, the products of the 19.1 and 4.2
transfected class I genes were indistinguishable by isoelectric focusing, despite having clearly different nucleotide sequences.
The class I gene from the 19.1 phage clone was subcloned into pBR322 to make pBoLA-19 which was used to determine its
sequence. This plasmid transfected at a very high frequency with more than 90% of HAT resistant colonies positive for class I
expression in the primary transfection. From the sequencing of the 19.1 gene and these transfection results it was clear that
pBoLA-19 contains all the upstream regulatory and promoter sequences necessary for class I expression. The lack of expression
from the three phage clones 1.3, 15.2 and 17.3x suggested that these clones might contain truncated class I genes or pseudogenes.
In order to test their ability to be expressed, these clones were reconstructed by replacing the coding region of pBoLA-19 with
the corresponding gene fragment from three non-expressing clones. For this the pBoLA-19 construct was modified into a class
I gene expression vector (pBoLA-21). Plasmid pBoLA-21 carries the 5' and 3'-ends of 19.1 class I genomic clone, flanking a
unique Eag I site which was used for subcloning PCR-amplified class I gene fragments. The exon 2 to 3'-untranslated region
fragments were generated using primers based on sequences conserved in exon 2 and in the 3'-untranslated regions of the published
bovine class I sequences. Both the 19.1 and 4.2 clones were reconstructed with this approach and expressed on transfection. The
three non-expressing phage clones did not express even after reconstruction, suggesting that they are pseudogenes.
The potential of the pBoLA-21 vector for cDNA cloning and expression was tested by subcloning the bovine class I cDNA clone
pBoLA-1, which is truncated at both the ends. The transfected cell line from pBoLA-1 showed detectable levels of class I
molecules using IL-A88. Since both of the expressible class I genomic clones isolated from this animal encoded A11 specificity,
a cDNA approach was adopted for the cloning of sequences representing possible A10 genes from this haplotype. A 1.2kb cDNA
was PCR-amplified using a selective primer based in the 3'ut region of the class I gene, and the PCR product was subcloned into
pBoLA-21 to test its expression. The transfectant obtained was recognised by IL-A88 and IL-A34 (an AlO-specific mAb)
indicating that the transfected cell line expressed a component of the A10 haplotype.
To correlate the serological specificities of the individual expressed products with nucleotide sequences, all three expressing
genes were sequenced. The new class I sequences from pBoLA-19, pBoLA-4 and pBoLA-10 were compared with each other and
the other published sequences in order to establish whether these sequences represented products of single locus or genes
representing different loci. It appeared from the sequence analysis that all three sequences isolated from this animal are likely
to represent different loci. The approach used in this project will facilitate the functional analysis of individual locus products,
and will allow the number of expressed class I loci to be resolved.
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Lymphocytes are the agents of antigenic specificity in the immune response. They
are divided into two main groups: B cells that make immunoglobulins (Ig), and T
lymphocytes that participate in almost all antigen-specific immune response. The
mechanism of antigen recognition by T lymphocytes has evolved to allow an
organism to define self and yet also to distinguish a sufficient number of non-self
antigens so that it can be protected from life threatening pathogens. A proliferative
response by T cells is triggered only when receptors on its surface interact with
antigen presented on the surface of the target cell. Fundamental to a T cell
encounter with any antigen is the interaction of major histocompatibility complex
(MHC) molecules with T cell receptor (TcR). The MHC molecules bind an
antigenic peptide, thereby forming a composite ligand recognised by the TcR.
There are two structurally distinct, but related, families of MHC molecules, class I
and class II, that present antigen to two subsets of T cells: class I MHC molecules
present antigens to T cells that express the CD8 cell surface glycoprotein, and class
II MHC molecules present antigen to CD4 T cells. One feature of MHC molecules
that distinguishes them from any other family of molecules is the high degree of
polymorphism maintained in both classes of molecules. Polymorphism in the MHC
has a profound effect on the extent and quality of the immune response, and provides
a better capacity to respond to a wider variety of antigens (Kappes and Strominger,
1988; Lawlor et al. 1990). Between individuals, the variability in the response to an
antigen can be due to the variable capacity of the MHC products to bind to a
particular peptide. Thus, the MHC plays a vital role in the immune response and it
1
is therefore important to investigate its features.
The major histocompatibility complex (MHC) is one of the best characterised areas
of the mammalian genome where a set of linked genes encoding cell surface and
plasma proteins that show various fundamental functions in the immune system. The
MHC is best known in humans and mice where it is divided into three areas : class
I, class II and class III (Klein, 1986; Campbell and Trowsdale, 1993). The class I
area is further sub-divided into class la and class lb (Klein, 1986). The human major
histocompatibility complex (MHC), also referred to as HLA, resides on the short arm
of chromosome 6 (Spring et al. 1985) and spans four million base pairs (Mbp) of
DNA. In mice, the MHC is named the H-2 complex and is located on chromosome
17. A description of the discovery and molecular elucidation of these loci now
follows:
1.2 History of the MHC
The first indications of the existence of the MHC were provided by Gorer (1936).
A year later, he reported on hereditary genetic differences in the blood of mice, and
this blood group antigen appeared to be involved in the rejection of transplanted
tumors in mice. Ten years later, a study on the phenomenon of graft rejection in
congenic mouse strains resulted in the definition of a set of genes coding for cell
surface molecules that determined tissue compatibility (Gorer et al. 1948).
The molecules involved in the process of tissue rejection were called
histocompatibility antigens and a set of loci coding these molecules in mice was
called the H-2 complex (Snell, 1948). These loci elicited a specific antigenic
response (by generation of antibodies) and all mapped to chromosome 17.
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Characterisation of these loci, by immune sera generated from tumor cells, from
inoculation of lymphoid tissue and by skin grafting, and their subsequent mapping,
was aided by the use of inbred (genetically identical) and congenic (genetically
identical except for a region of chromosome of interest) strains of mice, (Klein,
1975). Subsequent use of these strains led to the mapping of the serological
reactions to the region of chromosome, giving rise to the concept of two loci (K and
D), controlling tissue transplantation in mice (Klein and Shreffler, 1972). The
existence of the third locus, the L locus, was proposed to explain anomalous antibody
typing results in different strains of mice (Snell, 1974).
The exact role of these molecules did not become apparent until Zinkernagel and
Doherty (1974) reported the MHC-restricted T cell response against viral antigens.
They proposed that the CTL had dual specificity and that they recognised viral
antigens as well as MHC molecules expressed on the same target cell. This formed
the basis for all further research on MHC-restricted T cell responses, which led to
the definition of the role of MHC products in antigen presentation. The class I loci
capable of acting as MHC restriction elements (class la) are functionally distinct from
another group of class I loci (class lb). The class lb loci of mouse have been
subdivided into four subfamilies, on the basis of chromosome location and sequence
H-2Q, T and M encoded on distal half of the mouse MHC chromosome 17
(Stroynowski, 1990) and CD1 on chromosome 3 (Calabi and Bradbury, 1991).
1.3 Discovery of class I loci in man
Soon after the description of a genetic system involved in graft rejection in the
mouse, indications of a similar system in humans were found (Gibson and Medawar,
1943). They observed a graft rejection process in which the host became sensitized
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by the first graft, and therefore a second graft was rejected more rapidly. However,
in contrast to fast developments in the definition of the mouse MHC, it was not until
the beginning of the sixties that research on the human transplantation antigens
(human leucocyte antigens, HLA) started. From then on, the characterization of the
HLA system developed rapidly.
The human leucocyte antigens were first described by J. Dausset, R. Payne and J.
van Rood in 1958 (Klein, 1986), and were subsequently named HLA. These were
described as highly polymorphic (Dausset, 1981) and mapped to chromosome 6 (Van
Someron et al. 1974). The investigation of these antigens has relied on different
methods of generating sera than were used in mice. Most antibodies for the analysis
of the HLA system have been derived from a) multiparous women, b) people who
have received multiple blood transfusions and c) volunteers who have undergone
reciprocal skin grafts. Depending upon differences in HLA type and the degree of
antigenic stimulation, these antisera can be of sufficiently high titre and specificity
to be used as tissue typing reagents. These studies has led to the classification of
three classical class I loci, which are called HLA-A, HLA-B and HLA-C (Klein,
1986).
With the increasing knowledge of the HLA system, research on the MHC of other
species has also developed. At present, homologues of the human and murine MHC
have been detected in some twenty vertebrate species, including cattle. New
molecular techniques such as DNA cloning have also been used to uncover a
multitude of new genes/polypeptides related to classical class I and class II MHC
sequences.
4
1.4 Structure of the MHC class I and class II molecules
MHC molecules are membrane bound glycoproteins. They occur at the surface of
expressing cells as heterodimers, composed of two non-covalently associated chains.
According to difference in their structure, tissue-specific expression and function,
two categories of MHC molecules are distinguished: class I and class II molecules
(Fig 1.1).
1.4.1 Class I molecules
Class I MHC molecules, found on most cells, are composed of a 44kD integral
membrane a chain associated with a non-MHC-encoded nonpolymorphic 12kD light
chain known as (^-microglobulin ((\m). Broadly, the class I a chain can be divided
into three regions: an amino-terminal extracellular domain, hydrophobic
transmembrane region and carboxy-terminal cytoplasmic region. The details of this
organisation are described below :
The extracellular portion of the class I proteins can be sub-divided into three domains
(oq, OCj and 0^) comprising amino acid residues 1-90, 91-180 and 181-271 (Ploegh
et al. 1981). The membrane-distal domains (a, and 0^) are extremely polymorphic
and form the unique antigen binding region of the class I molecule, whereas the Ot,
domain is relatively conserved (Michaelson, 1983). The first domain (0^) has an
asparagine-linked carbohydrate attachment site at amino acid 86 in mouse and human
class I molecules.
5






The second domain (O^) has a second carbohydrate attachment site at amino acid 176
in H-2 class I molecules, but not in HLA class I molecules (Nathenson et al. 1981).
Cysteines capable of forming internal disulphide bridges occur at amino acids 101
and 164 in the second domain and at 203 and 259 in the third domain (Kimball and
Coligan, 1983) and allowed the delineation of the protein into three separate
domains. The a, domain associates non-covalently with [\m on the cell surface
(Yokoyama and Nathenson, 1983), which stabilizes the extracellular expression of
the molecule. Indeed, H-2Dband H-2Ld molecules which do not associate efficiently
with f^m, were detected in small quantities on the cell surface (Maloy et al. 1980;
Coligan et al. 1980). The membrane proximal extracellular domains (0^ and f^m),
resemble the C domains of immunoglobulin molecules (Tragardh et al. 1979). The
OCj domain plays an important role in interacting with class I restricted T cells
expressing the CD8 glycoprotein (Parnes, 1989). This role arises from juxtaposition
of the Ig- like domains, which are thought to be an adaptation for binding of the
CD8 a chain, with a, residue 227 having the most effect on binding (Salter et al.
1990; Potter et al. 1989). This domain supports the peptide binding domains (C^ and
Otj) and connects them to the transmembrane anchor and short cytoplasmic domain
of the class I a chain. The membrane binding region was localised to a hydrophobic
stretch of residues (284-307) in H-2Kb (Nathenson et al. 1981). Generally, the
membrane binding portion is approximately 24 amino acids long in HLA and H-2
class I molecules, and contains no charged or polar residues (Ploegh et al. 1981).
This number of residues is enough to allow it to span the lipid bilayer of a cell if an
a-helical configuration is assumed (Ploegh et al. 1981). Immediately outside the
lipid bilayer there are basic residues which are postulated to help anchor the molecule
in the cell membrane, by interacting with cytoskeletal elements. The cytoplasmic
region is 39 amino acids long in H-2 molecules (Nathenson et al. 1981), and 31
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amino acids long for HLA (Robb, 1978). This region has a high polar amino acid
content (up to 50%) and contains the phosphorylation consensus sequence (Ser-
Asp/Glu-Xaa-Ser(p)-Leu) which was identified in H-2 class I (Rothbard et al. 1980)
and HLA class I (Pober and Strominger, 1981). The phosphorylation site is well
conserved in the class I molecules of many species (Guild and Strominger, 1984).
Overall when comparing H-2 and HLA class I molecules in the transmembrane and
cytoplasmic regions of the molecule there is marked divergence. This lack of
homology suggests a general lack of structural constraint on these regions, in that
they may only need to remain hydrophobic and hydrophilic respectively (Ploegh et
al. 1981; Kimball and Coligan, 1983).
1.4.1.1 X-ray crystallographic structure
Huge advances have been made in recent years in determining the detailed structure
of the class I molecule and in particular the structure of the antigen binding site. The
three-dimensional structure of three human MHC class I molecules (HLA-A2, HLA-
A68 and HLA-B27) have been elucidated by X-ray crystallography studies and
currently serve as prototypes for all class I molecules (Bjorkman et al. 1987a; Garret
et al. 1989; Madden et al. 1991).
The HLA-A2 molecule is composed of two sets of structurally homologous domains.
The 0(3 and f^m are proximal to the membrane and are folded into (3-sandwich
structures (resembling the Ig constant domains), each composed of two antiparallel
(3 pleated sheets connected by internal disulphide bonds. The membrane distal
domains (a, and 0^) form a platform composed of eight anti-parallel (3-pleated
sheets, topped by a pair of a-helices with a long groove between the helices. The
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four (3-strands from each domain combine to produce a planar structure that forms
the floor of the peptide-combining site (Bjorkman et al. 1987b), and each domain
also contributes one of the two a helices which form the sides of the groove. This
cleft, between the two helices, has now been shown as the key functional domain of
MHC molecules for binding of antigenic peptides. The structures of HLA-A2 and
HLA-A68 provided details of the peptide groove structure (Saper et al. 1991; Garret
et al. 1989). The structure of the third class I molecule HLA-B27 revealed a clearer
picture of peptides in the groove, indicating that peptides are bound in an extended
conformation, with tight binding at either end of the groove between the peptide and
conserved MHC residues (Madden et al. 1991; Madden et al. 1992). As the groove
of class I molecules is closed at both ends, the length of peptides bound is restricted
in size to 8-10 amino acids (Falk et al. 1991). Longer peptides can be
accommodated by bulging in the middle (Guo et al. 1992). Six pockets, or subsites,
designated A- F (Saper et al. 1991) were identified within the groove, suggesting that
polymorphism, by creating and altering such sites, can influence the range of
peptides bound by class I alleles. Various workers have used mutant class I
molecules to evaluate the role of these pockets (Winter et al 1991; Buxton et al.
1992; Matsui et al.1993). Overall, all these studies demonstrated that peptide
binding pockets play an important and distinct role in the binding of peptides and
recognition of class I molecules by alloreactive CTLs.
1.4.1.2 Assembly ofclass I molecules
The newly translated heavy chains are guided to the endoplasmic reticulum (ER) by
classical amino terminal signal sequences which are cleaved off once the molecules
are co-translationally translocated across the ER membrane (Ploegh et al. 1979). The
assembly of MHC class I molecules begins in the ER after (3^m associates with
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class I heavy chain. Various workers have proposed a stepwise series of events in
the assembly of class I molecules (Townsend et al. 1990; Elliott et al. 1991, 1992a).
In one proposed pathway, the heavy chain (HC) can form a loose association with
/32m, which is then stabilized by peptide occupying the binding site. Alternatively,
a short, high affinity peptide might stabilize a specific HC conformation, which can
then associate with jS2m (Elliot et al. 1992b). The role of jS2m in class I assembly
has been investigated by various workers in human mutant cell lines lacking /32m,
which suggested that jS2m-free class I molecules were not exported from the ER to
the cell surface (Krangel et al. 1979; Roller et al. 1990; Ploegh et al. 1979).
However, H-2Db and H-2Ld molecules were detected on the cell surface of mouse
mutant cell lines defective in jS2m expression, although the presence of /32m may still
influence the stability or the expression levels of these molecules (Krangel et al.
1979; Allen et al. 1986; Williams et al. 1989). These molecules were not
recognised by Db and Ld specific CTLs suggesting the conformation of these
molecules were different from the native molecules. It was concluded from the
above studies that although /32m does not contribute to peptide binding directly, it is
considered essential for correct cell surface expression of peptide /MHC class I
complex as seen by CD8+ T cells (Vitello et al. 1990). Contrary to the above
reports, Glass and co-workers (1992) reported that MHC class I restricted T cells
can recognise targets from /32m- deficient mice. Recently, Zugel et al. (1994) have
also demonstrated the presentation of exogenous and endogenous peptides to CD 8
cells in the absence of jS2m. It was found that specific short peptides, 9-10 amino
acids (a.a.) in length, can induce folding of the heavy chain in the absence of j62m.
Both short and longer peptides (15a.a.) can stabilize preformed low-affinity
heterodimers (Silver et al. 1991; Ortiz-Navarrete and Hammerling, 1991).
Fahnestock and co-workers (1992), suggested that secreted empty class I molecules
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are immunologically reactive and structurally similar to peptide-carrying class I
molecules. However, class I molecules with peptides appeared to be more stable
than empty class I molecules. The class I molecules are transferred from ER to the
trans-golgi reticulum (TGR) where they are glycosylated before they are transported
to the cell surface (Parham et al. 1977).
1.4.1.3 Role of calnexin
The efficient assembly and transport of class I molecules to the cell surface is
critically dependent on the presence of suitable peptides. Inhibition of transport of
peptide- free class I heavy chains appears to be due to interactions with an
endoplasmic reticulum resident membrane protein called calnexin (p88; Degen et al.
1992). The ER retention of class I molecules serves as an example of quality control
since it ensures that only fully assembled complexes reach the cell surface. Failure
to achieve ER retention of class I molecules would upregulate expression of
incompletely assembled class I molecules on the cell surface which could bind
exogenous peptides, and lead to the recognition and destruction of normal cells by
CTL (Schumacher et al. 1990; Ortiz-Navarrete etal. 1991). Calnexin associates with
free class I heavy chains soon after synthesis, but this association is transient and
calnexin dissociates from completely assembled class I complexes (Galvin et al.
1992). Degen and co-workers (1992) proposed that both /32m and peptide were
required for the dissociation of class I HCs from calnexin. Recently, Sugita and
Brenner (1994) have shown that dissociation of class I heavy chain from calnexin is
only /32m dependent and peptide binding is not required. In addition to its role in
intracellular retention, calnexin also protects the heavy chains from rapid
intracellular degradation (Jackson et al. 1994).
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1.4.1.4 Antigen processing
The production of most of the peptides destined for presentation by class I molecules
begins in the cytosol, with the limited hydrolysis of antigenic proteins. Goldberg and
Rock (1992) were first to report that the proteasome, a multicatalytic complex in the
cytosol, played a vital role in generating peptides from cytoplasmic proteins The
involvement of this system in antigen presentation was further supported by the
finding that two proteasome subunits (LMP-2 and LMP-7), are encoded by genes in
the MHC adjacent to those of TAP (transporter associated with antigen processing).
However, functional studies using cells deficient in expression of these proteasome
subunits did not significantly impair the processing and delivery of antigens to class
I molecules (Momburg et al. 1992; Arnold et al. 1992). These studies revealed that
LMP-2 and LMP-7 are not essential for MHC class I presentation. Subsequently,
other groups have shown that proteasomes may generate peptides with COOH termini
that are appropriate for binding to class I (Driscoll et al. 1993; Gaczynska et al.
1993), and these may be trimmed in the ER at their amino termini, as suggested by
Falk et al. (1990). Recently, it has been reported by two different groups that
proteasome mediated proteolysis is probably the major source of class I presented
peptides due to their endopeptidase activity (Rock et al. 1994; Dick et al. 1994).
Rock and co-workers (1994) showed that when mouse cells were treated with
Proteasome inhibitors (peptide aldehydes) there was a block in the assembly of the
class I molecules.
1.4.1.5 Role of TAP in antigen transport
The discovery of ATP-dependent transporters encoded by TAP genes within the class
II region of human, mouse and rat MHC (Monaco 1992; Trowsdale 1990; Powis et
al. 1992b), immediately stimulated the speculation that they played a role in
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translocating peptides from the cytoplasm to the lumen of the ER (Shephard et al.
1993; Neefjes et al. 1993). Transport of peptides from the LMP complex to the
transporter, which resides in the ER membrane, was thought to be mediated by direct
physical interaction between the two structures, or by simple diffusion. According
to one hypothesis, these peptides are bound and protected from complete degradation
by a chaperone, Hsp70, before reaching TAP (Srivastava et al. 1994). The
involvement of TAP in peptide transport was suggested by the observation that cell
lines defective in expression of TAP, such as murine RMA-S and human .174 and
T2, do not efficiently express MHC class I molecules at the cell surface, but retained
them in the ER (Spies et al. 1992; Kelly et al. 1992). Gene transfer experiments in
these mutant cell lines demonstrated that the lack of class I surface expression and
antigen presentation problems could be corrected by transfecting TAP1 and TAP2
cDNAs (Spies and DeMars, 1991; Attaya et al. 1992; Powis et al. 1991). These
studies provided strong evidence that TAP mediates peptide translocation into the
ER. This was also supported by the work of Van Kaer and co-workers (1992) who
showed that mice deficient in LMP-2 gene expressed normal levels of class I
molecules, whereas TAP 1 deficient mice showed a 20 fold reduction in the levels
of class I surface molecules.
Polymorphism in the TAP gene results in an alteration of the spectrum of class I
bound peptides (Powis et al. 1992a, 1992b), providing further indirect evidence for
the role of TAP in peptide translocation. It has been suggested that TAP may
function as a molecular ruler, selecting peptides of appropriate length with a suitable
carboxy terminal residue for binding to a class I molecule (Germain, 1994; Momburg
et al. 1994; Neefjes et al. 1993). The ability of TAP to transport peptides with
different carboxy termini varies from species to species. In humans, TAP is
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permissive of peptides with all carboxy-terminal amino acids except proline and
glycine (Momburg et al. 1994), whereas mouse TAP is restricted to the transport
only of peptides with hydrophobic carboxy termini (Heemels et al. 1993).
Recent studies has demonstrated a physical association between class I molecules and
the TAP complex in the ER (Ortmann et al. 1994; Suh et al. 1994). This binding
is thought to promote peptide capture by class I molecules before the peptides are
exposed to the luminal enviornment. As a consequence of peptide binding, the class
I molecules dissociate from TAP (Ortmann et al. 1994). The results of this study
also showed that appropriate trimming and loading of the peptides into class I
molecules and their presentation at the cell surface can occur in the absence of the
TAP complex. Cytosolic peptides can additionally enter the ER in a TAP
independent manner, via the normal SRP (signal recognition particle) dependent
pathway (Forquet et al. 1993) and signal sequences of ER-targeted proteins are found
to be presented by HLA-A2 molecules (Van Bleek and Nathenson, 1993). Recently,
Elliot and co-workers (1995) have shown that in a TAP deficient cell line, large
fragments of influenza nucleoprotein (NP) could be translocated into ER via a
hydrophobic signal sequence. These large fragments were trimmed to a shorter
peptide epitope of 9 residues for recognition by CTLs.
The typical view of class I processing and presentation is that proteasome degrade
cytosolic proteins to 8 or 9 mer peptides which are then transported into the ER by
ATP-dependent TAP transporters, prior to association with class I molecules.
However, processed peptide ligands for class I molecules cannot be detected in the
cytosol. Furthermore, in order to be selected by class I molecules, the entire pool
of peptides would need to be transported into the ER. Rammensee and colleagues
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have proposed an alternative model of class I processing which assumes an
instructive role for class I molecules (Rammensee et al. 1993; Howard and Seelig,
1993). They suggest that proteins are first degraded into precursor peptides with
appropriate carboxy termini for class I binding. These peptides would then be
transported into the ER and bind with low affinity to fitting class I molecules via
their carboxy-termni. The amino terminus would then be trimmed, allowing the
peptide to snap into the groove and bind with high affinity. This model would
require the transport of only a subset of available peptides and would fit with the
current evidence for selectivity of the peptide transporters.
1.4.2 Class II molecules
The similar pattern of sequence polymorphism and conservation made possible an
accurate prediction of the structure of the class II molecule from the class I structure,
despite minimal sequence homology (Brown et al. 1988). Class II molecules consist
of an a and a (3 chain, both encoded by closely linked MHC genes. The
extracellular region of each subunit is divided into two domains a,- a, and -(\
each about 90 amino acids long. Class II molecules are mainly expressed on antigen
presenting cells (APC) and B cells. In the class II MHC molecules, the peptide
binding groove is formed by the interaction of the (X, and (3, domains, with the class
II (3j domain corresponding to the class I domain (Brown et al. 1993).
The structure of a class II molecule has been determined by x-ray crystallography of
the class II HLA-DR1 molecule and is similar to the class I HLA structure and also
to the earlier predicted class II structure (Brown et al. 1993). Class II molecules
differ from class I primarily in the separation of the antigen binding domain between
the two subunits, with one helix and four (3 strands contributed by each subunit.
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Despite their overall similarity, differences between the structure of the class I and
class II peptide binding grooves have important functional consequences. The most
obvious is that the grooves of class I molecules are blocked at both ends, while those
of class II molecules are open, allowing peptides to protude. This is due to slight
differences in the a helical regions of the class II antigen binding site (ABS). In
class I molecules, the groove tapers at both ends and is then blocked completely by
bulky amino-acid side chains, including Tyr 84 and Trp 167, which are conserved
in virtually all class I MHC sequences (Saper et al. 1991). In the class II MHC
molecule HLA-DR1, the blocking side chains are either replaced by smaller amino-
acids or/ are repositioned by secondary structure changes concentrated at the ends
of the cleft. Consequently, class II molecules bind longer peptides (12-24 residues),
and specificity is confined to the conserved residues distributed throughout the
binding site (Rudensky et al. 1991; Hunt et al. 1992). Another difference in
comparison to class I structures is that DR1 crystallised as a dimer of the af3
heterodimer i.e. a dimer of dimers. It has been suggested that this dimer of dimers
may influence T cell signalling by affecting CD4 binding and TCR crosslinking
(Ploegh and Benaroch, 1993; Brown et al. 1993).
1.4.2.1 Assembly and intracellular transport ofclass II molecules
Class II molecules typically assemble in the ER with a nonpolymorphic protein
termed the invariant chain (Ii) (Claesson-Welsh and Peterson, 1985). The nine-
chain complex formed is composed of three class II dimers and three Ii chains (Lamb
and Cresswell, 1992). Various functions have been ascribed to Ii, and it is clear that
it plays a central role in class II assembly and transport. The invariant chain directs
the a(3 dimers to the class II loading compartment which appears to be in specialised
vesicles characterised by the presence of class II molecules. The second function of
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Ii is the prevention of premature peptide loading to the class II molecules.
Avoidance of such binding is mediated by a short internal segment, the class II-
associated invariant chain peptide (CLIP) invariant chain (Riberdy et al. 1992) which
occludes or closes the class II ABS so that no peptide can bind. The delivery signal
is located in the cytoplasmic tail of the invariant chain. Studies conducted on cell
lines and mice deficient in invariant chain showed reduced assembly of class II a and
P chains, inefficient transit to the cell surface of those class II dimers that do form,
and reduced stability of class II molecules (Anderson and Miller, 1992; Viville et al.
1993). These results confirm the importance of Ii chain in class II assembly and
transport. During the last stage of transit to or following entry into the major
endosomal or lysosomal processing compartment, a combination of acidic pH and
specific proteases progressively cleaves the COOH-terminal portions of Ii (Blum and
Cresswell, 1988). A major role for Cathepsin E has been proposed for the
degradation of invariant chain (Roche and Cresswell, 1991). Inhibition of the
degradation of the Ii by Leuptin (and also lysosomotropic agents like NH4C1 or
Chloroquine) inhibit the transport of class II molecules to the cell surface. The rate
of breakdown of the invariant chain determines the endosomal transit time of the
class II molecules which varies from 1-3 hrs before they appear at the cell surface
(Neeljes et al. 1990). The peptides loaded onto class II molecules can be derived not
only from endocytosed proteins but also from proteins endogenous to the cells,
especially membrane bound proteins which can co-localize in the class II binding
compartment. At the cell surface, a small fraction of empty class II molecules can
bind peptide. Only the newly synthesized pool of class II molecules, not the
prexisiting cell surface pool, associates with peptides derived from internalised
antigen. This excludes a major functional role for the fractions of recycled class II
molecules in presentation of unprocessed exogenous antigen (Davidson et al. 1991).
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However, the role of recycled class II molecules in antigen presentation remains
controversial. Recently, Pinet and co-workers (1995) have reported that recycled
HLA-DR molecules were able to present immunodominant epitopes from the
haemagglutinin protein of influenza virus. It was also suggested that the
compartment for loading of peptide onto recycyled class II molecules is probably
distinct from the one where newly synthesised class II molecules are loaded.
1.4.2.2 Class IIprocessing
Recognition of antigen by MHC class II restricted T cells requires processing of the
native antigen into peptides (Unanue and Allen, 1987). Class II molecules obtain
their peptides predominantly from extracellular sources by endocytosis, with
subsequent degradation in acidified endosomes or lysosomes. The precise location
and nature of the acidic peptide loading compartment has, until very recently, been
ill defined. The prevailing view has been that class Il/Ii complexes meet the
unprocessed antigen in an endosomal compartment, and together proceed along a
proteolytic pathway so that the unoccupied class II molecules are produced
simultaneously with antigenic peptides. Several workers have recently reported the
identification of a unique subcellular compartment, the CPL (the compartment for the
peptide loading), in which class II loading occurs (Amigorena et al. 1994; Tulp et
al. 1994; West et al. 1994). The CPL have no detectable endosomal or lysosomal
markers and have distinguishable subcellular fractionation behaviour (Schmid and
Jackson, 1994). Most class II molecules in the CPL are not associated with Ii. It
has been suggested that the CPL undergoes a maturation process whereby Ii is
degraded, class II dimers assume an intermediate conformation and peptide loading
occurs subsequently.
18
1.5 MHC ligands and peptide motifs
Huge advances have been made in recent years in the analysis of peptides naturally
presented by class I MHC molecules. Naturally processed peptides associated with
class I and class II MHC molecules are usually isolated from immunoaffinity purified
material, followed by size fractionation to remove the MHC proteins themselves
(Buus et al. 1988; Van Bleek and Nathenson, 1990). However, the binding of some
antibodies to MHC molecules can be significantly altered by the structure of the
associated peptides (Bluestone et al. 1992), and isolation of some peptide-MHC
complexes may therefore depend upon the antibody used. Peptides eluted from
purified class I molecules can be separated by HPLC and their sequences analysed
by Edman degradation and /or mass spectrometry. A special application of Edman
degradation is pool sequencing, that is, sequencing of the complex mixture of
peptides eluted from a given MHC species (Falk et al. 1991) The most sensitive
means of detecting the isolated peptides is the T-cell assay, which can detect peptides
in sub-picomolar range, in cytotoxic T cells assays (Rotzschke et al. 1990). The
major shortcoming of the T-cell assay in peptide detection is that it does not give
sequence information. Such studies have revealed that each class I allelic molecule
has its own peptide specificity or peptide motif (Van Bleek and Nathenson, 1993;
Hunt et al. 1992; Falk et al. 1991). Pool sequencing of MHC class I ligands led to
the discovery of allele-specific motifs, and a large number of such motifs have now
been determined (e.g., H-2Ld, HLA-B7, HLA-B*5102 and HLA-B*5103),
(Rammensee et al. 1995). Recently, the peptide motifs for two bovine class I alleles
B0LA-AI8 and BoLA-All has been reported (Bamford et al. 1995; Hedge et al.
1995). Peptides bound to class I molecules are restricted to 8 or 9 residues in
length.
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The peptides bound to the same class I molecules were found to share sequence
motifs which complement the binding pockets in the class I molecule in question.
The specific interaction between a peptide and class I MHC molecule is mediated
through residues on the peptide, whose side chains protrude into complementary
pockets of the class I groove (Guo et al. 1993). The amino and carboxy-terminal
ends of the peptide bind with conserved residues in two pockets located at opposite
ends of the binding site, termed A and F, respectively (Madden et al. 1992).
Although all class I molecules analyzed to date appear to bind peptides in a common
orientation, polymorphic residues located in pocket F and four more centrally located
pockets (B, C, D and E) influence the specificity of peptide binding or bound peptide
conformation. Each peptide motif has anchor positions and these also vary
depending upon the class I molecule involved. Without exception, one anchor is
found at the carboxyl terminus of the peptide. These carboxyl terminal anchors are
generally hydrophobic or charged. The carboxy-terminal peptide residue is an
important determinant for binding of peptides associated with all class I MHC
molecules. The peptides associated with most class I molecules also show motif
residues at position 2 (P2) relative to the amino terminus, which interacts with the
B pocket of the binding cleft. For some class I molecules, (e.g. HLA-C, Falk et al.
1993a), a second anchor appears to be replaced by two or three auxiliary anchors
reflecting either MHC pockets with degenerate specificity, or the alternative use one
of at least one of two or three specific anchors. For most cases the determined
(Madden et al. 1993), or predicted pocket structure allows a satisfying explanation
for pocket specificity. For example, amino acid residues 77 and 116 of the class I
heavy chain contribute to a pocket accommodating the carboxyl terminal anchor side
chains of peptide (Madden et al. 1992). If both of these residues are negatively
charged, as in HLA-A31, for example, the corresponding anchor is a positively side
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chain (Falk et al. 1994). If only one of the residues is negatively charged e.g. as in
HLA-A1, a positively charged carboxyl-anchor side chain of the peptide P-C is no
longer allowed. Similar considerations can be made for the P2-accommodating
pocket, so that attempt can be made to predict MHC motifs almost entirely on
theoretical grounds (Thorpe and Travers, 1994). However, it has been suggested
that such interpretations should be made with caution, especially when the MHC
molecule in question has not yet been crystallized, and the pocket structure has only
been inferred by sequence homology. In addition to anchor residues, several, if not
all, of the other peptide residues can make contact within the MHC groove but these
interactions differ with different peptides.
Information on allele-specific motifs can be used to identify T-cell epitopes within
proteins of known sequence and detailed analysis of peptide/MHC interactions. The
successful identification of peptides presented by MHC molecules that orginate from
viruses or pathogenic agents will certainly lead to the identification of better
candidate antigens for vaccines, but also to development of new strategies for
autoimmune disease and tumor immunology.
An elegant approach for studying the peptide specificity of class II molecules has
been developed by Hammer and co-workers (1994). A peptide library was expressed
by bacteriophages. From the peptide expressing phages only those phages were
selected which bound to a given class II molecule. The peptide sequences expressed
by the selected phages were then determined. Motifs obtained with this method for
HLA-DR1 has been established and were in accord with the known crystal structure
of the HLA-DR1.
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1.6 Molecular cloning of class I genes in man and mouse
The pioneering works of Steinmetz et al. (1982a, 1982b) and Weiss et al. (1984)
provided the first insights into the molecular organisation of two murine MHC
haplotypes. These investigators carried out large scale chromosome walking in the
genomes of BALB/c (H2d) and C57B1/10 (H2b) and linked several clusters of
structurally related genes within H-2 complex. The molecular analyses of the human
MHC (HLA) began soon after the isolation of cDNA clones for HLA-B7 toward the
end of 1980 (Ploegh et al. 1980; Sood et al. 1981). Once isolated, these cDNA
clones were used to build a picture of class I loci in humans and mice by the dual
approach of southern blotting and genomic cloning. The complete mapping of the
class I region in man and mouse reveals that numerous genes are present, and that,
remarkably, there appears to be some conservation of genes between the species.
The human MHC map (Campbell and Trowsdale, 1993; Fig 1.2) is built on a
combination of mapping by pulse field gel electrophoresis (PFGE: Hardy etal. 1986)
and analysis of overlapping genomic clones in cosmid, bacteriophage X and yeast
artificial chromosome (YAC) vectors (Newell et al. 1994).
1.6.1 Class I gene structure
Southern blotting studies in mice highlighted the large numbers of class-I-hybridising
sequences in the genome; the majority of these which mapped outside the class I K
and D regions to the Qa and Tla regions. One of the first gene sequences to be
reported mapped to the Qa region in BALB/c mice; H-2Q7d had eight exons but
contained a stop codon which gave a truncated gene product (Steinmetz et al.
1981b). The intron/exon structure of this clone mirrored the domain assignments of
class I protein structure, with exons corresponding to each of the three external
domains and the transmembrane and cytoplasmic regions. Other gene sequence
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Fig. 1.2 The organisation of the human MHC complex.
The map of human MHC including the genes encoding for class I, class II, class II,











































































































































































































































included H-2Ld (Moore et al. 1982) which was also found to encode eight exons.
The fine structure of the sequenced clones showed the eight exon format was very
well conserved in the class la and the class lb genes in mouse (Steinmetz et al.
1981b; Evans et al. 1982a) and man (Malissen et al. 1982; Geraghty et al. 1987) and
can be dissected as follows:
5'-untranslated (5'-ut) This region normally varies from 20-30bp in the area
between the TATA Box and translation start.
Exon 1 The first exon encodes the leader peptide in the immature protein and
varies from 21 (Lalanne et al. 1982) to 24 residues in man (Srivastava et al.
1985) although exceptions include HLA-A3 which has a leader peptide of 29
residues (Strachan et al. 1984).
Exons 2, 3 and 4 These encode the three extracellular domains of the protein
which are 90, 92 and 92 amino acids long respectively. Exons 2 and 3
encode the polymorphic antigen binding site, exon 4 is relatively conserved
and binds with /32m. All these domains show structural similarities to
immunoglobulin constant regions. The structure of these domains appear to
be very well conserved across the species.
Exon 5 This encodes the 40 amino acid transmembrane region of the protein.
This domain is the most variable in length in class I genes from different loci
within species, and has been suggested to contain locus specific substitutions.
In human, HLA-C products have one more amino acid than HLA-A and
HLA-B. In the bovine MHC, the different sequences isolated have also been
shown to vary in the length of the TM region. In horses, five different sizes
of TM have been reported (Ellis et al. 1995).
Exon 6, 7 and 8 These encode the cytoplasmic domain and the exact role of this
domain is not clear. Influenza-infected cells expressing a transfected H-2Ld
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molecule lacking a cytoplasmic domain were recoginsed by cytotoxic T-
lymphocytes, but similar vesicular stomatitis virus infected cells were
recognised less easily without the cytoplasmic domain (Murre et al. 1984).
A serine in this domain is highly conserved, and may be phosphorylated,
which suggests a function, for this conserved sequence. A role for this
domain in intracellular transport (Zuniga and Hood, 1986) and endocytosis
(Capps et al. 1989) has also been suggested. Exon 6 is normally 11 amino
acids long in class I genes. Exon 7 can vary in length from 13 a.a. (H-2Ld,
H-2Kd) to 16 a.a. (HLA-Cw3) and exon 8 also varies in length from 1 a.a.
in H-2Ld and HLA-A genes, up to 10 a.a in H-2Kd. In all of the HLA-B
locus genes sequenced so far, a termination codon is found at the end of the
exon 7, so that B locus genes lack the residues encoded by exon 8 (Gussow
et al. 1987).
3' untranslated region It can vary in class I genes from approximately 300bp up
to 900bp for Tlac. This region lacks the structural constraints of coding
regions, and has retained less nucleotide similarity between the different class
I genes.
Most of the variation in length of the molecule is generated by exons 6, 7 and 8.
This includes variation in length by alternative splicing of exons (Steinmetz, 1981a).
Several instances of class I alternative splicing have been described: for example in
the mouse H-2Kb, H-2Kq, H-2Kk and H-2Ld (Lew et al. 1987; Vogel et al. 1989), in
human HLA-A24, HLA-A2 (Krangel 1986), and possibly HLA-C (Mizuno et al.
1989), in sheep and bovine class I genes (Grossberger et al. 1990; Ellis et al. 1992).
Most of these examples involve exons 7 and/or 8, and lead to truncated molecules.
Many non-classical class I genes also demonstrate alternative splicing of exons 5-8
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(Lew et al. 1987; Ulker et al. 1990). Transfection studies with alternatively spliced
class I molecules (Zuniga and Hood, 1986) indicate that structural variations in the
cytoplasmic domain can lead to the use of distinct pathways of intracellular
processing and can effect the way the molecules interact with the cytoskeleton.
Variations in the length of class I molecules can also be caused by in- frame
termination codons. This is particularly frequent in mouse Qa genes which all
appear to have a 8 exons, but have a termination codon in the fifth exon giving rise
to truncated proteins (Steinmetz et al. 1981b; Mellor et al. 1984; Robinson et al.
1988). Although the structure of class lb Qa genes is relatively similar to the
classical class I genes, this is not the case for the Ta genes. In these genes the first
five exons follow the same format as the classical class I genes, but exon 6 encodes
the entire cytoplasmic region of Ta\ which is two amino acids longer than H-2Ld
(Fisher et al. 1985).
1.6.2 Class I genes in the mouse major histocompatibility complex
The Murine major histocompatibility complex H-2 encodes the classical
transplantation antigens K, D and L which are related to A, B and C in man. The
genetic nomenclature of the H-2 complex is complicated and confusing. A particular
gene is designated by a capital letter (eg. K, D or L) for the locus and each locus has
alleles designated by a small letter superscripts in complex combination with H-2
symbol (eg Ka, Kb, Da). The availability of inbred strains of mice congenic for MHC
haplotypes (eg. BALB/c and C57BL line which are classified as H-2d and H-2b
haplotypes respectively) has facilitated extensive genetic analysis of this system.
Adjacent to the loci encoding these molecules on chromosome 17 is the Ta region,
which contains genes encoding the Q and T lymphoid differentiation antigens. These
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antigens, like class I antigens, are integral membrane proteins with molecular weights
of 40-45,000 D (Soloski et al. 1981) and are expressed on the cell surface in
association with f^m (Coligan et al. 1981), but Q and Ta are relatively non-
polymorphic (Flaherty et al. 1980). Cell mediated lymphocytosis (CML) can be
directed against Q antigens but is not MHC restricted (Kastner et al. 1979a), and Q
restricted CTLs cannot be generated (Kastner et al. 1979b).
1.6.3 Molecular cloning ofclass I genes in mouse
Steinmetz et al. (1982b) identified 36 distinct class I hybridising sequences from
BALB/C mouse (H-2d) and subsequent mapping placed 31 of these in the Q and Ta
regions (Winoto et al. 1983). This was done using congenic strains of mice that had
undergone recombination in the MHC. The strategy used was to digest cosmid
clones with frequently cutting enzymes to construct an overlapping map of the
cosmid so that the genes could be ordered into clusters. These cosmid clusters were
mapped to the genetically defined regions of the H-2 complex by restriction fragment
length polymorphism (RFLP). The RFLP mapping strategy relied on the isolation
of probes from the cosmids which detect unique or low numbers of genomic DNA
restriction fragments. These probes were used against DNA from congenic or
recombinant strains of mice to detect restriction site polymorphisms. Essentially
three types of polymorphism can be detected 1) Change in fragment size (mutation),
2) Loss of the fragment (deletion), 3) an increase in the number of fragments
(duplication). These polymorphisms can be correlated with serological
polymorphisms, allowing the mapping of a particular fragment to one of the four
class I regions characterised. The techniques of Southern blotting and genomic
cloning highlighted several new findings. The first was that class I genes could vary
in number in different haplotypes of mice. There is considerable divergence in the
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number of class I genes located in the H-2D/H-2L region of BALB/C (H-2d) and
BIO (H-2b) mice (Weiss et al. 1984; Stephan et al. 1986). The D region of BALB/C
mice contains 5 genes (H-2Dd, D2d, D3d, D4d, and H-Ld). This contrasts with the
single gene characterised in the D region of BIO mice (Weiss et al. 1984). The Ld
gene is most distal in this region and is separated by 60kb of DNA from the most
proximal gene of the Q region in Ql. However, the organisation of the H-2K region
is similar in BALB/c and BIO mice. Both these strains have two genes in H-2K
region, K and K2. Only the K gene appears to be expressed.
The second major finding was that the main source of variation in the numbers of
class I hybridising bands seen in genomic hybridisation studies was in the Q and Ta
genes. In contrast to the polymorphic K and D antigens, the Q and Ta antigens
lacked functional polymorphism as detected by serology, but showed a higher degree
of numerical polymorphism detected at the DNA level. This is discussed in more
detail in section 1.9.1.
1.6.4 Molecular cloning of class I genes in man
In order to find different class I loci Koller and co-workers (1989) derived locus-
specific probes from class I genomic clones detecting restriction fragment length
polymorphisms (RFLP) on genomic DNAs. These probes were used to analyse a
collection of mutant human lymhoblastoid cell lines derived from B-LCL 721. By
these methods 17 class I genes were mapped in the MHC region; 11 of these were
pseudogenes, three corresponded to HLA-A, -B and -C, and the remaining clones
corresponded to HLA-E (Koller et al. 1988), HLA-G (Geraghty et al. 1987) and
HLA-F (Shimizu et al. 1988). The class I gene family located towards the telomeric
end of chromosome 6 and a rough estimate of gene density was one gene every 20kb
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(Geraghty et al. 1993; Wei et al. 1993). Lamm and Olaisen (1985) showed, by
linkage analysis with serological reagents, that HLA -A, -B and -C loci were close
together. HLA-B was most centromeric at 0.1cM from the HLA-A locus, while the
estimated genetic distance between HLA-A and HLA-C was 0.7cM. Caroll and co¬
workers (1987), who analysed PFG patterns after DNA digestion with several rare-
cutter restriction enzymes, provided evidence of the physical distance of 250kb
separating HLA-B and HLA-C. In the case of the HLA-B and HLA-C genes, locus
specific probes, derived from the 3' region of both genes were used to detect two
distinct fragments in Mu I digested DNAs. By the use of linking probes, the HLA-
B and HLA-C genes were found to be in the same transcriptional orientation on the
chromosome with the 5' end centromeric to the 3'-end. Other probes derived from
class I genes such as pl2.4 or cdal2 were used to physically map the area
surrounding the HLA-A locus: pl2.4 lies within 200kb (Pontarotti et al. 1988) and
cdal2 within 50kb (Ragoussis et al. 1989) of the HLA-A locus. These data are
consistent with the earlier observations that the majority of the 20 unidentified class
I-like genes clustered around the HLA-A gene, while the HLA-B and HLA-C genes
are isolated (Chimini et al. 1988). The overall length of the class I region according
to this data is at least 1800kb and the whole region contains approximately 20 class
I related sequences. It seems highly probable that additional genes are present in this
region. Geraghty and co-workers (1992) isolated a series of overlapping YAC
clones in order to clone and map the entire HLA class I region. Using this approach
they identified all the possible HLA class I genes in this area.
A more recent strategy has been to isolate cDNA clones of the entire coding region
from individual loci by using polymerase chain reaction amplification with
oligonucleotide primers that hybridize with sequences in the 5' and 3' untranslated
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regions (Ennis et al. 1990). The 3' flanking sequence contains a pattern of
nucleotide substitutions that are characteristic of the individual loci and could be used
to design 3' primers giving preferential amplification of either HLA-A, B or C alleles
in human (Zemmour et al. 1992).
The HLA-A, HLA-B, and HLA-C antigens are expressed on the surface of almost
all nucleated cells (Ploegh et al. 1981). In addition to functioning as strong
transplantation antigens, these molecules also play a crucial role in the presentation
of viral and tumor antigens to cytotoxic T lymphocytes (McMichael et al. 1977;
Wallace et al. 1982). Their assignment to specific alleles was made possible by
expression studies after transfection in mouse Ltk- cells (Lemonnier et al. 1982,
1983). To date, complete coding region sequences have been determined for 43
HLA-A, 89 HLA-B and 26 HLA-C alleles (Parham et al. 1995). Unlike tissue
typing for HLA-A and HLA-B, a large percentage of individuals cannot be typed for
at least one HLA-C allele using human alloantisera, perhaps because of poor cell
surface expression (Takiguchi et al. 1989; Hajek-Rosenmayr et al. 1989). Gussow
and co-workers (1987) observed poor cell surface expression in mouse L cells
transfected with cloned genomic Cwl and Cw2, genes, of about 10% of the levels
of HLA-A and HLA-B. In this regard, HLA-C is similar to the H-2Ld molecule
(Dower and Segal, 1985) which is expressed on the cell surface at levels three or
four times lower than Dd or Kd (Beck et al. 1986). This poor cell surface expression
is contributed to by inefficient assembly with (i,m and a slower rate of transport to
the cell surface (Neefjes and Ploegh, 1988), and so the importance of these molecules
in antigen presentation was considered negligible. The question of functional
significance was addressed by Dill and co-workers (1988) using HLA-Cw3 transgenic
mice. These transgenics were able to produce HLA-Cw3-restricted CTL against
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influenza and Sendai virus. Thus, one HLA-C allele has been shown to be functional
a antigen presenting molecule.
1.7 Identifying functionally important regions in class I genes
Recombinant DNA technology has been used to dissect out the functionally important
exons of class I genes by exchanging homologous exons between different class I
molecules whilst but retaining all the information necessary for correct expression.
Studies utilizing HLA hybrid genes have revealed the association of serological
epitopes with first two extracellular domains CX, and 0^ (Jordan et al. 1983). Hybrid
murine class I genes were constructed between the following gene pairs: H-2Dd, H-
2Ld (Evans et al. 1982b; Murre et al. 1984); and H-2Kd, H-2Kb (Arnold et al. 1984).
These hybrid genes were reconstructed by joining the exons encoding the leader
peptide, CX, and 0^ regions from one class I gene to the exons encoding CX,, TM and
cytoplasmic regions from a second class I gene. Functional analyses performed on
the chimeric molecules showed that the majority of the anti-H-2 monoclonal
antibodies recognized determinants that are encoded by a, and Ot, regions. Thus,
the antigenic specificity of a hybrid gene correlated with the antigenic specificity of
the product of one of the donor genes (encoding CX, and CX,) rather than the other
donor gene (encoding CX, TM and the cytoplasmic regions). While a small number
of monoclonal antibodies did recognize determinants encoded by the CX, domain,
alloreactive and self-restricted CTL predominantly detected polymorphic epitopes
within CX, and/ or 0^ but not in a, (Allen et al. 1984; Ozato et al. 1983). To test if
monoclonal antibody or CTL recogntion sites reside in a single polymorphic domain,
the leader peptide and the CX,-encoding exon from H-2Dd was joined to the a,, CX,,
TM and cytoplasmic encoding exons from H-2Ld and vice versa (Ozato et al. 1985).
Serological analyses of these constructs indicated that some antibodies recognized
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determinants residing in the oq and oq independently domains while others detected
determinants resulting from the interaction of domains oq and Gq. These observations
suggested that there were strong interactions between the domains, so that even
where a polymorphic determinant only involves a stretch of amino acids from one
domain, its conformation is dependent on other domains of the molecule. Most
allospecific and virus-specific CTL were shown to behave in a similar fashion.
Therefore, it was suggested that the polymorphic epitopes recognized by T cells are
controlled by independent domains.
1.7.1 Site-directed mutagenesis for mapping the functional important areas of class
I molecule
Class I molecules could also be altered in vitro by site-specific mutagenesis, allowing
even more detailed examination of the functionally important areas. Analysis of such
mutant H-Ld gene products lacking the disulphide bridge of the oq domain as a result
of replacing the Cys 101 with Ser, resulted in near-total destruction of the epitope
recognised by allo-specific CTLs (Shiroishi et al. 1984). Diminished reactivity with
anti-Ld monoclonal antibodies specific for the 0q domain was observed, but antibody
reactivity was retained for the a, and oq domains on the substituted gene product.
It was suggested that the disulphide bridge controls only intradomain structural
features.
A more detailed analysis of in vitro generated mutants suggested that the oq domain
also has a crucial role in the correct folding of these molecules. Site directed
mutagenesis of. Glu 227 to Lys lost CTL recognition of H-2Dd (Potter et al. 1987).
It appears that the altered residue is recognised by CD8-independent T cells but not
by CD8-dependent T cells (Potter et al. 1989). CD8 is an accessory molecule which
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is a phenotypic marker of CTL and which interacts with class I molecules during
antigen presentation.
The conclusions reached from studies on exon shuffling and mutagenesis suggest that
the interaction between the first two domains is important in generating
conformational sites detected by allogenic and restricted CTL. In summary; a) small
changes in the first or second domains can cause significant alterations in recognition
by antibodies or CTL; b) CTL recognise conformational determinants produced by
interactions of residues located at sites in the first, second and third domains of class
I heavy chain polypeptides.
1.8 MHC polymorphism
In most species studied, polymorphism in the MHC loci is extensive and has been
maintained through time (Klein, 1987). This feature of MHC molecules is central
to their role in presenting a diverse range of peptides, there by providing protection
(at the population level) against evolving pathogens. Sequence polymorphism in
MHC molecules results in differences in the detailed shape and charge distribution
in the antigen binding site, but does not significantly alter the overall structure, which
appears to be well conserved between mammalian species. The selective advantage
of polymorphism at the class I loci provides the basis for presentation of a wide
range of pathogen peptides, but the increase in the range of antigens recognised may
be offset by a reduction in the T cell repertoire (Matzinger et al. 1984). This may
account for the small number of functional class I loci (usually one, two or three)
seen in all species studied (Robinson and Kindt, 1989), although there may be
additional genes coding for less ubiquitously expressed class I molecules.
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Many questions remain about the origins of MHC polymorphism and its functional
significance. Gene conversion or non-homologous interlocus recombination, where
a unidirectional exchange of information occurs (Bregegere, 1983), has been
suggested as a mechanism for the generation of polymorphism in the MHC. For
example, a mutant allele H-2Kbml of the H-2Kb gene was cloned by Weiss et el.
(1983a), which differed in three codons and was shown to be a result of gene
conversion. The altered residues in H-2Kbml were identical to those of H-2Ld. They
proposed that H-2Ld was the donor for the gene conversion event. Unfortunately,
this gene was absent from the haplotype in which the conversion event was proposed
to have happened. However, Mellor et al. (1983) provided evidence for Q10 as the
potential donor gene for the H-2Kb to H-2Kbml gene conversion in C57BL/10. Weiss
et al. (1983b) also showed that several of the differences in nucleotide sequence
between the H-2Kb and the H-2Kd alleles could be explained by a similar gene
conversion event.
More evidence for gene conversion came from the generation of two HLA-B27
subtypes of human class I genes (Seemann et al. 1986). Comparison of class I HLA
allelic sequences gives a quite a different picture from that seen with class I H-2
alleles, in that gene conversion between different loci has made a relatively minor
contribution to polymorphism (Parham et al. 1989). Instead, it appears that
intragenic or allelic conversion is the main mechanism of generating HLA
polymorphism. Holmes and Parham (1985) observed such recombination in the
HLA-Aw69 allele, which they suggested was due to in vivo exon shuffling between
the a, domain of the HLA-Aw68 and the cx3 domain of HLA-A2. It was also
observed that positions of high variability were directly involved in peptide-binding
as defined by the structure of HLA-A2 (Bjorkman et al. 1987a).
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Another mechanism suggested for generation of the polymorphism has been gene
duplication. The variation in the number of class I genes among various mouse
strains has been suggested to be due to gene duplication. Weiss and co-workers
(1984) reported that Q region genes mainly evolved by genes duplication. By the use
of restriction mapping and hybridization they showed that the Q5, Q7 and Q9 genes
were similar to each other, and likewise that the Q6, Q8 and Q10 genes were closely
related. They suggested that each of these three genes arose as a result of gene
duplication. In addition, a great degree of similarity between the two genes in the
H-2K region and the Q6-Q7 gene pair was also seen. These results suggested that
the H-2K region was generated by translocation of the gene pair from the Q region
or vice versa.
In man, HLA-A and HLA-AR are two closely linked genes which have been
suggested to have arisen as a result of gene duplication of an ancestral gene.
Although HLA-A is a functional class I gene, but all six alleles of the HLA-AR locus
are pseudogenes due to substitution by phenylalanine of the cysteine at position 164
which forms an essential disulphide bond (Zemmour et al. 1990). In contrast to the
HLA genes, in H-2 many interallelic differences are greater than interlocus
differences, for example in some haplotypes, the class I K and D molecules of the
same haplotype differ by fewer amino acids than do different allelic forms of the K
products.
Hughes and Nei (1988) proposed that polymorphism is due to over-dominant
selection (heterozygote advantage). They compared the rate of nonsynonymous
substitution in the antigen binding site with that of the remaining amino acids in the
first two domains. They found that the rate of nonsynonymous substitution was
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much higher in the antigen binding site, while in the rest of the domain the reverse
was true. Therefore the amino acid differences between class I alleles are localised
to the functionally important areas of the molecule, and this probably accounts for
the large number of alleles in the population via heterozygote advantage. The
possession of two different alleles at a locus would have the advantage of allowing
a response to more pathogens, so that heterozygotes would have a higher fitness than
homozygotes.
An elegant explanation for MHC polymorphism has been provided by the trans-
species hypothesis of (Klein, 1987; Arden and Klein, 1982). This theory assumes
that ancestral forms of the major alleles were present before speciation. When a new
species evolved, the whole set of alleles would be passed on when there are no
drastic enviornmental changes. Additional polymorphisms would result only from
random mutations. A truly new polymorphism would only be generated by drastic
changes in the mode of life (Klein and Figueroa, 1986; Lawlor et al. 1988; Mayer
et al. 1988). Evidence for this theory is seen in the studies of Mayer et al. (1988),
who compared class I cDNA clones of chimpanzee with class I genes of man, and
found 97.8% similarity between chLA-A108 and HLA-A11. This very high degree
of similarity between species suggests that this class I allele originally arose in an
ancestor of these two species.
1.9 Non-classical class I genes
In addition to the MHC genes, which are involved in the initiation of specific
immune responses, there is a group of MHC genes whose functional status is
uncertain. The two groups are often referred to as classical and non-classical MHC
genes respectively. The term 'non-classical genes' is usually applied to the class I
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loci, but in fact some of the families of class II loci (e.g. the mammalian DM
system) also fit the description. Both human and mouse MHC regions contain a
substantial number of non-classical (class lb) class I genes. It was speculated that
many non-classical class I genes were produced by duplication of classical class I
genes and that the majority became non-functional by accumulating deleterious
mutations (Hughes and Nei, 1989; Klein and Figueroa, 1986). The mouse MHC
class lb family consists of at least 30-40 genes encoded in the H-2Q, T and M
regions whereas HLA-E, F, G, H, I and J regions have been identified for the
human non-classical antigens (Shawar et al. 1994). Genes homologous to murine
Q and T region genes have additionally been identified in the rat (Kirisits et al. 1994;
Rothermel et al. 1993). These non-classical class I molecules are characterised by
limited polymorphism, restricted tissue distribution, poor surface expression and
short cytoplasmic domains (Stroyonwski et al. 1990; Flaherty et al. 1990).
1.9.1 Non-classical class I genes in mouse
The Q and M regions in the mouse each contain about 10 class I genes, and the T
region has twice as many. The Qa-2 genes are expressed in a wide variety of tissues
(reviewed by Morse et al. 1991). The Q2, Q5 and Q10 gene products have a more
tissue-specific expression pattern. The Q4, Qa-2 and Q10 gene products can be
detected as secreted molecules. The Q5 gene in H2b haplotype has acquired a
premature termination codon in exon 3 while the corresponding gene in H2k strain
is intact (Jaulin et al. 1985; Robinson et al. 1988). It has recently been reported that
two forms of soluble Qa-2 exist- one form corresponds to the translational product
of a truncated transcript, while the second form of Qa-2 is attached to the cell surface
via a GPI (glycophosphatidylinositol) linkage and has been implicated in
transmembrane signalling (Stroynowski et al. 1990). The Q6 and Q7 gene products
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have been suggested to play a role in T cell restriction (Mann and Forman, 1988).
The T region gene products are predominantly expressed on normal thymocytes and
thymic leukaemic cells. Earlier it was thought that T genes were non-functional
(Rogers et al. 1986). However, various workers have recently reported the
expression of T region gene products in the intestinal epithelium where they have
been suggested to function as restriction elements for y5 T cells (Wu et al. 1991;
Hershberg et al. 1990; Eghtestady et al. 1992). Furthermore, cell surface expression
of a transfected Q&-1 molecule was stabilised following heat shock and by addition
of a tryptic mycobacterial digest (Imani and Soloski, 1990), suggesting a role in
peptide presentation.
The most thoroughly studied non-classical class I genes are the M region genes of
the mouse MHC (reviewed by Fischer Lindahl et al. 1991). This region of the
mouse MHC is presently known to contain 8 genes (Wang et al. 1993). H-2M3 is
the best understood example of a non-classical class I presentation element. It has
been found that H-2M3 molecules bind and present peptides with a unique structural
component of prokaryotic proteins, N-formyl methionine (Shawar et al. 1990). The
presentation of such peptides is TAP- dependent and the availability of endogenous
peptides carrying the N-formyl group limits surface display of H-2M3 on
mammalian cells (Vyas et al. 1994) suggesting that it can be expressed at high levels
only during infection by prokaryotic organisms. It has been subsequently been
demonstrated that H-2M3 can indeed present bacterial peptides to CTL during
Listeria monocytogenes infection (Pamer et al. 1992: Kurlander et al. 1992)
providing a formal proof of the involvement of this class lb antigen in the immune
response against an intracellular pathogen. Wang and colleagues have proposed that
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the HMT molecule may be considered as a neoclassical class I molecule, since its
developmental expression and pattern of cytokine induction parallel that observed for
classical class I molecules (Wang and Fisher Lindahl, 1993).
1.9.2 Non-classical class I genes in man
The human MHC was originally thought to contain only 15 class lb genes or gene
fragments. The four non-classical HLA class I loci include HLA12.4 (HLA-H,
Chorney et al. 1990), RS5 (HLA-E, Orr, 1989 ), HLA6.0 (HLA-G , Koller et al.
1989) and HLA5.4 (HLA-F, Geraghty et al. 1987, 1990).
The lack of surface expression of HLA-12.4 has been attributed to the substitution
of cysteine 164 by phenyalanine in the domain of this molecule, disrupting the
correct folding of the class I protein. Two class I sequences RS5 and HLA6.2 have
been assigned to the HLA-E locus (Koller et al. 1988). Both of these sequences have
more than 97 % homology with each other and have unique features that distinguish
HLA-E loci from all other loci reported. The sequence of the TATA box (TCTAA)
in the RS5 gene has undergone a A—>C transition at the second nucleotide (Srivastava
et al. 1985) and thus resembles the TATAA sequence found in the class I genes
(Hedley et al. 1989). This gene has also acquired a frameshift alteration in the
seventh exon, and thus encodes a shorter cytoplasmic tail of 29 amino acids. The
HLA-E transcript appears to be ubiquitously expressed at low levels in most adult
tissues and in placenta (Koller et al. 1988).
The distinguishing feature of the HLA-G locus is the presence of termination codon
at the start of the exon 6 (Koller et al. 1989). Thus, HLA-G products have only six
amino acids in their cytoplasmic tail as opposed to 29 to 32 amino acids in other
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human class I proteins. The HLA-F non-classical class I gene has a defective splice
junction. HLA-F related transcripts have been detected in B cell lines, resting T cells
and in skin cells. HLA-G expression has been found only in foetal tissue. Several
studies have reported its expression in placenta and extraplacental membranes (Ellis
et al. 1990; Kovats et al. 1990) and is assumed to be involved in materno-fetal
interactions. Shukla and co-workers (1990) also reported its presence in the foetal
eye and thymus.
Although speculations have been made for a possible role of non-classical class I
molecules, there is no strong evidence for their proper function. Klein and
colleagues have long held the view that the non-classical class I genes constitute an
evolutionary junkyard (Klein et al. 1991). They consider that these genes have no
functional significance and that they represent relics of genes once used in antigen
presentation or the products of unsuccessful attempts at producing new genes. It has
been proposed that these genes may provide a source of donor sequences for the
generation of sequence variation in classical class I genes (Lawlor et al. 1990).
Others have suggested that the non- classical class I genes may function in a manner
analogous to the classical class I molecules (Strominger, 1989; Srivastava and
Lambert, 1991).
1.10 Molecular cloning of class II genes in man and mouse
The class II products are encoded in the HLA-D region of the human MHC and
consist of 14-16 genes (Hardy et al. 1986). They were initially defined in mixed
lymphocyte cultures (MLC) using homozygous typing cells. By use of serological
techniques it soon became clear that there were several class II loci (HLA-DR, HLA-
DQ, HLA-DP). The gene products of the class II family present peptides of
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extracellular pathogens to T cell helper/inducer subsets. They are expressed on
macrophages and B lymphocytes and other professional antigen presenting cells.
Three families of class II genes have been identified in the HLA system, HLA-DP,
DQ and DR (Trowsdale et al. 1984; Okada et al. 1985), each consisting of a distinct
a and (3 chain. The number of DRB genes appears to vary between human
haplotypes (Bell et al. 1987; Bohme et al. 1985). Cosmid cloning from the three
DRB gene DR3 haplotype and the four DRB gene DR4 haplotype (Rollini et al.
1985; Spies et al. 1985) confirmed the variations m DRB gene number. The existence
of DP, DQ, and DR antigens might serve to diversify the range of immune responses
that each individual can mount. However, other class II loci might exist. The class
II region also contains a group of genes (RING3, 6, 7, 12, 4, 9, 10 and 11; Hanson
et al. 1991; Trowsdale et al. 1991; Kelly et al. 1991a) for which no clear function
was initially seen. A role also remains to be found for the DNA and DOB products,
equivalent to the non-polymorphic Oa and Ob genes in mouse (Tonnelle et al. 1985;
Karlsson et al. 1992). RING 3 is the only one of these genes remaining with
unknown function (Beck et al. 1992). RINGs 10 and 12 (LMP-2 and LMP-7
respectively) are thought to encode components of the antigen processing pathway
for class I molecules (Kelly et al. 1991b). RINGs 4 and 11 (TAP1 and TAP2
respectively) are thought to encode the transporter molecules involved in
translocating antigenic peptides into the ER lumen in order to be coupled to class I
molecules (Kelly et al. 1992). In recent nomenclature for HLA genes (Bodmer et
al. 1994), RINGs 6 and 7 have been assigned to alleles of DM genes. The DM
genes have been suggested for the correct loading of peptide onto class II molecules
(Fling et al. 1994; Morris et al. 1994; Wolf and Ploegh, 1995).
The H-2I region, on the other hand, has two defined gene families I-A and I-E. The
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I-A molecules are considered to be homologues of the molecules encoded by the
HLA-DQ genes, and I-E are homologues of HLA-DR (Widera and Flavell, 1985).
The H-2 class II region differs from the human primarily by the absence of genes
equivalent to the HLA-DP genes. There also do not appear to be homologues of
DNA, DQ2 or DQB2 genes or the human pseudogenes. No variation in number of
the class II genes has been reported between different haplotypes of mouse.
The majority of genes identified in the human MHC to date are found in the class
III region, a stretch of 1000 kilobase (kb) pairs flanked by the class II region on the
centromeric side and the class I region on telomeric side. The class III region
contains a range of tightly linked genes, some of which may be immune system
components such as the C2, C4 ,Bf and TNF genes. (Campbell and Trowsdale,
1993). The class III region genes are neither structurally nor functionally related to
class I or class II genes, and it has been suggested (Klein, 1986), that the class III
region is not a part of the MHC, but resides on the same chromosome by
coincidence.
1.11 MHC of other species
Apart from mouse, the most extensively studied rodent is rat. The organisation of
the rat MHC (RT1) is like that in the mouse. In the RT1 complex six MHC loci
have been identified A, B, D, E, G and C which are arranged in this order. The
RT1.A and RT1. E loci are classical class I loci homologous to mouse H-2D and H-
2K and human HLA-B and HLA-A loci respectively. RT1.A is the main
polymorphic locus with 12 alleles, but only two alleles have been detected for
RT1.E (Misra et al. 1985). The level of functional polymorphism of classical class
I antigens detected serologically in the rat is very low (Gill et al. 1983) whereas in
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the mouse approximately 100 alleles have been reported for the K and D loci
(Steinmetz et al. 1982b). The rat equivalent of the mouse Q/T region is called
RT1.G/C (Kunz et al. 1989). The RT1.C locus has been defined by skin graft
rejection and by serology, and it has three alleles which have been designated by the
haplotypes of strains in which they were discovered (a,l,u). The RT1.G locus has
two expressed alleles designated as a and b and a blank c allele. Several class I
genes have been mapped to the RT1.C region and most seem to be of the class lb
type (Lutz et al. 1994). Rat M genes, like the mouse M, have also been found (Gill,
1994). RT1. B and /?71.D are class II loci corresponding to mouse H-2A and H-2E
loci, respectively, and each encodes a and (3 chains.
In rat, antigens encoded by different class I genes of the same haplotype are
homologous. This has been shown in the Au and Eu antigens which are the product
of the two different loci but which differ only by 1-3% whereas the Au and A"
antigens encoded by alleles of the same gene differ by about 30% (Misra et al.
1987). This finding is significant in the light of the restricted polymorphism of the
rat MHC antigens. The RT1.A locus encodes both membrane bound (45kD) and
soluble (40kD) class I molecules. The soluble form is homologous to the murine
Q10 gene product and is generated as a result of alternative splicing which removes
the transmembrane domain (exon 5) and possibly exons 6 and 7 (Singh et al. 1988).
Rat also differs from the mouse in terms of having two major allelic forms of the
TAP2 genes, differing by 25 amino acids. Since the rat has only one major
expressed class I locus, the different TAP alleles may provide an alternative way of
diversifying the immune repertoire (Howard, 1991).
The lagomorph MHC (rabbit) shows considerable homology in gene number and
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organisation with HLA. The class I region contains between 8 and 13 genes. The
cDNA clone pR9 was isolated from the rabbit cell line RL-5 and conforms to the
typical class I structure (Tykocinski et al. 1984). A genomic class I clone has also
been sequenced (Marche et al.1985), and this clone displays the characteristic 8 exon
class I gene structure. In the class II region, DR, DP, DQ1, DQ2 and DO
homologues have been identified (LeGuern et al. 1985; Sittisombut and Knight.
1986). Rabbit DPA and DPB genes have also been sequenced and appear intact
(Sittisombut et al. 1988).
1.12 Class I MHC genes from domesticated animals
Although the MHC of man and mouse are best characterised and understood, cloning
of MHC genes from other species will provide additional insights into the
evolutionary relationships of these genes and expose any features which are atypical.
Domestically important species are particularly relevant in this type of approach
because the results of investigations of smaller animals e.g. mice, rats and rabbits,
may not always be directly applicable to the immunology of larger animals. This is
reflected in studies of MHC influence on disease resistance/susceptibility, because
each species has its own particular disease repertoire.
Ungulate MHCs have been examined in cattle, sheep, pigs and horses by the
application of Southern blotting hybridisation. All of the above species have multiple
class I hybridising sequences. A striking feature of the swine MHC (SLA) class I
region is that it contains only seven genes (Singer et al. 1988). Two swine genomic
clones PD1 and PD14 show all the features attributable to class I genes and have
been expressed in L cells (Singer et al. 1982; Satz et al. 1985). PD1 has been
introduced into mice as a transgene (Frels et al. 1985) and shown to function in graft
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rejection. Singer's group has isolated and sequenced five of the seven genes and on
the basis of sequence homology they fall into three different groups. However, there
is evidence for only two class I loci in pigs (Lunney et al. 1988).
The horse MHC (ELA) is located on chromosome 20 and contains up to 30 class I
genes (Alexander et al. 1987). Serological analysis has identified 19 specificities at
a single class I locus whereas biochemical studies of horse class I indicates that there
are at least two expressed genes (Donaldson et al. 1988). It has been also reported
that horses have soluble class I antigens in their serum (Lew et al. 1986) at levels
comparable to that of mouse Q10 (Mellor et al. 1984). Recently, Ellis and co¬
workers (1995) have reported that four class I genes are transcribed in the horse
based on the number of different sequences identified.
The sheep MHC (OLA) has been shown to contain three expressed class I genes by
cDNA cloning experiments and biochemical studies (Grossberger et al. 1990; Puri
et al. 1987). However, it is not known if all three genes are polymorphic. Like
cattle, sheep MHC class II region also contains duplicated DRB, DQA and DQB loci
(Andersson and Davies, 1994).
1.13 The bovine MHC
The bovine MHC (BoLA), is located on the short arm of chromosome 23 (Fries,
1986), and its general organisation is very similar to human. A tentative map of the
bovine MHC is shown in Fig 1.3. The map has been drawn partly on the basis of
gene order established in man, mouse and rat (Trowsdale et al. 1991) as in the cattle
the exact order of the genes has not yet been completely determined. The BoLA
complex is divided into four regions: class I; class Ha, which encodes the functional
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class II molecules; class lib, which harbours a number of class II genes whose
function is not yet known; and class III, which contains a large number of genes
several of which encode proteins of immunological function. The class I region is
the most telomeric part of the MHC and the class III region is located between class
I and class Ha. The class Ha region is tightly linked to class I region (Usinger et al.
1981; Lindberg and Andersson, 1988). The class lib region is separated from the
class Ha region by a recombination distance of approximately 17cM (Andersson et
al. 1988; Van Eijk et al. 1993). The class I, class III and class Ha loci are generally
considered as a genetic unit and are inherited en bloc.
1.13.1 Discovery of bovine class I loci
The class I antigens of bovine MHC were identified by Spooner et al. (1978) and
Amorena and Stone (1979) on the basis of the skin grafting experiments and
serology. The class I molecules in cattle have so far only been analysed by serology
using alloantisera, which are polyspecific. Class I alloantisera have been obtained
from cows (Spooner et al. 1979a; Amorena and Stone, 1982), since a maternal
immune response to paternally inherited foetal MHC antigens can occur during
pregnancy (Redman et al. 1987). However, methods more reliable for the
production of class I alloantisera are by immunization with leucocytes, or by
subcutaneous skin implantation (Spooner et al. 1978; Amorena and Stone, 1982).
Alloantisera obtained by immunization usually give higher antibody titers than sera
obtained from parous cows. The allo-antisera were tested against a panel of cells
and absorbed to reduce their cross-reactivity, and produce "operationally
monospecific" allo-antisera that are thought to recognise single BoLA specificities.
These allo-antisera, whether against class I or class II, are employed in a
microcytotoxcity assay to determine the different specificities expressed in a
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particular animal.
A series of international comparison tests conducted in five workshops using serology
typing, defined a total of 53 class I specificities which behave as alleles of a single
polymorphic class I locus (Davies et al. 1994). Twenty-seven specificities have been
assigned to the BoLA-A locus, while 26 are still classified as workshop (denoted by
"W") specificities. The assignment of the serological specificities to one locus was
based on the observation that individual animals express a maximum of two
specficities, with no evidence of recombination (Bull et al. 1989; Bernoco et al.
1991). However, a high frequency of null alleles (undefined) in many cattle breeds
shows that a considerable number of bovine MHC class I gene products have yet to
be identified. As more typing reagents become available, the antigens presently
characterised will, in a number of cases, be 'split', resulting in the detection of
epitopes which are characteristic of individual gene products. Such a splitting of A
locus antigens has been seen with the W6 specificity (Spooner and Morgan, 1981).
Marked differences in BoLA gene frequencies are seen between European breeds
(Oliver et al. 1981), and also between breeds throughout the world including the
tropics (Kemp et al. 1988). Interestingly, local specificities can be found which are
defined by sera that do not react well with the samples of other breeds, suggesting
breed-specific influences on polymorphism. It should be noted at this point that most
of the animals tested in BoLA workshop have a similar genetic Background {Bos.
taurus) with only 7.7% of the animals in the third workshop representing Bos indicus
and only 6.6% were B.taurus x B.indicus crosses (Bull et al. 1989). This, coupled
with the fact that most of alloantisera are produced in B.taurus animals, draws
attention to the possible bias that this may incur in serological studies with non-
european animals.
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The complexity of many BoLA class I reagents has stimulated considerable debate
about whether BoLA class I typing sera detect alleles at a single locus or are
haplotype-specific, and reacting with the products of more than one polymorphic
class I gene. Stear and co-workers (1982) have shown that some distinct locally-
defined antigens which were inherited together in some families, may represent the
products of a second locus. This could be for two reasons tight linkage of class I
loci may result in sera identifying haplotypes, rather than individual products. The
sera produced in cattle may also identify only the most antigenic locus.
Although alloantisera have been the basic tools for bovine class I antigen definition,
monoclonal antibodies have the advantage that they see individual epitopes and that
they can be produced in large quantities. Several monoclonal antibodies (mAbs)
detecting epitopes on class I antigens of other species have been tested with bovine
cells, but most detect non-polymorphic determinants (Brodsky et al. 1981). Only a
limited number of mAbs which define bovine class I polymorphism have been
reported (Spooner and Pinder, 1983; Teale et al. 1986 ).
The number of the expressed bovine class I loci has also been addressed using
biochemical techniques such as 1D-IEF, which has greater resolution then serology.
This method, when used with anti-HLA class I monoclonal antibodies that cross-react
with bovine class I molecules, produces multi-band patterns (2-4) from each
haplotype, some of which can be assigned to serological specificities (Joosten et al.
1988; Oliver et al. 1989; Al-Murrani et al. 1993). Each haplotypic pattern observed
was unique, but there were bands that were shared between patterns. Whether these
bands represent identical products from a particular locus or distinct products that
focus at the same pi cannot be determined at present. These IEF banding patterns
49
may reflect the expression of several bovine class I loci at the protein level. Using
1D-IEF, these investigators have identified serologically undetected (blank)
haplotypes, BoLA-A locus polymorphisms (splits) that were not resolved using the
available serological reagents, and the products of more than one expressed class I
gene. Joosten and co-workers (1992) detected subtypes of the serologically-defined
A10 specificity in African Boran cattle. The subtypes appeared to be associated with
different second locus products. Therefore, they concluded that serologically-defined
A10 haplotypes encoded at least two independent class I locus products, expressed
on normal bovine PBM. Similar subtypes have been reported for HLA-B27 and
HLA-A2 (Lopez de Castro, 1989). In the Fifth BoLA workshop, IEF typing was
included to improve and support the serological definition of class I antigens by
detecting three subtypes of the A15 (A8) serotype and two subtypes of A22 (w49)
(Davies et al. 1994).
1.13.2 Class I region
The class I region spans several hundred kilobases (kb) (Bensaid et al. 1991), and
southern blot analysis using a human class I cDNA probe indicated the presence of
multiple class I genes, possibly 20 or more (Lindberg and Andersson, 1988). There
is some uncertainty about the number of class I genes present in cattle, and little is
known concerning the number of the class I genes expressed. The presence of two
or three expressed class I genes is supported by cDNA cloning experiments (Ennis
et al. 1988; Bensaid et al. 1991; Ellis et al. 1992). The presence of at least three
expressed class I loci was supported by Garber et al. (1993), based upon comparison
of their cDNA sequences with those published previously. Recently, Garber et al.
(1994) isolated six different class I cDNAs from one heterozygous animal and
suggested the expression of at least three class I genes. However, these clones were
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not transfected to determine the number and nature of the expressed products from
this animal. Expression of more than one class I gene by a single haplotype has also
been demonstrated by the use of monoclonal antibodies. The independent nature of
two loci was demonstrated by the differential reactivity of monoclonal antibodies with
class I molecules on mouse L cells transfected with DNA from a MHC homozygous
cow (Toye et al. 1990). The cDNA clones from the same haplotype isolated by
Bensaid and co-workers (1991) were shown to be different locus products by
differential hybridization of their 3'-untranslated regions to the L cell transfectants.
The 3'-untranslated regions from these clones were also used as locus -specific
probes to map the two loci. The two genes were shown to be less than 210kb apart.
This evidence suggests that the two loci were tightly linked. To resolve the number
of expressed class I genes in cattle, it is important to combine cDNA cloning studies
with the investigation of expression of individual class I gene products by
transfection, and then to correlate the functional serological specificity with the
nucleotide sequence.
1.13.3 Class II region
Using human probes, Andersson and Rask (1988) extensively analyzed the BoLA
class II region. They concluded that this region includes homologues of the human
DR and DQ genes. In the class Ha region there is one DRA gene and three DRB
genes, one of which is highly polymorphic. In contrast to the mouse and human
MHCs, in which only the DR-like genes vary in number, in cattle the number of DQ
genes vary from two to four in different haplotypes, while the number of DR
equivalent genes appears constant. One arrangement consists of single DQA and
DQB genes, a second contains two DQA genes and a single DQB and the third has
two of each type.
51
1.13.4 Class lib region
Southern blot analysis has revealed the presence of DOB, DNA, DYA, DYB and DIB
genes (Andersson et al. 1988; Andersson and Rask, 1988). These genes do not
appear to be highly polymorphic, and there is no evidence of their expression at the
cell surface. In addition no evidence of DP-like genes has been found, which
suggests that they have either diverged considerably from their human counterparts,
or that they have been deleted, as in the mouse (Andersson and Rask, 1988).
In the class III region of cattle, only the CYP21, C4 and Bf genes have been mapped
by linkage analysis (Andersson et al. 1988; Teutsch et al. 1989, 1990).
1.14 MHC and disease association
The capacity of a given MHC molecule to bind a peptide and to form a complex is
determined by the sequence of its antigen binding site. In other words, the MHC
alleles carried by an individual will influence whether that individual can mount an
appropriate immune response to a given antigen, be it self or non-self derived.
Thus, a particular MHC allele or haplotype might confer susceptibility or resistance
to a certain infectious disease, but may be protective against other agents. MHC
polymorphism is an adequate answer for a population to the problems caused by
many diseases: some individuals will be sacrificed because they succumb to certain
agents, but the majority may survive and develop immunity. The relevance of MHC
polymorphism to the regulation of the immune response has stimulated many
researchers to study the association between disease and MHC. In man, numerous
diseases (autoimmmune, immune complex mediated and non-immune) are shown to
associate with particular HLA alleles or haplotypes (Todd et al. 1987). Some of
these HLA-associated diseases are: ankylosing spondilytis, coeliac disease, juvenile
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diabetes mellitus, Graves disease, systemic lupus erythematosus, rheumatoid
arthritis. In addition, susceptibility to typhoid, yellow fever and malaria is HLA
associated (Piazza et al. 1972, De Vries et al. 1976, 1979, 1989; Hill et al. 1991).
One reason for undertaking studies of the BoLA system is that it may provide a
means for selecting more productive or disease resistant cattle, by identifying BoLA
types which are associated with good characteristics, or selecting against those
associated with bad traits. Various associations between BoLA (mainly class I
serotypes) and a number of diseases have been reported. However, most of these
studies relied on statistical analysis and not on any immunological or biochemical
data. The first report of MHC-disease associations in cattle came from Solbu et al.
(1982), who analyzed the effect of BoLA class I polymorphism on mastitis among
cows of the Norwegian Red breed. They found that the BoLA type W2 was
associated with resistance, while wl6 was associated with susceptibility. These data
were later confirmed (Larsen et al. 1985; Solbu and Lie, 1990; Vage et al. 1992).
Other MHC disease association studies in cattle include studies on bovine leukaemia
virus (BLV) infection, bovine viral diarrhoea, endo and ectoparasite. Lewin and
Bernoco (1986) were first to provide evidence that the subclinical progression of
BLV is influenced by genes in the BoLA complex. They demonstrated that in a herd
of short horn cattle, resistance to B-cell proliferation in BLV infected cows
segregated with w4 and w7-bearing haplotypes and susceptibility with w26 bearing
haplotypes.
In addition to MHC disease associations, MHC effects on other traits like ovulation
rate, body weight and milk production have been proposed (Hines et al. 1986; Batra
et al. 1989). However, these studies indicated weak associations which were
difficult to confirm. Evidence of the involvement of MHC compatibility in
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reproduction has also been presented (Joosten et al. 1991). They hypothesised that
MHC incompatibility between dam and calf would facilitate the expulsion of the
placenta. In accordance with this class I compatibility might be associated with
retention of placenta (Joosten and Hensen, 1992).
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1.15 Aims
Most of the knowledge about the MHC of cattle (BoLA), over the first decade of its
study has come from serological studies. However, in the last few years much has
been done to employ more sensitive methods in the study of the BoLA system,
although they represent only the first steps along a long path towards a clear
understanding of the bovine MHC.
Serological studies, which represent the vast majority of investigative studies on the
BoLA system, have indicated the presence of a single highly polymorphic locus
encoding class I molecules. However, other biochemical and molecular biological
studies have indicated that the system is much more complex than is suggested by
serology alone. The main thrust of this project was to apply molecular biological
approaches to the analysis of class I genes in cattle. The aim of the project was to
dissect individual functional class I expressed products from a heterozygous animal,
class I typed as BoLA- A10/A11, by transfection and characterisation of a series of
bovine class I genomic clones. The transfected cell lines expressing individual class
I molecules were used for the characterisation of the expressed products. Lastly, in
order to determine how many different functional class I genes were expressed from
this haplotype, the nucleotide sequence coding these expressed molecules was






The chemicals used during the research for the project were supplied by Sigma
Chemical Co., Poole Dorset, UK, or Fisons Scientific Equipment, Loughborough,
UK unless stated otherwise. Radiolabeled compounds were supplied by Amersham
International PLC, Amersham, UK. Restriction endonucleases and DNA modifying
enzymes were purchased from New England Biolabs (NEB), UK or Boehringer
Mannheim, BCL, Lewes, UK. Tissue culture medium was purchased from Life
Technologies, Renfrewshire, UK. Recipes for solutions used during this project are
given in Appendix 2A and B.
2.2 Bacterial cultures
2.2.1 Bacterial growth media
The basic bacterial growth medium was Luria Bertani (LB) broth. This medium was
supplemented with the antibiotic ampicillin at 100/xg/ml for selection of transformed
cells, since all of the plasmid vectors used during this project contained the gene |3-
lactamase which confers ampicillin resistance. LB agar /plates were made with LB
+ 1.5% (w/V) bacteriological agar. These plates were used with bacteria
transformed with pBR322 derivatives. In this system, transformed cells were selected
on plates containing ampicillin. Solid or liquid NZY medium was used for
propagation of phage.
Liquid NZY broth was supplemented with 0.2% Maltose, and MgS04 was added to
20mM just before pouring the plates.
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2.2.2 Bacterial strains. E.coli strains used during this project, are given in Table 2.1












Young and Davis (1983)
The <EB0d /acAZM15 marker provides complementation of the (3-galactosidase gene
fragmention on PUC or similar vectors and, therefore, can be used to for blue/white
screening colonies on bacterial plates containing X-Gal.
2.2.3 Preparation ofplating bacteria
The host strain used for propagation of phage AEMBL3 clones was Y1088. 50ml
of broth supplemented with 0.2% maltose was inoculated with a single bacterial
colony. The culture was grown with shaking at 37°C until the culture optical density
at 600nm reached 0.5. The cells were then harvested by centrifugation at 3000rpm
for 10 minutes at room temperature. The supernatant was discarded and the cell
pellet was resuspended in 20ml of sterile 0.01M MgS04. The preparation of plating
cells was stored at 4°C and could be used up to 3 weeks.
2.3.Preparation of phage DNA
A single colony of Escherichia coli Y1088 was inoculated into 100 ml NZY broth
in a 500ml conical flask. The culture was incubated at 37°C for 5-6 hours with
vigorous shaking. The optical density (OD) was read at 600nm. Cell concentration
was calculated assuming that 1 OD 600 = 8 x 108 cells/ml (Sambrook et al. 1989).
Aliquots of 1010 cells were centrifuged at 3000rpm for 10 minutes. The supernatant
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was discarded and cells were resuspended in 3ml of phage buffer (SM Buffer). An
aliquot of 5 x 107 pfu of phage stock was adsorbed to 1010 plating cells at 37°C for
20 minutes before being added to 500ml of NZY broth, prewarmed at 37°C in a 2L
flask. The culture was vigorously shaken until lysis occurred i.e approximately after
6 hours. To induce lysis, 10ml of chloroform per 500ml of culture was added and
the culture was incubated at 37°C for 10 minutes. The lysed culture was cooled to
room temperature and DNAase and RNAase were added to final concentrations of
1/xg/ml. The lysate was left at room temperature for 30 minutes before the bacterial
debris was removed by centrifugation at 10,000rpm for 10 minutes at room
temperature. Polyethylene glycol 6000 (PEG 6000) 10% (w/v) and NaCl (1M) was
added to the supernatant which was left 4°C for at least 1 hour. The precipitated
phage was pelleted by centrifugation at 10,000 rpm for 30 minutes at 4°C. The
phage pellet was dissolved in 1.5ml of SM buffer and layered on a CsCl step
gradient comprising 1ml of 1.7g/ml CsCl, 1ml of 1.5g/ml CsCl and 0.75 ml of
1.3g/ml CsCl. The gradient was centrifuged in a Beckman Sw50 rotor for 2 hours
at 38000 rpm and 4°C. The bluish phage band was collected by puncturing the side
of the tube with a 21 gauge needle and 1ml syringe. The phage were dialysed for
two hours against two changes of lOmM Nacl, 50mM Tris HC1 pH 8.0, 30mM
MgCl2 at room temperature. The dialysed phage particles were used for the
extraction of DNA. DNA from the phage particles was extracted with an equal
volume of 1:1 v/v phenol: chloroform followed by an equal volume of chloroform
alone. Each extraction was thoroughly mixed for 10 minutes and spun at 3000rpm
for 10 minutes to separate the phases. The aqueous phase from the last extraction
was dialysed overnight against 2 x 21 of TE pH 8.0. It was then analyzed on 0.7%
agarose gel to check the size and quality of preparation. The concentration of the
DNA was estimated by spectrophotometry as described in section 2.6.5.
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2.4 Prepartion of plasmid DNA
2.4.1 Small-scale plasmid DNA minipreps
Small-scale purification of plasmid DNA was performed using Wizard Minipreps
DNA purification system (Promega). E.coli cultures containing plasmid (l-3ml) were
grown in LB medium + ampicillin (lOOpg/ml) at 37°C overnight with shaking and
1.5 ml aliquots were harvested in microfuge tubes. The cell pellets were
resuspended in 200/d of cell resuspension buffer, lysed by cell lysis solution, and
lysates were mixed by inversion and left on ice for 5 minutes. Once the cells were
disrupted, high molecular weight DNA and proteins were precipitated by addition of
200/d of neutralization solution (pH 5.0). The debris was pelleted by centrifugation
for 5 minutes. Approximately 600^1 of the supernatant was removed to fresh tubes.
To this, 1 ml aliquots of resin mix were added and mixed by inversion. The mixture
was poured into 2ml syringe barrels attached to minicolumns, and allowed to run
through by gravity. The columns were washed with 2ml 80% isopropanol, and dried
by spinning for 20 seconds at 12000rpm. The plasmid DNA was then eluted in 50/liI
of TE by spinning for 20 seconds at 12000rpm.
2.4.2 Large-scale preparation ofplasmid DNA for double stranded sequencing
The method used for preparation of plasmid DNA from 200ml cultures was
essentially the same as that described for plasmid minipreps, up to the preparation
of cell lysates except that volumes were scaled up for larger quantities. The
purification of plasmid DNA was performed using Qiagen tip 500 as per
manufacturer's instructions. The cleared lysate was loaded on pre-equilibrated
Qiagen-tips by gravity flow. The Qiagen tips were then washed with 1M NaCl wash
buffer (QC) for removal of contaminants. DNA was eluted from the Qiagen-tips
with 15ml of elution buffer (QF) 1.25M NaCl at (pH 8.5). The eluted plasmid DNA
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was precipitated with 0.7 volumes of isopropanol by centrifuging at 10000 rpm at
4°C. DNA pellets weres washed with 70% ethanol to remove traces of salt. After
briefly air drying, the purified DNA was resuspended in 100/xl of TE, and was ready
for use in transfection,sequencing and cloning.
2.5 Preparation of genomic DNA
Genomic DNA was prepared by the salt extraction method of Miller et al. (1988).
Fresh or frozen PBL (107 cells/ml), or cells from 10ml of blood, were mixed with
40-45ml lysis buffer (0.3M Sucrose, 1M Tris-HCl pH 7.5, 1M MgCl2, Triton-X-100)
in a 50ml tube, and left on ice for 10 minutes to allow the lysis of RBC's.
Remaining lymphocytes were pelleted at 2500rpm for 10 minutes at 4°C, and
resuspended in 9ml of solution B (0.5M NaCl/0.5M EDTA) after discarding the
supernatant. To this 0.5 ml of proteinase-K/SDS solution from a stock of 8mg/ml
proteinase-K, 10% SDS was then added. The mixture was incubated at 50°C
overnight. 2ml of saturated NaCl was then added to the lysate, and shaken
vigorously for 15 seconds. After centrifugation for 10 minutes at 3000rpm, the
supernatant was poured into a new tube, and volume was measured. If the
supernatant was not clear, this step was repeated. DNA was precipitated by adding
two volumes of ice cold 100% ethanol and mixing by inversion. The DNA
precipitate was removed with a pipette, washed in 70% ethanol, vacuum dried and
resuspened in TE.
2.6 Purification and quantitation of DNA
2.6.1 Gel electrophoresis ofDNA
DNA fragments were analyzed on 0.8-1.5% w/v agarose gels containing 0.5/xg/ml
ethidium bromide. TAE buffer was used when it was necessary to purify DNA from
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the gel, since TBE buffer can reduce efficiency of DNA recovery, and may inhibit
subsequent enzyme manipulation. TBE buffer was used on all other occasions.
Mini-gels generally used 1-1.5% agarose and were run at 10-12 volts/cm. Large
20cm gels were cast at 0.8% concentration and run either slowly overnight at 1-2
volts/cm or during the day at 3-6 volts/cm. Preparative gels used either ultrapure
agarose or low melting temperature agarose (Nusieve GTG, FMC, Bioproducts) at
appropriate concentration and were run overnight at l-1.5volts/cm. All samples
contained 0.2 volumes of DNA loading dye (3% Ficoll, 0.1%SDS, lOOmM
Na2EDTA pH 8.0, and 1.2mg/ml of Bromophenol Blue). Eco RI, Hin d III digested
lambda DNA markers were included on gels for size estimation.
2.6.2 Non-denaturing Acrylamide gels
All acrylamide gels (Acrylamide /N,N',-methylenebisacrylamide, 29:1) were cast as
1.0mm thick gel using BioRad gel casting apparatus. The percentage of acrylamide
was selected depending upon the sizes of fragments to be separated. These gels
were run at approximately 30 watts. Once the electrophoresis run was complete the
gels were stained with ethidium bromide at the concentration of (0.5/ug/ml in lxTBE)
for 30 minutes, and viewed by UV transillumination.
2.6.3 Purification ofDNA fragments
DNA fragments were purified from agarose gel using Spin-X tubes (Costar). Bands,
visualised by UV illumination were excised in small agarose blocks and transferred
to separate Spin-X tubes. The tubes were placed at -20°C for 30 minutes to freeze
the agarose blocks, and DNA was eluted from the agarose by spinning the tubes at
12000rpm for 20 minutes. In some cases the Wizard DNA clean-up system
(Promega) was used to purify DNA from restriction or modification reactions.
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2.6.4 Ethanol precipitation ofnucleic acids
This method is used to concentrate DNA and RNA. Ethanol precipitation of nucleic
acids involved adding 2.5-3 volumes of 100% ethanol with 0.3 volumes of 3M
sodium acetate pH 5, mixing and incubating at either -20°C or -70°C for periods of
3 hours or 30 minutes respectively. The DNA or RNA could then be recovered by
centrifugation followed by removal of the ethanol supernatant. Excess ethanol was
then evaporated either at room temperature or in a vacuum drier. The pellet was
then dissolved in the appropriate buffer and stored at either 4°C (genomic DNA
samples only), -20°C (DNA samples) or -70°C (RNA samples only).
2.6.5 Spectrophotometry analysis ofDNA and RNA samples
The concentration of DNA in a purified sample was generally estimated by running
a small aliquot on a 0.8-1.5% w/v agarose gel, and examining the intensity of the
fluorescence under UV illumination. The concentration of DNA in larger
preparations was estimated from its absorbence at a wavelength of 260nm (OD260).
An OD260 of 1.0 is roughly equivalent to 50/xg/ml double stranded DNA, or 40jag/ml
single stranded DNA or RNA. The OD260/280 ratio gave an estimate of the purity of
the sample, where a ratio of 1.8:1 indicated a sample free from significant protein
or phenol contamination (Sambrook et al. 1989).
2.7 Preparation of plasmid and insert DNA for cloning
2.7.1 Preparation ofplasmid vector for cloning
3-5/ig of plasmid vector was digested with 5-20 units of the required restriction
enzyme(s) in a total volume of 20/xl, using the manufacturer's buffer, normally for
l-3h at the recommended temperature. If the vector ends could self-ligate then they
were dephosphorylated by the addition of 1-2 units of calf intestinal phosphatase
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(CIP; Boehringer Mannheim), followed by incubation at 37°C for 30 minutes.
Inactivation of CIP was achieved by using the Wizard DNA clean-up system
(Promega). DNA was eluted in 20-30/xl of TE and analyzed by gel electrophoresis.
2.7.2 Preparation ofDNA fragments for blunt ended cloning
DNA fragments from PCR were prepared for blunt-ended cloning using T4 DNA
polymerase (Boehringer Manneheim) to "fill in" recessed 3' ends, and T4
polynucleotide kinase (New England Biolabs) to phosphorylate the 5' ends. The
DNA fragments were incubated at 37°C for 30 minutes with ATP and 10 units of
kinase in the manufacturer's buffer in a total volume of 30/xl. For the filling-in
reaction, approximately 10 units of T4 DNA polymerase were added along with
100/xm of each dNTP, and 2/d of lOx buffer to give a total volume 50/xl, and the
incubation was continued for a further 30 minutes. DNA was purified using the
Wizard Clean up system, and the DNA fragments eluted in 20/d of TE.
2.7.3 Ligation ofDNA fragments
Ligations were carried out using lOOng of vector DNA with the insert DNA present
at threefold molar excess. Ligations were generally performed in 15/jlI volumes
containing 2-4 units of T4 DNA ligase (New England Biolab) and the manufacturer's
buffer. Ligation reactions were incubated at 16°C overnight. In the case of TA
cloning of PCR products the manufacturer's instructions for ligations were followed
(Invitrogen). In addition, appropriate controls ligations were set up to assess ligase,
CIP and restriction enzyme.
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2.7.4 Transformation of ligations
Subcloning efficiency DH5a competent cells (Life Technologies) were thawed on ice,
and used as per manufacturer's instructions. Cells from 50/xl transformations were
plated out on LB + Ampicillin agar plates as described in section 2.2.1. Plates were
incubated at 37°C for 16 hours, and single colonies were picked for analysis of
plasmid DNA.
2.8 DNA Sequencing
2.8.1 Sequencing ofdouble standard templates
Prior to double stranded sequencing, the DNA template was denatured and annealed
to the sequencing primer. 3-5pig of double stranded DNA in 18/xl of H20 was
denatured by adding 2jul of 2M NaOH/2mM EDTA and incubating at room
temperature for 5 minutes. The denatured plasmid DNA was neutralised by adding
2/nl of 3M NaAcetate pH 4.5. To precipitate the DNA 2-3 volumes of 100% ethanol
were added, mixed and tube was kept at -20°C for 20 minutes. DNA was pelleted
by centrifuging at 12000rpm for 20 minutes. The pellet was washed with 70% ice
cold ethanol, dried and resuspended in l\x\ of distilled H20 and was immediately used
in annealing reactions by adding 2/xl of 5x sequenase buffer and l/il of primer (1
pmol//Lil). The annealing mixture was incubated for 2 minutes at 65°C, and then
cooled slowly to room temperature.
2.8.2 Sequencing reactions
DNA sequencing reactions were generally performed by the dideoxy chain
termination method of Sanger and co-workers (1977). Most reactions were carried
out in eppendorf tubes using the Sequenase Version 2.0 kit (USB Corporation) with
the supplied Sequenase Version 2.0 T7 DNA polymerase and a-35S dATP
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(Amersham: 3000Ci/mmol) according to the manufacturer's protocol.
2.8.3 Cycle sequencing
The sequencing of double stranded PCR products was performed using Thermal
Cycle-sequencing kit (New England Biolabs) as per manufacturer's instructions. To
improve the quality of sequence data, the PCR products were first purified by the
Wizard DNA clean-up system. This system was also used, to obtain DNA sequencing
information from regions which had a high degree of secondary structure and were
not resolved by the dideoxy chain termination method.
2.8.4 Sequencing gel electrophoresis
DNA sequencing gels were composed of 4.5% or 6% (W/V) acrylamide (29:1
acrylamide:N-N methylene bisacrylamide), 8M urea (Sigma; molecular biology
grade), in lx TBE buffer. The gel casting plates 21cm x 50cm x 0.4mm and
sequencing from BioRad Sequi-gen were used throughout with lxTBE as the running
buffer in upper and lower reservoirs. Before loading samples, excess urea was
washed out of the wells, using a needle and syringe. The sequencing samples were
denatured by heating at 85°C for 3-5 minutes, and 3/xl of each sample was loaded
onto the gel. Gels were run for 3-5 hours at 50 watts. Sequencing gels were dried
on to Whatman no. 3 paper at 80°C under vacuum on a BioRad gel drier. Gels were
exposed to AGFA Curix X-ray film for 2-4 days at room temperature.
2.8.5 Analysis ofsequence data
Sequence data was analyzed using version 7 of the University of Wisconsin Genetics




For RNA work all glassware, tubes and aqueous solutions were autoclaved. Total
RNA was isolated with RNAzol solvent (Biogenesis labs, Poole, England), using a
modified version of manufacturer's instructions. Cells were spun for 5 minutes at
lOOOOrpm and the pellet was thoroughly solubilised in 1ml of RNAzol. 100/xl
chloroform supplemented with 4% iso-amyl alcohol (Fisons) was added and the
samples vortexed for 15 seconds. The tubes were incubated for 10 minutes on ice
before spinning for 15 minutes at 14000rpm in a refrigerated microfuge at 4°C.
The upper aqueous layer (approximately 500/xl) was then removed from the tube to
a fresh sterile eppendorf tube, taking care not to transfer any of protein interface.
RNA was then precipitated by adding 800/xl ice cold 100% ethanol. The pellet was
centrifuged as before for 10 minutes, and the ethanol wash was repeated. After the
second ethanol wash, the pellet was dried under vacuum for approximately 5 minutes
before resuspension in a small volume (10-50^1) of autoclaved distilled H20. The
amount of RNA obtained was determined by spectrophotometry as described earlier.
2.9.2 RNA formaldehyde gel electrophoresis
The integrity of isolated total RNA was determined by agarose gel electrophoresis
under denaturing conditions (Sambrook et al. 1989). Gels were run using MOPS
buffer (appendix 2A). 5-10/zg of RNA in 12/xl of dHzO was prepared for
electrophoresis by adding lOx MOPS, 8/xl paraformaldehyde, 25ptl deionised
formamide and 1/zl of lOmg/ml ethidium bromide, and heating to 55°C for 15
minutes. Before loading 3/i\ of loading buffer (section 2.6.1) was added to the
samples. Formaldehyde gels were run overnight at 25 mA, and when viewed under
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UV illumination, RNA was visualised primarily as ribosomal RNA (rRNA), 18s, 12s
and 5s bands. The sharpness of the RNA bands generally indicated that total RNA
prepared was of reasonable quality.
2.9.3 cDNA synthesis
First-strand cDNA synthesis was carried out by reverse transcriptase using the
"Superscript" system (Life Technologies), following the manufacturer's instructions.
Optimally, 5/ig of RNA in 13/ul dH20 was used. The reaction was first primed by
adding 1/zl of 500/xg/ml oligo dT primer, heating to 70°C for 10 minutes and
chilling quickly on the ice. The resulting mixture, with the oligo dT bound to the
polyA tail of the mRNA, was then reverse transcribed to make cDNA by adding: 2/al
lOx synthesis buffer, 2/d 0.1M dithiothreitol (DTT), 1/d lOOmM dNTP mixture and
lfil 20IU//zl reverse transcriptase. After incubating at room temperature for 10
minutes, the mixture was incubated at 42°C for 50 minutes. The reaction was
terminated by heating to 90°C for 5 minutes and then chilling on ice for 10 minutes.
After a brief centrifugation to collect any condensation, the cDNA was either used
immediately in a PCR amplification, or stored at -20°C.
2.10 Tissue culture materials and methods
2.10.1 Cells and culture media
A mouse Ltk" fibroblast cell line (Spandidos and Wilkie 1983) was used for DNA-
mediated gene transfer of bovine MHC class I genes. The Ltk" cells were maintained
in complete tissue culture medium (Tc) comprising RPMI 1640 containing 25mM
Hepes (Life Technologies), 2mM L-glutamine (Life Technologies) supplemented with
10% foetal calf serum (FCS) (Meridian address). The cells were passaged using a
1:20 split ratio just prior to confluence (every 3 days). For transfection, cells were
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plated at about 5 X 10s cells per 25cm2 tissue culture flasks (Life Tech) 24 hours
prior to use.
2.10.2 Preparation offrozen L cells
Cells were removed from 75cm2 culture flasks just prior to confluence and pelleted
by centrifugation at lOOOrpm for 5 minutes at 4°C. The cells were counted using a
haemocytometer. The pellet was resuspended in ice cold freezing solution A (50%
FCS, 50% RPMI 1640). An equal volume of ice cold freezing solution B (20%
DMSO in FCS) was added dropwise with gentle swirling to give a final concentration
of lxlO7 cells/ml. Aliquots of 1ml in freezing vials were frozen at -70°C and then
stored under liquid nitrogen.
2.10.3 Isolation ofperipheral blood mononuclear cells (PBM)
PBM were separated from venous blood by centrifugation over ficoll-hypaque S.G.
1.077 (Lymphoprep) at 1500g for 25 minutes at room temperature. The
mononuclear cells were removed from the interface of the plasma and the ficoll-
hypaque, and washed in phosphate buffered saline pH 7.2 (PBS) by centrifugation
at 300g for 10 minutes. The cells were washed twice in PBS and once in RPMI-
1640 by spinning at lOOg for 10 minutes. Finally, the cells were resuspended in
tissue culture medium, counted and adjusted to the required cell concentration.
2.11 Generation of alloreactive cytotoxic T lymphocytes
Alloreactive cytotoxic T cell lines were generated which were specific for the BoLA
A10 and All class I antigens of donor animal from which the genomic library was
prepared. An anti-All haplotype cell line was generated using a responder animal
typed as BoLA class I A3/A10 and an anti-AlO haplotype cell line was generated
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from a responder animal typed as BoLA class I A11/A15 in an allogenic mixed
lymphocyte culture as described by (Teale et al. 1985). The responder cells were
restimulated every week with irradiated peripheral blood mononuclear cells (PBM)
from the donor animal. The CD4+ T helper cells were removed by complement-
mediated lysis with mAb IAH-CC8 (Howard et. al. 1991). The CD8+-enriched
populations were maintained as continuously-growing cell lines by weekly addition
of 10 units/ml of human recombinant IL-2 (Boehringer Mannheim), and stimulation
with irradiated PBM from the animal used to prepare the genomic library. The cell
lines were assessed with the mAb IL-A51 (Ellis et al. 1986), which is specific for
CD8+ to ensure that the cell lines were CD8+ enriched.
2.12 T cell cytotoxicity assay
The target cells were labelled with 100/rCi of 51Cr sodium chromate in RPMI-1640
at 37°C for 60 minutes with periodic mixing. A standard 4 hour chromium release
assay was performed involving the effector (CTL) and target cells in different
effector:target ratios (Teale et al. 1985; Spooner et al. 1987). Modifications were
made when using the adherent Ltk and cell lines transfected with phage 19.1 and
4.2. These cells were harvested with EDTA 16 hours before performing the
cytotoxicity assay. The cells were resuspended in medium and left in untreated
polystyrene tissue culture petri dishes (Sterlin or Corning) to which they do not
adhere. The cells were washed twice with medium immediately prior to use in the
assay (Townsend et al. 1984) This modification was made because cell death caused
by EDTA can interfere with the results. The chromium release assay was also
performed for 6 hours instead of 4 hours because fibroblasts are much less sensitive
to cytotoxic killing than PBM (Simpson and Chandler 1986). The percentage specific
51Cr release was used as a measure of target cell lysis and was calculated using the
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formula.
test release - spontaneous release x 100
% specific release =
maximum release- spontaneous release
2.13 Transfection
Plasmid and phage DNA preparations made by Qiagen columns and CsCl gradient
methods respectively, (sections 2.3 and 2.6.2) were sufficiently pure to be used for
transfection. The cationic lipid DOTAP (Boehringer Mannehim) was used for
transfecting mouse Ltk cells as per manufacturer's instructions. The DOTAP forms
unilamellar vesicles (liposomes) in aqueous solution, which spontaneously interact
with DNA to form stable complexes. These complexes adhere to the cell surface,
fuse with the cell membrane and release the DNA into the cytoplasm. Since a very
small fraction of recipient cells incorporate DNA in a manner that permits its
expression, selection techniques are required to isolate these cells. In the
experiments described here, the thymidine kinase (tk) gene of Herpes Simplex Virus
was co-transfected with the DNA into cells lacking an enodogenous tk gene. Stable
transfectants were then selected by survival in HAT medium which is toxic to
untransfected Ltk" cells. Expression of a selectable marker after co-transfection often
indicates that a cell has also been transfected with the accompanying DNA. The
transfections were carried using the following protocol: The Ltk" cells were seeded
at 5xl05 per flask one day before the transfection. 30/zl of Transfectin reagent
(DOTAP lmg/ml) was diluted to 100/u.l with HBS (20mM Hepes, 150mM NaCl, pH
7.4) in a polystyrene reaction vial. 5/rg of DNA was separately diluted to 100/u.l in
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a separate vial. The solutions were mixed and incubated for 10 minutes at room
temperature and the mixture was added to the Ltk cells in Tc medium for 3-24 hours
at 37°C, 5-10% C02. After transfection the tissue culture medium was replaced and
then incubated for a further 48-72 hours. This medium was then replaced with
selective medium containing HAT. The HAT media was replaced every 2 days
initially and every 3-4 days subsequently as the colonies developed. Transfected
cells were harvested with 0.02% EDTA (Sigma) and grown to confluence in 75cm2
flasks for further analysis by FACS for class I expression.
2.14 Flow cytometry
Samples of 107 cells were pelleted by centrifugation at lOOOrpm for 5 minutes at 4°C,
and were resuspended in 100/xl of mAb specific for the cell surface marker (1:1000)
dilution for 30 minutes. Unbound antibody was removed by three washes in ice cold
PBS. After the final wash the cell pellet was incubated with 25/xl of FITC-
conjugated anti-mouse Ig (1:250 dilution) for 30 minutes. Unbound conjugate was
washed off three times and the cells were resuspended in 200/^1 of PBS for analysis
by the FACScan cell analyser (Becton and Dickinson). A list of the various
monoclonals used for FACS analysis is given in appendix 2B.
The Lysis II programe was used for acquisition, storage and analysis of the single
colour flow cytometric parameters of the labelled cells. The cytometer
configurations were calibrated using negative control Ltk" cells stained with
appropriate mAb and the conjugates. FITC fluorescence (520nm) emission was
detected with photomultiplier tube (PMT) voltage set at 600-620mV. FITC
amplification (FL1) was logarithmic (log all 1024 channels). Forward scatter (FSC)
and side 90° scatter (SSC) amplifications were linear and set at EOO and 400
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respectively. Using FSC verses SSC dot plot, cells were live-gated for acquisition
and analysis while cell debris and dead cells were excluded.
2.15 Cell sorting by magnetic activated cell sorter (MACS)
MACS is used to separate cells in suspension according to specific cell surface
markers. The cells are labelled on their surfaces with antibodies to which
supermagnetic microbeads are coupled. After magnetic labelling, the cells are passed
through a separation column which is placed in a magnetic separator. Labelled cells
attach to the magnetized matrix in the separation column and are separated from the
unlabelled cells which flow through. The magnetic fraction can be eluted and
recovered after the removal of the column from the magnetic field. High gradient
magnetic cell separation with MACS (Miltenyi et al. 1990) was used for sorting the
cells. A total of lxlO7 cells were used for each sort. Cells were incubated with
mouse anti-bovine class I mAb IL-A88 (1:100 dilution) in cold PBS with 2% FCS
(MACS PBS buffer) for 30 minutes. The unbound antibody was washed off with
PBS. After washing, cells were labelled with IgG2a + IgG2b magnetic beads for
20 minutes at 4°C. Excess beads were washed off with MACS PBS buffer. Cells
were then passed through the separation column and were separated from the
unlabelled cells. The bound cells on the magnetic matrix in the column were eluted
after removing the column from the magnetic field. The positive cells were counted
and resuspended in HAT medium for further growth and FACS analysis.
2.16 Micro-lymphocytotoxicity testing
2.16.1 Target cells
The adherent Ltk", and transfected cells were harvested from flasks and counted
using a haemocytometer. They were resuspended in Hank's Balanced Salt Solution
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(HBSS) at a concentration of 2.5 x 105 cells/ml. Ltk- cells were the negative
controls and PBM from animal 10769 (class I BoLA type BoLA-AlO/All) provided
the positive controls.
2.16.2 Allo-antisera
The alloantisera used in this test were produced at the division of Molecular Biology,
Roslin Institute from cattle, by reciprocal skin grafting between dam and offspring
(Spooner et al., 1979a). These operationally allo-monospecific sera have been used
in the five international comparison tests carried out to date (Spooner et al. 1979b;
Annon. 1982; Bull et al. 1989; Bernoco et al. 1991; Davies et al. 1994) and have
been assigned workshop (A) specificities. The BoLA typing sera were stored
undiluted in small aliquots at -20°C or -70°C. Control negative serum, which was
selected for non-reactivity with any of the test cells, was included in the
lymphocytotoxicity test to estimate the baseline test cell viability.
2.16.3 Complement
The source of complement was pooled rabbit sera. Batches of complement were
screened for lack of inherent cytotoxicity and for potency in the micro-
lymphocytotoxicity test using test cells and antisera of known reactivity. Suitable
batches of complement were then stored at -70°C until required in the test.
2.17 Isoelectric focusing
The BoLA class I molecules were immunoprecipitated from 35S-methionine
metabolically- radiolabeled PBM having the A10/A11 specificity, and also from the
19.1 and 4.2 transfected cell lines. Cells (2xl07) were centrifuged at 250xg for 10
minutes, resuspended in 2.5ml of methionine-free medium and incubated at 37°C in
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an atmosphere of 5% C02 for 30 minutes. Radiolabelled 35S-methionine (15mCi/ml,
Amersham) was added to a concentration of 20/zCi/ml and cells were incubated
overnight under the same conditions as above.
2.17.1 Immunoprecipitation ofBoLA class I molecules
Labelled cells were centrifuged for 5 minutes at 200xg and washed once by
resuspending in 1ml PBS The sample was then transferred to an eppendorf tube and
centrifuged at 16000g for 20 sec. The pellet was resuspended in 1ml of TX114 lysis
buffer (0.5% TX114, 50mM Tris-HCl pH 7.4, 5mM MgCl2 and lmM PMSF) and
incubated on ice for 30 minutes. The cell lysate was centrifuged at 8000xg for 10
minutes at 4°C. The supernatant was transferred to a new tube and incubated at 37°C
for 4 minutes. The detergent/aqueous phase were subsequently separated by
centrifugation at 300xg for 4 minutes at 37°C and the aqueous phase was discarded.
The lower detergent phase (50jd) which contained the bulk of class I molecules was
precleared by incubating with 4^1 of normal rabbit or mouse serum and 1ml of NET
buffer (50mM Tris-HCl pH 7.4, 0.5% NP40, 150mM NaCl, 5mM EDTA and lmM
PMSF). The mixture was incubated on ice for 30 minutes, followed by addition of
75/xl "Pansorbin" (Calbiochem, 10% cell suspension of Staphylococcus aureus) and
again incubated for 15 min on ice. The samples were then centrifuged and the
supernatant was transferred to a fresh tube. The last preclearing step was repeated.
For each immunoprecipatation 330/xl of labelled precleared lysate and was incubated
with 5/xl of MHC class I-specific mAb (ascitic fluid) on ice for 75 minutes. The
MHC class I/antibody complexes were subsequently precipitated by incubating with
100/xl of Pansorbin cells on ice for 30 minutes. Preparations were then centrifuged
at 8000xg for 4 minutes, and the supernatant was discarded. The pellet was washed
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four times in 0.5ml NET buffer. After the final wash, the pellet was resuspended
in 100/zl of lU/ml neuraminidase in 50mM sodium acetate, pH 5.5 containing
154mM NaCl and 9mM CaCl2 (Behring) and incubated at 37°C overnight. A further
0.1U of neuraminidase was added and the incubation was continued for an additional
6hrs. The supernatant was removed and 35/xl of sample buffer added. The IEF
sample buffer contained 9.5M urea, 2% ampholine pEl range 3.5-10, 2% NP40 and
5% 2-mercaptoethanol. Samples were incubated at 37°C for 30 minutes prior to
application to the gel.
2.17.2 ID-isoelectric focusing gel
1D-IEF was performed using 20x20cm slab gel in a BioRad protein II system. The
composition of the gel was 2% NP-40, 4.5% polyacrylamide, 9M urea, and 1% (v/v)
ampholyte (Sigma). Before running the sample, wells were rinsed with dH20. The
bottom reservoir of the IEF apparatus was filled with 20mM H3P04 and top reservior
contained 50mM NaOH. The samples were centrifuged at 8000xg for 4 minutes, and
loaded on to the gel. The samples were overlaid with 8-10/xl of overlay buffer (1:3
dilution of IEF buffer containing 0.1% of bromophenol blue). Gels were run with
a voltage gradient of 400V-900V until equilibration (overnight). The gels were then
removed and treated with DMSO and DMSO/PPO. The banding patterns were
visualised by fluorography by incubating -70°C for 7 days.
2.18 Polymerase chain reaction (PCR)
PCR reactions were carried out in 50/xl or lOO/il volumes in sterile 0.5ml tubes. The
basic PCR components were as follows: lxPCR buffer (50mM KC1, lOmM Tris
HC1 pH 8.3, 1.5mM MgCl2); 200/dVI of each dNTP (Pharmacia); 25pmoles of each
primer; and 2.5 units of Thermus aquaticus. (Taq) DNA polymerase (Life Tech) and
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DNA template. For certain applications which required the amplification of larger
sized PCR products, and also to ensure the accuracy of replication (fidelity),
thermostable proof-reading DNA polymerases such as Deep Vent DNA polymerase
was used. The reaction buffer (lx) for Deep Vent DNA polymerase (New England
Biolabs) contained lOmM KC1, lOmM (NH4)2S04, 20mM Tris-HCl (pH 8.8), 2mM
MgS04 and 0.1% Triton X-100. Deep Vent DNA polymerase was used in
combination with Taq DNA polymerase at a 1:10 ratio for extended PCR. These
reactions were carried out in Deep Vent PCR buffer. When all the reaction
components were assembled, a mineral oil overlay was added and cycling carried out
as described, using either a Techne Programmable or Hybaid-Omnigene thermal
cycler. Following PCR amplification, 10% of the product was analyzed by gel
electrophoresis, as described in section 2.6.1.
The primers used for PCR were synthesized by Oswel DNA services (Dept.of
Chemistry, Kings Buildings, Edinburgh) and their sequences are given in appendix.
Typically, PCR primers were 18-24 nucleotides in length and approximately 50% GC
so that both primers in a reaction had similar annealing temperatures. Primers
sequences were selected to avoid 3' end complementarity which would lead to the
formation of primer-dimers (Rolf et al. 1992). Primers sequences were checked for
specificity for only bovine class I sequences using the GCG program FASTA.
2.18.1 Polymerase chain reaction for screening ofrecombinant colonies.
Recombinant plasmids in bacterial cells were analyzed directly by PCR by the
method of Hawker and Billadello (1993). A bacterial colony on a sterile pipette tip
or ljul from an overnight culture was used to inoculate lOO/xl sterile distilled water.
The sample was boiled for 1 minute and chilled on ice for 5 minutes. 80/rl was
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withdrawn and added to 20/xl containing: PCR buffer, 1.5mM MgCl2; 200/xM
deoxyribonucleoside triphosphates (dNTPs); 25pmol of each PCR primer; and 2.5
units of Taq DNA Polymerase (Life Technologies). The samples were subjected to
PCR in a DNA Thermal Cycler (Technc). The PCR program used an initial
denaturation step consisting of 1 cycle of 94°C for 5 minutes, 55°C for 4 minutes and
72°C for 4 minutes followed by 25 cycles of 94°C for 1 minute, 55°C for 2 min and
72°C for 4 min. After PCR, 15^1 of each reaction were subjected to electrophoresis
on 1.5% agarose gels.
2.18.2 PCR primers
The primers used for the PCR amplification of class I gene fragments and for the















The following ambiguity codes represent mixed-base positions in the primer
sequences: S, G or C; M, A or C; Y, C or T; W, A or T; K, G or T; B, G or T or
C; D G or A or T; R, A or G.
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Chapter 3
PURIFICATION AND CHARACTERISATION OF PHAGE CLONES
3.1 Background
As part of previous work done in our laboratory, fifteen bovine class I genomic
clones had been isolated (Hasima, 1992). These clones were isolated from a
genomic library prepared in the lambda vector EMBL-3 using peripheral blood
mononuclear cell (PBM) DNA from an animal with the BoLA-AlO, and All
serotypes. The 15 clones selected from the library hybridised with both 5'-end and
3'-end probes from the bovine MHC class I cDNA clone pBoLA-1 (Brown et al.
1989), and were considered candidates for full length genes. These clones were
transfected into mouse L-cells by calcium phosphate mediated transfection (Hasima,
1992), as described by (Wigler et al. 1979), with the thymidine kinase (tk) gene as
selectable marker.
Only one clone, 19.1, showed significant levels of expression of a BoLA class I
product. This clone was characterised by restriction mapping, and by serological and
biochemical methods. The transfected cell line was shown to express a bovine class
I molecule with All specificity. The remaining 14 uncharacterised clones potentially
represented both the A10 and All specificities. One possible reason for the lack of
expression in these clones was that all fifteen had been accidentally contaminated
with wild type lambda (Hasima, 1992), and the transfected DNA contain only a small
proportion of class I DNA from the phage clones. So, the initial part of this project
was to plaque purify each of the (class I) phage clones and to transfect the DNA
from different phage clones to characterise functional class I products.
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3.2 Plaque purification of phage clones
A PCR screening protocol developed by Mason (1992) was used for purification of
plaques, instead of conventional methods of screening by hybridisation with specific
probes.
3.2.1 Screening of individual plaques for class I sequences by PCR
Plaque assays were done on all phage stocks from the 15 clones (1.3, 4.2, 5.2, 6.3,
7.1, 7.2, 7.3, 14.2, 14.3a, 15.2, 17.3x, 17.3y, 18.16, 18.3b and 19.1) isolated by
Hasima (1992) as described in section 2.3. Ten individual plaques from each assay
were picked for screening of each clone. The single plaques were eluted overnight
in 300jid of SM (Phage buffer). 100/d of eluted phage was precipitated by adding
20pi of phage precipitant (20% PEG, 2.5M NaCl) and left overnight at 4°C.
Samples were spun at 14000 rpm for 20 minutes and the supernatant was removed
carefully. The phage pellets were resuspended in 20pl of water and then transferred
to PCR tubes.
3.2.2 PCR amplification of class I gene exon 2 and exon 7 sequences
PCR primers for amplification of exon 2 (770, 771) and exon 7 (773, 772) as given
in section 2.18.2 were designed from conserved regions of the published bovine
cDNA sequences (Ennis et al. 1988; Brown et al. 1989; Bensaid et al. 1991; Garber
et al 1993). The PCR mixture was assembled as described in section 2.18. Cycle
conditions for PCR amplification were: denaturation for 90 sec at 94°C followed by
25 cycles of 30s at 94°C, 30s at 55°C and 30s at 72°C. The final extension time was
2 minutes 72°C. Following exon 2-specific PCR amplification, plaques with a class
I insert gave a product of 270 bases (Fig 3.1). Positive plaques were further
screened using exon 7 primers to give a product of 200 bases (Fig 3.2).
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Fig. 3.1 PCR amplification of the 270bp exon 2 fragment from single phage plaques
containing class I genes, analysed by gel electrophoresis. Lanes 1 to 10 represent
the amplification products from single plaques of phage clone 15.2. Lanes 11 to 19
are single plaque amplifications from clone 1.3.
Fig. 3.2 PCR amplification of the 200bp fragment from exon 7 to 8 from individual
plaques analysed by gel electrophoresis. Lanes 1 to 10 represent plaques from
clone 4.2 and lanes 11 to 19 are plaques from clone 17.3x.
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Despite high degree of contamination, 2-3 class I -positives plaques were identified
from each clone. However, no positives plaques were found from clone 7.1.
3.2.3 Selection of different clones from exon 2 sequences
Once the various phage clones were purified, the next stage was to determine how
many different genes were represented by the 15 clones. The quickest way to
differentiate the clones was to directly sequence the PCR-amplified polymorphic
exon 2 by cycle sequencing as described in section 2.8.3. This avoided the need to
subclone the PCR products for sequencing. Cycle sequencing of PCR amplified
exon 2 fragments gave a high background so that very long reads from the gels were
not possible. However, the small area of exon 2 sequence which was readable was
sufficient to show differences among the phage clones (Fig 3.3). When the exon 2
sequences from the different clones were compared, at least three different sequences
were found. The three groups which shared readable exon 2 sequence are
summarised in Table 3.1.









Table 3.1: Three groups of phage clones which were similar in exon 2 sequence.
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L A T . . . .
; G-A-C-G-AA GTG G
>1 G-A-C-G-AA- - GTG G
>2 G-A-C-G-AA GTG ..
3A G-A-C-G-AA
5X G-A-C-G-AA
3.3 Alignment of exon 2 sequences from the fourteen genomic class I clones, obtained by the
j sequencing of the exon 2 PCR product. Dashes (-) indicate homology with the 19.1 sequence
reas dots (.) indicates unbreakable areas of the sequence. The second decimal digit of clone
;ates the plaque number.
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Further, when comparative gels were run with A, G, C and T lanes from different
clones side by side visible differences were seen between the apparently identical 4.2
and 15.2 clones in regions of the gel from which clear sequence could not be read
(Fig 3.4).
3.3 Amplification of class I genes from genomic clones
Six lambda clones (1.3, 4.2, 15.2, 17.3x, 18.3b and 19.1) were selected for further
study based on exon 2 differences. Although the clone 18.3b looked similar to 19.1
in comparative runs of A, G, C and T, due to lack of exon 2 sequence for
comparison it was included in this experiment for further analysis. To ease the
characterisation of the clones, a fragment spanning the exon 2-exon 8 fragment was
amplified from phage DNA using 5'-end forward primer for exon 2 (770) and the
3'-end reverse primer for exon 8 (772) as described earlier. PCR conditions used
were slightly modified for amplification of the larger sized fragments: 90s at 94°C
for denaturation, followed by 30 cycles of 30s at 94°C, 30s at 60°C and 2 minutes
at 72°C with the final extension time 5 minutes at 72°C. The amount of Taq DNA
polymerase was also increased from 1 unit to 2.5 units per reaction. All six clones
selected for further characterisation gave a product of 3.2kb using the above primers
(Fig 3.5a).
3.4 Characterisation of the exon 2-exon 8 fragments
The 3.2kb fragment amplified from the different clones were digested with six
restriction enzymes in attempts to further characterise the different clones. Aliquots
of 5/xl of the amplified product were digested with the restriction enzymes Sma I, Sac
I, and Rsa I for 3 hours using protocol recommended by the manufacturer. The
digestion products were resolved on 1% agarose for Sac I and Sma I or 6%
Acrylamide gels for Rsa I as shown in (Fig 3.5b and 3.5c).
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Fig. 3.4 Comparative sequence analysis of purified class I exon 2 PCR products.
Clone names are given above each set of A, G, C, T sequence track.
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Fig. 3.5a PCR amplification of a 3.2kb exon 2 - exon 8 fragment from the six phage
clones (Lane 2 to Lane 7) using primers 770 and 772. 10% of each PCR product
was analysed by gel electrophorsis on a 0.75% agarose gel. The molecular weight
markers (lkb ladder) are shown in lane 1.
Lane 2: clone 1.3
Lane 3: clone 4.2
Lane 4: clone 15.2
Lane 5: clone 17.3x
Lane 6: clone 18.3b








Fig. 3.5 b and c Restriction digests of the 3.2kb amplified PCR fragment from
phage clones 1.3, 4.2, 15.2, 17.3x, 18.3b and 19.1 with Sma I, Sac I and Rsa I.
Sma I and Sac I digests were analysed on 0.75% agarose gel. Rsa I digests were run
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In the Sma I digests clones 1.3, 4.2 and 15.2 shared a band of 2.1kb (Fig 3.5b).
However, clone 1.3 had another band of 900bp while in clones 4.2 and 15.2 this
band was split into two bands of 600bp and 300bp. Both 19.1 and 18.3b shared
bands of 600bp and 300bp with top band of a smaller size compared to 4.2 and 15.2.
In Sac I digestion four clones (4.2, 15.2, 18.3b and 19.1) had similar restriction
patterns, 1.3 did not cut and 17.3x showed a different pattern from all of other
clones. All of the clones generated different restriction pattern with Rsa I except
18.3b which had a 19.1- like pattern. These results indicated that five clones (1.3,
4.2, 15.2, 17.3x and 19.1) were different patterns with one or more enzymes.
Clones 19.1 and 18.3b were found to have similar restriction patterns with all of the
enzymes used, so 18.3b was not included in above group for further analysis.
3.5 Discussion
In order to screen plaques for class I genes, primers were designed specifically for
exon 2 and the exon 8/3'-untranslated region. Primers sites were chosen based on
regions conserved in all of the published BoLA cDNA sequences (Ennis et al. 1988;
Brown et al. 1989; Bensaid et al. 1991 and Garber et al. 1993), thus maximizing the
chance of amplifying class I sequences in genomic clones. The primers were located
at the furthest ends of the genes for which complete sequence data were available,
and plaques which gave a positive amplification product with both sets of primers
gave further evidence of the completeness of the clones. The five clones chosen for
further study all gave a product of 3.2kb on amplification of the class I exon 2-exon
8 fragment. This fragment size is in accord with the published data, as the size of
class I genes in swine, mouse and man range from 3.6kb to 5kb (Satz et al. 1985;
Strachan et al. 1984; Weiss et al. 1985 and Isamat et al. 1990). Furthermore,
digestion of the 3.2kb PCR fragments from these genomic clones with six selected
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restriction enzymes generated unique restriction patterns for each clone. There is
growing evidence that more than one loci are expressed in cattle (Garber et al. 1993;
1994; Al-Murrani et al. 1994). In order to investigate the expression and function
of the individual class I products encoded by these clones, purified phage DNA was




TRANSFECTION OF BOVINE CLASS I GENOMIC CLONES
4.1 Introduction
Transfection of cloned genes encoding products with immunological relevance, such
as major histocompatibility antigens has provided important information on the
structure, function and gene regulation of these molecules. This experimental system
has been used to identify functional MHC class I molecules of swine, murine, ovine
and human origin in mouse L cells (Singer et al. 1982; Goodenow et al. 1982; Evans
et al. 1982a; Lemonnier et al. 1982). In the bovine genome there is evidence for a
large number of class I genes (at least 10) from southern blot analysis using a human
class I cDNA probe (Lindberg and Andersson, 1988). In contrast, the use of bovine
allo-antisera in a lymphocyte micro-cytotoxicity assay (Spooner et al. 1979a)
suggests that a single highly polymorphic class I product is expressed by the BoLA
system. The actual number of expressed MHC class I genes in cattle is as yet
unknown. Biochemical and cDNA cloning experiments, however, suggest the
presence of two or three expressed class I genes in cattle (Ennis et al. 1988; Bensaid
et al. 1991; Ellis et al. 1992; Al-Murrani et al. 1993, 1994; Garber et al. 1993,
1994). Because of the lack of availability of amino acid sequence data corresponding
to each of the serologically defined BoLA class I specificities, the identification of
genes encoding each of the corresponding molecules has to rely on transfection
experiments. Shotgun transfection and expression of bovine class I molecules has
been described previously (Toye et al. 1990), but the genes involved were not
isolated. In order to investigate the expression and function of individual class I
locus products, transfection and characterisation of a series of BoLA class I genomic
clones isolated from a single animal was performed. The selection of the class I
clones described in this chapter, and the transfection of one clone (19.1), was the
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subject of a previous study (Hasima, 1992).
The murine L cell has been the most commonly used recipient for studies on the
function and expression of transfected genes encoding murine and human class I
antigens. Most, but not all anti-HLA monomorphic and polymorphic monoclonal
antibodies detect HLA/mouse heavy chain f^m hybrid molecules (Malissen, 1986).
It has been shown that heterologous association between mouse (\m and HLA class
I heavy chain is sufficient for cell surface expression (Brodsky and Parham, 1982).
Various workers have also shown that free f^m can exchange with (\m associated
with heavy chains expressed on the cell surface (Kefford et al. 1984; Bernabeu et al.
1984). However, the failure of expression of HLA-B27 at the L cell surface after
transfection was due to the inability of the HLA-B27 gene product to interact with
murine f^m (Rein et al. 1987). When the HLA-B27 gene was transfected into L cells
containing the human [\m gene, expression was detected. The production of L cell
transfectants, and in vitro mutagenesis of class I genes provide important tools in
location of determinants on class I molecules which are recognised by antibodies and
cytotoxic T cells.
4.2 Transfection of class I-positive phage clones
A wide of variety of transfection techniques have been described:
i) Polycations (Kawai and Nishizawa, 1984);
ii) Calcium phosphate (Graham and Van der Eb, 1973);
iii) Liposome fusion (Cudd and Nicolau, 1984);
iv) Addition of DNA via electroporation (Neumann et al. 1982);
v) Transfection with viral vectors (Sudgen et al. 1985);
vi) Micro-injection (Capecchi et al. 1980);
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However, all of these methods suffer from one or more problems related to either
cellular cytotoxicity, inconvenience or inefficiency of DNA delivery. During this
project we used a cationic lipid (DOTAP) that forms liposomes which interact with
tissue culture cells to facilitate delivery of functional DNA. Liposomes are
relatively non-toxic, and yield 5-100 fold higher transfection efficiencies than either
calcium phosphate or DEAE dextran methods (Feigner et al. 1987). Phage DNA,
prepared by CsCl step gradient purification (section 2.3) from the five clones 1.3,
4.2, 15.2, 17.3x and 19.1, was transfected in mouse Ltk" cells as described in section
2.13.
4.2.1 Optimization ofrelative dose ofphage DNA andpTK marker
Since the total quantity of DNA transfected in the DOTAP method is 5/ig, as per
manufacturer's instructions (section 2.13), a preliminary experiment was designed
to optimize the dose of clone DNA and marker (pTK) for the maximum level of class
I gene expression. This was done using the phage clone 19.1 which had previously
shown to express BoLA-Al 1 specificity on transfection.
Four different combinations of 19.1 phage DNA and marker pTK were used as
follows:
19.1 (4Mg)+ pTK (lyrtg); 19.1(3Mg)+ pTK (2/xg); 19.1 (2/ig) + pTK (3Mg ); and
19.1 (1/xg) + pTK (4/xg). The transfections were carried using the protocol described
in section 2.13.
Results of the dose titration are summarised in Table 4.1 :
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19.1 pTK Number of HAT Expression of clone
DNA resistant colonies 19.1 (%)
l|"g 4/*g >1000 2.8
2^g 3/xg >750 5
3/*g 2^g >400 6.2
4^g li"g >125 17.8
Table 4.1 Transfection efficiency and class I expression of different doses of clone
19.1 and pTK.
The results illustrated in the table indicate that the maximum level of class I product
expression (17.8%) for clone 19.1 was obtained when 4/rg of 19.1 phage DNA and
lyng of pTK was used for transfection (Fig 4.1). Interestingly, the number of HAT
resistant colonies was lowest at this phage: pTK ratio. All the transfection
experiments carried out during this project were done using this optimised ratio of
4/rg of class I-carrying phage or plasmid DNA to lfxg of pTK marker.
4.2.2 Analysis of transfected mouse L cell lines
The phage clones (1.3, 4.2, 15.2, 17.3x and 19.1) characterised by their exon 2
sequences and by restriction analysis of the amplified 3.2kb class I gene fragment,
were transfected into mouse L cells, using the DOTAP protocol with the optimum
ratio of 4/xg phage DNA to 1/ig pTK. After 2 to 3 weeks, HAT resistant colonies
were analysed for BoLA class I expression by using class I-specific monoclonal
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Fig. 4.1 Histogram Fluorescence-activated cell scan (FACS) analysis of bovine class
I molecules on the surface of L cells transfected with different relative doses of 19.1
phage DNA and pTK marker. The cells were labelled with murine monoclonal
antibody specific for a non-polymorphic determinant on bovine MHC class I products
(IL-A88). Different amounts of phage DNA transfected are shown by different
colours.
Red : Ltk"; Royal Blue : 1/xg ; Green : 2/ig; Black : 3/*g; Turquoise Blue : 4jug.
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antibodies: Anti HLA mAb W6/32 and anti BoLA class I mAb IL-A88 in flow
cytometry section 2.14. Neither W6/32 nor IL-A88 cross-reacted in this test with
murine class I antigens expressed by the L cells. Of the five clones transfected, only
19.1 and 4.2 showed expression at the L-cell surface. The phage clone 19.1 which
had been previously shown to express a bovine class I molecule with All specificity
(Hasima, 1992) served as a control in this experiment. Clone 4.2 showed 7.6% of
cells expressing bovine class I molecules on their cell surface when subjected to
FACScan analysis with IL-A88 (Fig 4.2), while clone 19.1 showed 17.8% cells
positive for class I expression in (Fig 4.1). The other three clones (1.3, 15.2 and
17.3x) did not show any significant class I expression. The cells transfected by
these three clones were nevertheless sorted by MACS in case a very small population
of class I expressing cells could be isolated. However, no class I expression was
detected even after MACS sorting of these cells. The 19.1 and 4.2 transfected cell
lines were enriched over five rounds of sorting and expansion in culture to increase
the proportion of cells expressing class I up to 80% (Fig 4.2). In addition, the
transfectant were routinely MACS sorted so that most experiments were done with
a expression level of between 70 and 80%.
4.3 Characterisation of the clone 4.2 transfected cell line
The bovine class I product expressed on the 4.2 transfected cells was characterised
by flow cytometry analysis, BoLA class I typing by a micro-lymphocytotoxicity
assay (Spooner et al. 1979a), T cell cytotoxicity assays (Teale et al. 1985) and iso¬
electric focusing (Joosten et al. 1988). The 19.1 transfectant cell line had been
previously characterised by all of these methods and had been shown to express an
Al 1-specific BoLA class I product. Therefore the 19.1 transfected cell line was used
as a control in the characterisation of the 4.2 expressed product.
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Fig. 4.2 Histogram FACS analysis of progressive sorting for class I expression of
mouse Ltk" cells transfected with DNA from the 4.2 phage.
The figure show the relative fluorescence of transfected cell populations stained with
IL-A88 at different stages of sorting, represented by different coloured peaks in the
histogram.
Red : pTk; Royal Blue : Primary transfection; Green : First sort; Black : Second
sort; Turquoise Blue : Third sort; Pink : Fourth sort; and Yellow : Fifth sort.
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in the characterisation of the 4.2 expressed product.
4.3.1 Screening of the 4.2 transfected cell line with BoLA AlO-specific monoclonal
antibodies
Since mAbs for one of the haplotypes on the cloned animal were available, the 4.2
transfected cell line was first analysed using a group of AlO-specific mAbs. Three
AlO-specific mAbs (IL-A7, IL-A10 and IL-A34; Toye et al. 1990) were used in flow
cytometry experiments to determine whether the product expressed by the 4.2 gene
had A10 specificity. All three mAbs recognised A10 serotype PBM (Fig 4.3), but
failed to recognise the product expressed on 4.2 transfected cells.
4.3.2 Mcro-lymphocytotoxicity assay
To identify the expressed product on the 4.2 transfectant, the micro-
lymphocytotoxicity assay described in section 2.16 was used with specific allo-
antisera routinely used to define the A10 and All specificities (Davies et al. 1994).
The 4.2 transfected cells were lysed with three of the four All allo-antisera used
(Table 4.2). Control L cells were not killed with any of the All sera, and neither
control nor transfected L cells were killed with sera defining the A10 specificity.
The 19.1 transfected cell line was lysed with all four All-specific allo-antisera. The
killing of the transfected cell lines was observed at higher concentrations of allo-
antisera than normal cattle PBM. The results are summarised in Table 4.2.
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Fig. 4.3 FACS analysis of PBM from animal 10769 (BoLA-AlO, All) (A) with
BoLA-AlO specific mAb IL-A7, (B) the BoLA-AlO specific mAb IL-A10, (C) the
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All A10
Cells Ed 73 Ed 76 Ed 102 Ed 110 Ed 69 Ed 71
PBM + + + + + +
Ltk" - - - - - -
Ltk 4.2 + + - + - -
Ltk 19.1 + + + + - -
Table 4.2: Results of micro-lymphocytotoxicity assay
4.3.3 Tcell cytotoxicity assay
A close correlation has been established between serologically defined BoLA
specificities and the activity of allospecific T cells (Teale et al. 1985; Spooner et al.
1987). Functional analysis of the product expressed on clone 4.2 transfected cells
was performed using anti-All and anti-AlO allo-reactive cytotoxic T lymphocytes
(CTL) as described in section 2.12. In this assay the 19.1 transfected cell line which
expressed All specificity was used as a control. The All-specific CTL line killed
PBM with All specificity and both the 19.1 and 4.2 transfected cell lines in the same
manner (Fig 4.4), whereas neither the 19.1 or 4.2 transfected cell lines were lysed
by the AlO-specific CTL line. The control L cells were not killed by either CTL
line. This result further supported the findings that both the 19.1 and 4.2 gene
products expressed All specificity.
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Fig. 4.4 BoLA class I-specific 51Cr-release cytotoxicity assay of clone 19.1 and 4.2 -
transfected cells with A) anti A-ll specific and B) anti-AlO specific CTL. The panel
of target cells as follow:
o T.annulata from the donor animal, 10769, BoLA A10/A11
■ 10795 PBM, BoLA All/20
a 10812 PBM, BoLA A10/A31
a Clone 19.1 transfceted L-cells
□ Clone 4.2 transfected L-cells
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4.3.4 Isoelectric focusing of the clone 4.2 gene product
W6/32 (IgG2a) was used for immuno-precipitation of BoLA molecules from 19.1
and 4.2 transfected cells, and from All PBM, as previously described (Joosten et
al. 1988). W6/32 recognises a conserved epitope present on BoLA molecules
(Brodsky et al. 1981), which is dependent upon the association of jS2m (Parham et
al. 1979; Jefferies and MacPherson, 1987). The banding pattern of the PBM
contained several charge variants (Fig 4.5) as described earlier (Al-Murrani et al.
1994), a number of which are associated with the Al 1 haplotype. Both the 19.1 and
4.2 transfectants showed a single band which had the same iso-electric point and
corresponded with one All-specific band observed on PBM, which was not seen in
the control Ltk" cells (Fig 4.5). The difference in the intensity of the band derived
from the transfected cells and PBM may be due to variation in the level of the
expression of transfected gene. By all of the above methods the 4.2 expressed
product could not to be discriminated from the 19.1 product. Although with 1D-IEF
it was expected to see a difference in the mobility of the 19.1 and 4.2 transfectant
bands, as both these genes had different sequences in exon 2. These results required
further investigation of the transfected cell lines to ensure that they contained the
proper DNA.
4.3.5 PCR amplification of exon 2 from genomic DNA of the 4.2 and 19.1
transfected cell lines
In order to determine whether the 19.1 and 4.2 transfected cell lines contained the
proper DNA, PCR amplification of exon 2 was performed on genomic DNA
extracted from the 19.1 and 4.2 transfected cell lines as described in section 2.7 and
3.3. The exon 2 PCR products were TA subcloned and four TA clones from each
transfectant were assayed for the presence of the diagnostic Kpn I site which was
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Fig. 4.5 Isoelectric focusing of class I antigens. The gel shows 35S-labelled
molecules immuno-precipitated with anti-HLA class I monoclonal antibody W6/32
which recognises a monomorphic determinant on class I heavy chain associated with
fW
Lane 1 : PBM from animal with BoLA-AlO/All class I specificity. Arrow indicates
All specific bands.
Lane 2 : L cells transfected with 19.1 phage DNA.
Lane 3 : L cells transfected with 19.1 reconstructed plasmid pBoLA-25.
Lane 4- L cells tranfected with 4.2 phage DNA.
Lane 5 : Ltk" control, untransfected cells.
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known to be present in exon 2 sequence of clone 4.2 but not 19.1 (Fig 3.3). All
four TA clones from the 4.2 transfectant could be digested with Kpn I to give
fragments of 204 and 66bp from exon 2, but the fragment amplified from the 19.1
transfected cells did not cut with Kpn I (Fig 4.6). Furthermore, partial sequencing
of the exon 2 TA clones demonstrated that the 19.1 exon 2 clones looked like 19.1
and the 4.2 exon 2 clones looked like the 4.2 phage sequence.
4.4 Discussion
The cell surface expression of BoLA class I molecules by transfected cell lines was
revealed by flow cytometry analysis with IL-A88. Micro-lymphocytotoxicity results
showed that both the 19.1 and 4.2 transfected cell lines expressed BoLA-All
specificity. However, lysis of the transfected cell lines was observed either at
undiluted or 1:2 dilution of allo-antisera and with a significantly longer incubation
than PBM, suggesting that the degree of expression of the transfected gene was much
reduced, or that L cells are more robust than cattle PBM. Three All-specific allo-
antisera used in the micro-lymphocytotoxicity assay lysed the 4.2 transfected cells,
but the 19.1 transfected cells were lysed with all four anti-All allo-antisera. In
previous experiments the Ed76 allo-antiserum was found not to lyse the 19.1
transfected cell line (Sawhney et al. 1995). These variations in results both within
and between the transfected cell lines could be due to variations between stocks of
antisera, or might reflect variable BoLA class I product expression on the transfected
cells. Complement mediated lysis of uncloned populations of human transformed cells
transfected with HLA-A3 and HLA-Cw3 genes has also been shown to give varying
results (Lemmonier et al. 1982), while consistent lysis was seen when cloned
population of transfected cells selected for high expression were used. Reduced
levels of expression was also observed on the transfectants at confluence.
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Fig. 4.6 Kpn I restriction digestion of exon 2 270bp fragment amplified from
genomic DNA prepared from the 19.1 and 4.2 transfected cell lines.
Lane 1: Uncut PCR amplified exon 2 from the 4.2 transfected cell line.
Lane 2 : Kpn I digest of exon 2 amplified from the 4.2 transfected cells.







Therefore, the growth stage of the transfected cells may also have had an influence
on the results of some of these assays.
The products from the 19.1 and 4.2 genes were indistinguishable both serologically
and by CTL assays, and were thought to be components of the All haplotype.
Several workers have used 1D-IEF to characterise serologically defined BoLA class
I haplotypes, and BoLA-A locus polymorphisms (splits) that were not resolved using
the available serological reagents. Interestingly, the bands from the 4.2 and 19.1
transfected cell lines appeared identical on IEF, but the cell lines clearly carried
BoLA genes with different exon 2 sequences as evident from previous results. Many
HLA antigens such as A3.2 and B7.2; B8 and B27.5; B13 and Bw47 have similar
pis and so have been found difficult to discriminate using IEF (Guttridge and Klouda,
1989). These observations support the view that 4.2 and 19.1 encode distinct
elements of the All haplotype, and so probably represent different class I loci. To
study this possibility further, the structural organisation and DNA sequence of the
4.2 gene was determined. The coding region (exon 2 -exon 8) from clone 4.2 was
PCR-amplified from phage DNA, and was subcloned into pBoLA-21 for sequencing
(chapter 7). These results and sequence comparison of the 4.2 gene with the 19.1
gene are discussed in chapter 8.
Three clones did not express on transfection (1.3, 15.2 and 17.3x). There are
several possible reasons for this. Firstly, these clones might contain truncated class
I genes, ie without functional promoter sequences or other elements necessary for
transcription and translation. The completeness of all of the clones was determined
by hybridisation using the cDNA clone pBoLA-1, which is truncated at both 5'-
and 3'-ends, so that the lack of some 5' or 3' sequence would not have been
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detected. In addition, the PCR experiments done in chapter 3 to characterise these
clones used primers in exon 2 and exon 8, so that these did not give any further
information regarding the completeness of genes or of the presence of functional
class I promoters. Alternatively, these clones may carry pseudogenes which could
not be expressed, or non-classical class I genes whose expression is tissue-specific
or whose products could not be detected because of lack of appropriate serological
reagents. In addition, there are only a few anti-BoLA class I mAbs available, and
it is not clear whether IL-A88 recognises the products of all class I loci. The other
monomorphic anti-BoLA class I mAb, IL-A19, could not be used in these
experiments as it was found to cross-react with murine class I products. To try to
distinguish between these possibilities, the coding region of clone 19.1 was replaced
with the corresponding gene fragment from the non-expressing clones. These results
of these experiments are described in chapter 6.
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Chapter 5
SUBCLONING AND SEQUENCING OF 19.1 GENE
5.1 Introduction
DNA sequencing studies of a number of mammalian genes have examined the
molecular basis of genetic diversity. Most studies have focused on genes from
different mammalian species or, within a species, have compared non allelic genes
from multigene families. Much less information is available on nucleotide diversity
between allelic genes. It is of particular interest to examine the molecular diversity
of the MHC class I gene family because polymorphism is related to the function of
the MHC-encoded molecules. The structural diversity in mouse and human class I
alleles (Parham et al. 1989; Pease et al. 1991) is found mostly in the amino terminal
domain of the glycoproteins, localised within the peptide binding cleft. It appears
that this diversity has been selectively maintained because of its influence on the
spectrum of peptides that can bind and be presented to T cells. The class I proteins
have domains with structure similar to those noted among various members of
immunoglobulin gene superfamily. The domain structure of these proteins is also
reflected in the molecular organisation of the corresponding class I genes with a
separate exon encoding each domain. The characteristic features of functional class
I genes expressed at the cell surface are the leader peptide (exon 1), three
extracellular domains (a,, Ot, and a,) approximately of 90 amino acids each, a
hydrophobic transmembrane domain which anchors the molecule in the plasma
membrane (exon 5) and the cytoplasmic domain which is formed by exon 6- exon
8 and contains a conserved site for serine phosphorylation. The oq and (X, domains
form antigen binding site and are highly polymorphic, Ot, is relatively conserved and
is the binding site for the non-MHC- encoded component (^-microglobulin (fi,m).
This domain displays amino acid homology with the constant region domains of
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immunoglobulin molecules. The transmembrane and cytoplasmic domains are
generally well conserved, but may contain locus-specific substitutions in various class
I molecules. The lambda clone 19.1, isolated from a genomic library, expressed a
BoLA-All specificity on transfection. In order to correlate this serological
specificity with the structural organisation of the genomic clone, the 19.1 gene was
subcloned into plasmid pBR322 to obtain sequence information.
5.2 Subcloning of the 19,1 gene in pBR322
The lambda EMBL3 clone 19.1 contained a 21kb DNA insert with all of the pBoLA-
1 hybridisation localised to a lkb Sal I-Bam HI fragment and the adjacent 7kb Bam
HI fragment (Hasima, 1992), (Fig 5.1). This region was flanked by about 2kb of
DNA at its 5'-end and about 12kb at its 3'-end, with respect to the orientation of the
gene (Hasima, 1992). The phage DNA from clone 19.1 prepared by the Cscl-step
gradient method (section 2.3), was digested with Bam HI and Sal I, the fragments
were gel-purified as described in section 2.6.3. The lkb Sal I-Bam HI fragment
from clone 19.1 was ligated into pBR322 cut with Sal I and Bam HI to form pBoLA-
17. Next, the 7kb Bam HI fragment was subcloned in Bam HI cut, pBR322
dephosphorylated (section 2.7.1) to form pBoLA-18. Finally, the original
arrangement of the fragments was reconstructed in pBoFA-19. The correct
orientation of the fragments in pBoFA-19 was then confirmed by Eco RI and Sac I
double digestion.
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Fig. 5.1 Restriction map of 19.1 phage clone (from Hasima, 1992)
Clone 19.1 contained a 21kb insert fragment. The 7kb Bam HI fragment which
hybridised to pBoLA-1 is shaded. The orientation of the gene encoded in 19.1 is as
shown in the figure. EMBL3 vector DNA is shown as a thick line while insert DNA























5.3 Transfection of pBoLA-19 in Ltk cells
In order to show that pBoLA-19 carried the entire class I gene from the phage clone
19.1, it was co-transfected into Ltk" cells with the tk gene as described in section
4.2.1. After HAT selection, 90% of the surviving transfectants expressed a bovine
class I molecule as detected by FACS analysis with IL-A88 (Fig 5.2). This confirmed
the integrity of the gene on pBoLA-19. Transfection of the pBoLA-19 plasmid
always gave more than 90% class I expression after transfections, while transfection
of the 19.1 phage clone showed only 15-20% cells expressing class I molecules in
primary transfection. This difference in the expression levels of primary
transfectants might be due to the smaller size of the plasmid DNA compared to the
phage DNA which increases the relative concentration of the class I gene transfected.
In subsequent experiments both phage and plasmid-derived transfectants from the
19.1 gene gave identical results. From the transfection results of pBoLA-19 it
appeared that the 19.1 gene subcloned in pBR322 had all of the flanking 5'- and 3'
sequences necessary for transcription of the gene.
5.4 Sequencing of the 19.1 gene.
The sequencing of the 19.1 gene was done from the three plasmids pBoLA-17,
pBoLA-18 and pBoLA-19 by the dideoxy chain termination method of Sanger and
co-workers (1977), with modified T7 DNA polymerase as described in section 2.8.2.
Since the 19.1 gene came from a genomic library, intron sequences were present
within the gene. Initial sequencing therefore used primers designed in the conserved
regions of the exons from published bovine class I cDNA sequences (Ennis et al.
1988; Brown et al. 1989; Bensaid et al. 1991; Ellis et al. 1992; Garber et al. 1993)
and pBR322-specific primers flanking the cloned fragments.
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Fig. 5.2 Flow cytometry analysis of L cells transfected with the 19.1 plasmid clone
pBoLA-19. The cells were stained with bovine class I mAb IL-A88 and control Ltk"
were stained with IL-A12 which was used a an isotype control for IL-A88.
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Extension primers, based on the sequence data obtained, were used to complete the
sequences of all of the exons in the class I gene on clone 19.1 including contiguous
segments of 1034 base pairs (bp) and 886 bp at the 5'and 3' ends of the gene,
respectively (Fig 5.3). The length of the unsequenced introns in the 19.1 genomic
clone were subsequently determined by PCR amplification of the introns using
flanking exon primers, and substracting the known distances from the primer sites
to the intron boundary. The estimated sizes of the introns are given in the Fig 5.3.
The 19.1 gene has all the characteristic features of an antigen presenting molecule,
with conserved cysteines residues to form the disulphide bonds characteristic of the
immunoglobulin domain structure, a glycosylation site in the 0^ domain, and the
conserved site for phosphorylation in the cytoplasmic domain. The location of the
exon/intron boundaries was determined by homology with the published cDNA
sequences and the position of splice donor and acceptor dinucleotides AG and GT
(Fewin, 1980). The organisation of the pBoFA-19 gene is similar to that determined
for the HFA class I genomic sequence of HFA-A2 and HFA-A3, and also to that
found for murine class I genes (Strachan et al. 1984).
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Fig. 5.3 The nucleotide sequence of the class I gene from the lamda clone 19.1.
Intron sequences are given in lowercase. The translated amino acid sequences of
the exons are given in three-letter code above shown in italics. The region
equivalent to the class I regulatory complex (CRC) sequence in HLA genes is shown
in bold type, and promoter sequences are underlined and indicated as follows:
CAAT, CCAAT-box; TATA, TATAA box. Predicted polyadenylation sequences are
in bold italics. Restriction enzyme sites are overlined and labelled as follow: Bam,
Bam HI: Pvu, Pvu II. The estimated sizes in bp of unsequenced regions are given










































































































The sequencing primers used, and their locations on the 19.1gene, are given in the
Table 5.1:
Primer Location Sequence
4477 exon 1 reverse 5' GTTCCCTCCAGACCCCGC 3'
1573 Repetitive forward 5' CAGCATTTCTCATCATGAGGT 3'
1572 promoter reverse 5' ACCGCCCTTGACCT 3'
770 exon 2 forward 5' GCTCCCACTSMTGAGGTATT
771 exon 2 reverse 5' CTCGCTCTGGTTRTAGTAGCC 3'
1595 exon 3 forward 5' GGCTGCKACGTGGGGCC 3'
1596 exon 3 reverse 5' TCCAGGTATCTGCGGAGC 3'
1597 exon 4 forward 5' CCTCCAAAGGCACATGT 3'
1598 exon 4 reverse 5' GGCTCCTGAAGCCCC 3'
1599 exon 5 reverse 5' CCTCAGMCTCCTTCCTC 3'
4482 intron 5 reverse 5' TACCTAGGAATGGAAACC 3'
1600 exon 7 reverse 5' AGACACATCAGAGCCC 3'
773 exon 7 forward 5' GGCTCTGATGTGTCTCTCACG 3'
772 exon 8- 3'ut reverse 5' GATGMAGCATCACTCAGTCCC
1601 3'-ut forward 5' GGGGGACTGAGTGA 3'
4476 3'-ut- poly A forw 5' TCCCCACCCTGACCTGTGTTC 3'
5.4.1 General features of the sequence
The leader sequence, exon 1: Two in-frame initiation codons located at nucleotides
938 and 947 of the pBoLA-19 sequence result in two possible leader peptides of 21
and 24 amino acids. This is similar to the organisation observed for the HLA-A2
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gene (Roller and Orr, 1985; Sodoyer et al. 1984). The mature pBoLA-19 antigen is
encoded by exon 2- exon 8. Each of the three extracellular domains of mature
pBoLA-19 protein is encoded by a separate exon ie exon 2- exon 4. Exon 5 encodes
the hydrophobic transmembrane segment which contains of about 35 amino acids.
Exons 6-8 form the cytoplasmic tail of the molecule containing mainly hydrophilic
amino acids.
5.4.2 The promoter region
Transcription of class I genes is controlled by regulatory elements residing in the 5'
flanking region (David-Watine et al. 1990). In addition to the TATA and CAAT
box sequences necessary for RNA polymerase II positioning, the MHC class I
promoter contains an upstream enhancer region (EnhancerA) that partially overlaps
the Interferon Response Sequence (IRS: Kimura et al. 1986). The EnhancerA/IRS
is necessary for class I transcription modulation through cytokine stimulation (Harms
and Splitter, 1992).
The 5' flanking sequence of the 19.1 gene was found to be homologous with MHC
class I promoters, containing an identifiable class I regulatory complex (CRC) and
promoters elements). The "CAT" box (CCAAT) is found 74 base pairs upstream to
5' of the initiation codon. Approximately 20 base pairs (bp) down-stream from the
CAT box, the 19.1 sequence contains a canonical "TATA" box (TATAA). These
elements are believed to be crucial for the accuracy and efficiency of transcription
by RNA polymerase II (Breathnach and Chambon, 1981). The upstream region to
CAATand TATA boxes contained a 12bp palindromic sequence TGGGGATTCCCC
which was identified as a possible binding site for the nuclear transactivating factor.
This consensus sequence is also found conserved in the H2-Kb and HLA -B7 (Israel
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et al. 1987; Baldwin and Sharp, 1988). Another regulatory motif found was the
interferon responsive element (IRE) AGTTTCACTTTC. The IRE in class I genes
is necessary for stimulation by interferon (IFN) and seems to be conserved in various
class I sequences.
There are only two other bovine class I promoter sequences available in the database
which were used for comparative analysis of the 19.1 promoter. The degree of the
identity between the 241bp CRC of pBoLA-19 and cattle promoter sequences
BTMHCI (J.S. Harms, unpublished data; accession L19193) andBoLAenh-9 (Harms
and Splitter, 1994) is 92% and 86% respectively. In man, the CRC sequences are
highly conserved between alleles of a single locus (96%- 99% identity), but are less
conserved between loci (78-89% identity; Cereb and Yang, 1994). These
comparative results in humans suggests that pBoLA-19 and BTMHCI promoters may
arise from different loci. This is further supported by the observation that the exon
1 sequence of BTMHCI is identical to that of the cDNA BL3-6, while pBoLA-19
appears to be allelic with BL3-7. The BL3-6 and BL3-7 cDNAs were suggested to
be from different loci on the basis of the length of the transmembrane region (Ennis
et al. 1988).
5.4.3 5' upstream region
The pBoLA-19 sequences upstream of exon 1 can be split into two distinct areas
based on the similarity to known sequences. The region from position 1-630 showed
a high degree of homology (84-86%) with sequences within the bovine lysozyme
gene, gamma globin and a2 casein, in searches of the EMBL nucleotide sequence
database. On further analysis it was found that this region is similar to the Art2
repetitive element in cattle lysozyme genes (Irwin et al. 1993), suggesting that this
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region may be part of the repetitive element. The variation in length of the three
cow lysozyme genes appears to be due to the presence or absence of these repetitive
DNA within the introns of the genes. The Art2 repetitive element has been
identified in the goat in addition to the cow (Spence et al. 1985; Duncan, 1987; Li
et al. 1991).
5.4.4 Analysis of the coding region
The analysis of the nucleotide sequence and amino acid sequences of the 19.1 gene
are presented as a comparative analysis in chapter 8.
5.5 Discussion
The 19.1 genomic clone was analysed by restriction mapping, and a 7.0kb Bam HI
fragment was shown to contain a class I gene by Southern blotting. The expressed
product from this gene was characterised by serology, IEF and by CTL assays and
encoded a component of the BoLA-All haplotype. Genetic information about the
cattle MHC class I has been limited to studies of cattle class I cDNA sequences and
little is known regarding the size of the introns and the flanking sequences which
control expression. All other BoLA class I sequences available are from the cDNA
clones which do not provide any information regarding the introns and flanking
regulatory sequences. These regions are useful in comparative analysis of class I
genes since they are less well-conserved between alleles of different loci than the
exon sequence. In addition, the size of the introns are also much less conserved
between species. The length of the first intron from the 19.1 gene was
approximately 200bp, which compares with lOObp in human and 350bp in swine.
The pBoLA-19 promoter was found to be allelic to BoLAenh-9 (Harms and Splitter,
1994), and from a different locus to BTMHCI based on their degree of similarity.
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This observation of locus-specific and allelic variation seen in CRC regions may
provide a structural basis for modulation of transcription as seen for HLA class I
genes (Cereb and Yang, 1994). The sequence immediately upstream of the class I
promoter in pBoLA-19 (Sawhney et al. 1995) appears to contain a repetitive DNA
element which clearly defines the start of the class I gene. This region could be
used to design primers for locus-specific amplification of the adjacent class I gene.
As more bovine class I flanking sequences become available, this approach could be
very useful in genetic analysis of different class I loci and in rapidly assigning
sequences to different alleles or genes.
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Chapter 6
CONSTRUCTION OF CLASS I GENE EXPRESSION VECTOR
6.1 Introduction
The plasmid construct pBoLA-19 which contained the entire class I gene from the
phage clone 19.1 showed over 90% class I expression on transfection. From the
experimental data on the transfection and sequence of the 19.1 gene, it appeared to
contain all of the upstream regulatory and promoter sequences necessary for class
I gene expression (Sawhney et al. 1995). The pBoLA-19 plasmid was therefore
used as the basis for the construction of a class I gene replacement vector.
The lack of class I gene expression on transfection of the three transfected phage
clones 1.3, 15.2 and 17.3x has been discussed in the section 4.4. In order to rule
out the possibility that these clones did not express because they were truncated at
the 5' or 3'-ends of the gene, the subcloning of these clones was undertaken. The
aim of this reconstruction was to replace the coding region of the pBoLA-19 gene
with the corresponding gene fragment from the three non-expressible phage clones
to provide each gene with a functional class I promoter and 3'-ends to test their
expressibility.
6.2 Cloning strategy
In order to reconstruct the phage clones, a 3.2kb fragment which contained the
coding region from exon 2 to the 3'-UT region of the class I genes in these clones
was amplified using primers based on sequences conserved in exon 2 and in the 3'-
untranslated region of the published bovine class I cDNAs (Fig 6.1). To subclone
these fragments so they could be expressed, a vector acceptor fragment with a
functional class I promoter and 3'-end was first made. This vector fragment was
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Fig.6.1 Multiple nucleotide sequence alignments illustrating the selection of primers
for amplification of MHC class I gene fragments. In the alignments residues
identical to the pBoLA-19 sequence are represented by dashes (-), regions of
sequence which were not determined are shown by dots (.), and gaps inserted to
maximise similarity in the alignment are shown by carets (A). The sequence of
primer 2407 and the reverse complement of primers 2406 and M0700 are given
beneath the alignments. Sequences in italics in primers 2407 and M0700 are
restriction enzyme sites included to facilitate subcloning of the PCR products, and
the following ambiguity codes represent degenerate positions in the primer
















gtctcaccct cttgccccag GCTCCCACTC CCTGAGG
GAGGTCCGGCCG cttgccccag GCTCCCACTC SMTGA
Primer 2407
W10 TGCTG CCCTTCCCCA C GT T
BL3-6 TGCTG CCCTTCCCCA C GT G T
pBoLA-1 TGCTG CCCCTCCCCA CCCTGAC-
KN104 TGCTG CCCCTCCCCA C ... T T
BL3-7 - G ..
pBoLA-19 CCCAC C ATGCC..CCC TCCCCACCCT GACCTGTGTT CTCCTCCC
CCCACTGCTG CCCYTCCCCA CGGCCGCCCC
Primer M0700 CCC TCCCWACCCT GACCGGTGTT CTCYTCC
Primer 2406
generated from the pBoLA-19 construct. To facilitate this cloning, both vector and
insert fragments were amplified using primers designed with terminal restriction sites
to allow directional cloning of the class I gene fragments.
The construction of the expression system is outlined in Fig. 6.2, and is summarised
below.
6.2.1 Generation of the acceptor vector from pBoLA-19
A 1.2 kb Sal I- Eag I fragment from pBoLA-19 containing 5'-flanking sequences,
the class I promoter, exon 1 and 150 bases of the first intron was gel-purified and
subcloned into Sal I- Eag I cut pBR322 to make pBoLA-20. Next, a 450bp Pvu II
fragment from pBoLA-19 containing most of the 3'-untranslated region and the
putative poly-adenylation sequences was subcloned in pBoLA-20 by blunt-end
ligation as described in section 2.5.2 to make pBoLA-21 (Fig 6.2). The correct
orientation of the Pvu II fragment was checked by Pvu II and BstE II double
digestion. pBoLA-21 carried the 5' and 3'-ends of the 19.1 gene, and was used
as a template for PCR amplification of the expression vector receptor fragment with
appropriate restriction sites at the ends to allow directional cloning of the exon 2-3'-
UT fragment.
6.2.2 PCR amplification of class I expression vector
The receptor fragment was generated by PCR from pBoLA-21 using a reverse
primer (2405) in intron 1 which included the Eag I site, and a forward primer in a
conserved region of the 3-'-UT region. The 3'-end oligo (2408) had a single base
(T/G) mismatch from the original pBoLA-21 sequence to create an Age I restriction
site at the end of the vector receptor fragment. PCR conditions were modified for
the amplification of this large (4.4kb) product by the addition of Deep vent DNA
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Fig. 6.2 The expression vector pBoLA-21 was constructed as follows: (A) a 1.2kb
Sal I- Eag I fragment containing the class I promoter and exon 1 was subcloned
from pBoLA-19 into pBR322. Next, a 450bp Pvu II fragment from pBoLA-19
containing most of the 3'-untranslated region and polyadenylation sequences was
added to make pBoLA-20. (B) Inverse PCR using primers C and D (marked by
arrows) was then used to amplify a 4.4kb receptor fragment from pBoLA-20.
Primer C was based on intron 1 sequences flanking the Eag I site, and primer D was
the reverse complement of primer B. Finally, the PCR fragment amplified from
pBoLA-20 was self-ligated to make pBoLA-21.
Restriction enzyme sites, and important features of the sequences are shown as
follows: S, Sal I; E, Eag I; P, Pvu II; Pr, class I promoter region; Exl, pBoLA-19
exon 1; ApR, Ampicillin resistance gene; TcR, Tetracycline rsistance gene; ori,





























polymerase to Taq DNA polymerase at a 1:10 ratio as described in section 2.18.
The addition of the Vent DNA polymerase to the PCR amplification allowed more
reliable primer extension of products greater than 4.0kb. The PCR conditions used
for amplification were: denaturation at 94°C for 30 sec, followed by 30 cycles of
94°C for 30 sec, 55°C for 30 sec and 72°C for 2 minutes. The last extension step
was for 5 minutes at 72°C. A single band of the expected size was amplified from
pBoLA-21 using the above conditions. The amplified 4.4 kb fragment was digested
with Eag I and Age I to generate cohesive ends for cloning of the exon 2-3'-
untranslated region fragments from the phage clones.
6.3 Amplification of the coding region fragment from the phage clones
The exon 2 -3'-untranslated region amplification was performed using DNA from all
five different phage clones (1.3, 4.2, 15.2 ,17.3x and 19.1). The primers were based
on conserved sequences in exon 2 (2407) and in the 3'-untranslated region (2406) of
the published bovine class I sequences (Ennis et al. 1988; Brown et al. 1989;
Bensaid et al. 1991; Garber et al. 1993), as shown in Figure 6.1. The PCR
conditions used in the amplifications were the same as those used to amplify the
vector acceptor fragment in section 6.2.2. In theory, this primer pair should amplify
all class I sequences. In addition to the conserved regions, the exon 2 primer also
included 10 bases of the 5'-flanking intron sequence to allow correct splicing to the
vector-encoded first exon, and a terminal Eag I site. The 3'-UT region primer
included a terminal Age I site for precise cloning in the expression vector fragment.
Four phage clones (19.1, 4.2, 15.2 and 17.3x) gave a product of 3.2 kb on
amplification. Amplification was not achieved from clone 1.3 even after repeated
PCR under a variety of conditions.
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Since both the amplified vector and insert DNAs had terminal Eag I and Age I
restriction sites, the strategy was to digest the PCR-amplified vector and insert DNA
fragments with Eag I and Age I, and then ligate the fragments to yield the
reconstructed class I gene(s). The vector and insert PCR products were purified
with the Wizard DNA clean-up system to remove Taq DNA polymerase and excess
nucleotide to facilitate the subsequent digestion and ligation reactions. However, this
approach of ligating the restriction-digested PCR fragments did not work. It was
speculated that the Age I site introduced at one end of the insert and vector fragments
might have been refractory to digestion and so rendered this cloning inefficient.
6.4 Change in strategy
A new strategy was worked out to use only the Eag I sites to make the cloning
exercise effective. In this approach, the 4.4 kb vector fragment amplified from
pBoLA-21 was self- ligated. The recircularised DNA molecule was then transformed
in E. coli DH5o;, and transformant colonies were tested for the recircularised
plasmid carrying the Eag I and Age I sites (pBoLA-21). Plasmid pBoLA-21 gave
1.2kb fragments on digestion with both Sal I -Eag I and Sal I -Age I, which showed
that the ends of the PCR amplified vector fragment were correctly ligated. This also
further demonstrated that the Eag I and Age I restriction sites were separated by only
few bases of intervening primer sequences. This plasmid, which carried the 5'- and
3'-ends of the 19.1 gene flanking a unique Eag I site, was used as the acceptor for
class I gene reconstruction.
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6.4.1 Subcloning of exon 2-3'-untranslated fragment in TA cloning vector
To utilise the Eag I cloning site in pBoLA-21, the exon 2 - 3'-UT insert fragments
from the phage clones (4.2, 15.2, 17.3x and 19.1) were TA subcloned as descibed
in section (2.7.3). The presence of Eag I sites in the polylinker of TA cloning
vector pcRII facilitated the Eag I subcloning of the inserts into pBoLA-21. The
orientation of the class I gene fragment in pCRII was not critical for subcloning in
pBoLA-21 since the pCRII polylinker has two Eag I sites flanking the cloning site.
The TA clones were screened by colony PCR as described in section 2.18.1 using
exon 2 -specific primers (770 and 772). Those clones which gave product of 270 bp
were used to prepare plasmid minipreps for further analysis. The plasmid DNA
prepared from these TA clones was digested with Eag I to determine the size of the
insert fragment. Four TA clones carrying the 3.2kb class I gene fragment were
obtained for each of the phage clones. Plasmid DNA from the four TA clones
representing each individual phage clone were combined in equimolar amounts,
digested with Eag I, and the 3.2kb insert fragment was purified from agarose gels.
The 3.2kb fragment representing each phage clone was then subcloned into Eag I-
digested pBoLA-21.
6.4.2 Reconstruction process
In order to reconstruct functional class I genes from the phage clones, pBoLA-21
DNA was Eag I digested and dephosphorylated with Calf intestinal phosphatase as
described in section 2.7.1, before ligation with the Eag I digested 3.2kb insert
fragments. The correct orientation of insert fragment in the reconstructed clones was
determined by Sal I- Pvu II double digests. Clones with the correct orientation gave
a 3.2 kb Sal I- Pvu II fragment, whereas a 1.2 kb fragment was seen in clones with
the wrong orientation.
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6.5 Transfection of reconstructed phage clones
Representatives of the four reconstructed phage clones (19.1, 4.2, 15.2 and 17.3x)
pBoLA-25, pBoLA-4, pBoLA-27 and pBoLA-28 were transfected as described in
section 4.2.1. The reconstructed version of clone 19.1 in the pBoLA-25 plasmid
expression constructs showed more than 90% of HAT resistant transfectants
expressing class I molecules (Fig 6.3). The second positively-expressing phage clone,
4.2, when transfected as a reconstructed version in pBoLA-4 also expressed as
expected. The two clones 15.2 and 17.3x which did not express in earlier
experiments were again found to be negative for class I expression even after
reconstruction in the expression vector. These two clones are most likely to be
pseudogenes.
6.6 Flipping of Sal l-Pvu II fragment from pBoLA-21 into pBR322
The reconstructed phage clones (4.2, 15.2, 17.3x and 19.1) in the pBoLA-21
expression construct had clockwise orientation of the class I gene with respect to the
pBR322 sequences, whereas the orientation of the class I genes in pBoLA-19
construct was anti-clockwise. In order to investigate that whether the orientation of
the class I genes had any influence on the expression, a 1.6kb Sal l-Pvu II fragment
containing the class I promoter, exon 1 and 3'-untranslated sequences from pBoLA-
21 was sucloned into Sal I- Eco RV digested pBR322 to reverse its orientation and
make pBoLA-22. This was done to mimic the orientation of the 19.1 gene in
pBoLA-19 to determine whether flanking plasmid sequences had any effect on the
expression of the gene after transfection. The 19.1 reconstructed class I gene in
pBoLA-26 showed similar levels of the class I gene expression on transfection to
those observed in pBoLA-19 and pBoLA-25 in earlier experiments.
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Fig. 6.3 Fluorescence-activated cell scan (FACS) analysis of bovine class I
molecules expressed on the surface of transfected cells. Cells were labelled with the
anti-bovine class I monoclonal antibody IL-A88, followed by a fluorescently-labelled
anti-mouse IgG secondary antibody. After washing, the degree of cell fluorescence
is plotted against cell number for both the negative control (untransfected L cells,




6.7 Sequencing of the 4.2 gene
The 4.2 gene was amplified as an exon 2- 3'-UT fragment from the phage clone, and
was subcloned in pBoLA-21 to make pBoLA-4. DNA sequencing was done from
this reconstructed plasmid version of the 4.2 clone which showed expression in L
cells. The sequencing primers designed for the sequencing of the 19.1 gene was
used for initial sequencing of the 4.2 gene. In addition, new primers were designed
to complete regions of exon sequences which were not read by the earlier primers
(Table 6.1). The 4.2 gene has similar organisation to the 19.1 gene of its introns and
exons (Fig 6.4). The predicted amino acid sequence of the 4.2 gene has all the
features expected of functional antigen presenting molecules including the four
conserved cystine residues in the a2 and a3 domains. The conserved site for
glycosylation at position 86 of the domain was also present. However, there was
a single amino acid substitution in the conserved phosphorylation site, with arginine
replacing the leucine at position 334. The analysis of the coding and non-coding























































Fig. 6.4 The nucleotide sequence of class the I gene from the lamda clone 4.2.
Intron sequences are given in lower case. The translated amino acid sequences of
the exons are given in three-letter code above the DNA sequence. The estimated
sizes in bp of unsequenced regions are given at their appropriate positions in ellipses
(..) conserved phosphorylation site, with arginine replacing the leucine at position
334. The analysis of the coding and non-coding regions of the 4.2 gene are
































































By reconstructing the phage clones it was possible to answer the some of the
questions which were raised by the phage transfection results. The failure to amplify
the exon 2 -3'-untranslated fragment of clone 1.3 with primers 2406 and 2407,
appeared to be due to primer 2407 in the 3'-untranslated region, since the exon 2
forward primer (2406) marked in conjunction with a different 3'-end reverse primer
(772), which annealed 100 bases upstream of primer 2407. This suggests that clone
1.3 might be truncated at the 3'-end of the gene, or might have different sequence
at the 2407 primer site which could have resulted in failure of this primer to anneal.
This clone could have been reconstructed using the 2406 and 772 primers which
would amplify lOObp shorter product, but due to lack of time it this could not be
done.
The PCR amplified vector and insert fragments could not be ligated together after
Eag I- Age I double digestion. The reasons for this are not clear, but it may be
because the restriction sites incorporated in primers were close to the ends of the
primers, at a distance of five or six nucleotides from the end. It is unknown whether
this is sufficient to allow efficient digestion with Eag I or Age I. This might be one
reason that restriction enzymes did not cut efficiently to make cohesive ends for
ligation.
The two plasmid expression constructs, pBoLA-25 and pBoLA-26 which had
different orientations of the class I promoter in the plasmid, were found to behave
in a similar fashion in transfection assays of clone 19.1, suggesting that flanking
DNA sequence had little influence on the expression of the gene. The other three
clones were not reconstructed in pBoLA-22, since no difference was observed in the
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level of expression of the two versions of the 19.1 gene.
The two non-expressing clones (15.2 and 17.3x) that could be amplified with primers
2406 and 2407 did not express after reconstruction, suggesting that these clones are
likely to carry pseudogenes. It is not surprising that two phage clones from the
group of five appeared to be pseudogenes. The number of pseudogenes in human
class I region have been observed to be quite significant (Klein, 1986). It has been
proposed that these genes may provide a source of donor sequences for generation
of variation in classical class I genes (Lawlor et al.1990).
The expression system devised here for analysis of genomic clones can also be used
for the cloning and expression of cDNAs. Furthermore, the class I promoter in the
pBoLA-21 vector is flanked by unique Sal I and Bam HI restriction sites which




CLONING AND EXPRESSION OF cDNA CLONES IN pBoLA-21
7.1 Introduction
The primers used for amplification of class I genomic fragments from the phage
clones were based in transcribed regions of the gene and so could be used for cDNA
amplification as well. After recloning and successfully expressing class I gene
fragments from the coding regions of two positively-expressing genomic clones (19.1
and 4.2) in pBoLA-21, the expression of cDNA clones was tested in pBoLA-21. In
order to characterise the expression potential of the pBoLA-21 vector for cDNA
clones, a plasmid-encoded bovine class I cDNA available in the laboratory (pBoLA-
1; Brown et al. 1989) was subcloned into pBoLA-21. The pBoLA-1 cDNA clone
is truncated at both ends of the gene, which would make it difficult to express in
standard systems without considerable manipulation. In general, full length cDNA
clones are required for expression. However, since the approach used here involved
only the subcloning of sequences from exon 2 to 3'-ut into the expression cassette,
it should make the pBoLA-1 cDNA expressible.
7.2 PCR amplification of pBoLA-1 cDNA
The exon 2 -3'-UT fragments from the 19.1 and 4.2 genomic clones were amplified
using the exon 2 forward primer 2406, and the 3'-UT reverse primer 2407. The
amplified fragments were then subcloned into a TA vector to generate Eag I ends for
cloning into the unique Eag I site of pBoLA-21.
To subclone and express the pBoLA-1 cDNA in pBoLA-21, an exon 2- 3'-UT
fragment for pBoLA-1 class I cDNA was amplified from its plasmid-encoded
recombinant clone. For PCR amplification, the exon 2 forward primer (2406)
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previously used to amplify the 3.2kb class I gene from genomic clones was used.
However, a different reverse primer (M0700) was required because pBoLA-1 is
truncated at the 3' end and does not include the primer 2407 site. Primer M0700
was based at the end of the pBoLA-1 cDNA sequence to include the maximum 3'-
untranslated sequence. This primer had a 15bp sequence conserved in four of the
published bovine cDNA sequences BL3-6, pBoLA-1, A10 and KN104 (Ennis et al.
1988 and Bensaid et al. 1991) and a terminal Eag I site (Fig 6.1). PCR conditions
were: denaturation for 94°C for 90 sec, followed by 10 cycles of 94°C for 30 sec,
50°C for 30 sec and 72°C for 2 minutes. A further 20 cycles were then done with
an annealing temperature of 55°C. The lower annealing temperature was used during
the initial cycles to allow the exon 2 forward primer (2406) to anneal sufficiently.
This primer had only the first 12 bases of exon 2 to anneal with the pBoLA-1 cDNA
as the rest of the primer contained flanking intron sequences and an Eag I site for
cloning into pBoLA-21. In order to increase the yield of the specific PCR amplified
product the annealing temperature was raised from 50°C to 55°C for the last 20
cycles using these conditions. A major band of 1.2kb was seen on agarose gels along
with some smaller size bands. The 1.2kb amplified product contained the exon 2-3'-
UT insert fragment from pBoLA-1 cDNA.
7.3 Reconstruction of the pBoLA-1 amplified cDNA
The 1.2kb ampflied pBoLA-1 cDNA contained terminal Eag I sites which were
based in the 5' and 3'-end primers and was subcloned into Eag I site of the
expression vector pBoLA-21, to make pBoLA-30. The correct orientation of the
insert in pBoLA-30 was determined by Sal l-Pvu II double digestion. The
reconstructed pBoLA-1 cDNA in pBoLA-30 was transfected into L cells as
described in section 4.2.1 to test its expression.
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7.4 Transfection of the reconstructed pBoLA-1 cDNA clone (pBoLA-30)
The primary transfectants obtained from pBoLA-30 showed a very low percentage
of cells positive for bovine class I molecules when analyzed with IL-A88. After
two MACS sorts, however, a separate peak of class I- positive transfectants was
evident (Fig 7.1). This results suggests that the expression vector pBoLA-21 can
express coding sequences from cDNA clones in addition to genomic class I clones.
In order to further characterise functional class I genes from the A10 and All
haplotypes, the primers 2407 and M0700 were used to amplify class I genes from
crude cDNA made from total cellular RNA for cloning (into pBoLA-21) and
expression. This experiment is described below.
7.5 RT-PCR amplification of bovine class I cDNA with AlO-specificity
The data from the 19.1 and 4.2 transfected cell lines demonstrated that both these
clones had BoLA-All specificity. These phage clones had been isolated from a
genomic library prepared from an animal (10769) with A10 and All serotypes, but
a functional class I genomic clone corresponding for the AlO-specificity had not been
isolated. Moreover, the primers which had been previously used to amplify the
pBoLA-1 cDNA might also work in selective amplification of A10 cDNA. This is
because the 3'-UT primer had 15bp of sequence which was not present in either of
All genomic clones 19.1 and 4.2. Thus, using this oligo as the 3' primer for PCR
amplification, it was likely to selectively amplify AlO-like sequences from the
cDNA. In order to express and characterise these class I sequences, a cDNA
approach was adopted for the cloning of AlO-encoding gene from this haplotype into
pBoLA-21. Total RNA prepared from a Theileria annulata-infected cell line derived
from animal 10769 serotype was reverse- transcribed to produce a cDNA template
as described in section 2.9.3. 10/xl of this cDNA was used for the PCR amplification
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Fig. 7.1 FACS analysis of the pBoLA-30 transfected cell line with IL-A88. The
Ltk cells were labelled with an isotype-matched negative control antibody (IL-A12).
After washing, Log cell fluorescence was plotted against cell number for both the
negative control mAb and for the class I specific mAb (red curve).
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of class I sequences using the exon 2 forward primer 2406 and the reverse primer
M0700. PCR conditions for amplification were the same as those used to amplify
the pBoLA-1 cDNA section 7.3. A control PCR reaction was also done using the
exon 7 forward primer 773 and the 3'-UT reverse primer M0700 to assess the
quality of the cDNA used for amplification. A single band of the expected size
(approximately 1200 bp) was obtained for the exon 2- 3'-UT cDNA (Fig 7.2)
whereas the control reaction with 773 and M0700 gave a 200bp product. The yield
of the 1.2kb PCR amplified cDNA appeared to be much less than 200bp amplified
control from the intensity of the ethidium bromide stained bands. In order to
subclone the 1.2kb product into the TA vector, the amplified products from three
reactions were pooled and precipitated with ethanol to concentrate the DNA as
described in section 2.6.4. After ethanol precipitation the PCR product DNA was
resuspended in 10/xl of dH20, 1/xl of which was used for TA cloning.
The recombinant clones were screened by colony PCR using exon 2-specific primers
as described in section 6.4.1. Three TA clones from 80 transformants gave an exon
2 product of 270 bp and were further examined for the size of the insert fragment.
The size of insert was determined by Eco RI digestion of plasmid minipreps. One
clone contained an insert of 1.2kb which was of the right size, while the other two
clones carried shorter inserts, suggesting they were truncated cDNA products. The
plasmid DNA from the TA clone with full- length insert was digested with Eag I for
subcloning the 1.2kb insert fragment into pBoLA-21. Unfortunately, when the
plasmid DNA from this clone was digested with Eag I to release the 1.2kb cDNA,
two insert bands were observed (750 and 450 bp), indicating the presence of an
additional Eag I site within the insert. In order to subclone the 1.2kb cDNA
fragment into pBoLA-21 a different strategy was adopted.
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Fig. 7.2 RT-PCR amplification of a 1.2kb fragment using primers 2406 and M0700
from crude RNA prepared from T. annulata infected cell line derived from animal
10769.
10% of the PCR products from three independent RT-PCR reactions were analysed
by gel electrophoresis on 0.75% agarose gel.
Lane 1 and 3 show a 1.2kb amplified product whereas in Lane 2 no amplification







To obtain a 1.2kb exon 2- 3'-UT cDNA insert fragment from the TA clone, a partial
Eag I digestion approach was used. Aliquots of plasmid DNA (1.0/xg) each were
incubated with two-fold serial dilutions of Eag I restriction enzyme in the
manufacturer's buffer at 37°C for 30 minutes. The reaction was then stopped
immediately by adding 5/xl of stop buffer. Two units per jig were found to give a
partial digestion pattern of the plasmid DNA. From the partial digestion products,
the complete 1.2kb cDNA fragment was gel-purified for subcloning into Eag I-cut
pBoLA-21. A clone with the correct orientation of the reconstructed cDNA was
isolated by Sal l-Eag I double digestion and called pBoLA-10. pBoLA-10 was then
transfected to investigate the expression of this cDNA clone and to characterise the
expressed product.
7.7 Characterisation of the pBoLA-10 transfected cell line
Flow cytometry of the primary pBoLA-10 transfectants derived from clone with IL-
A88 showed a small population of cells expressing bovine class I molecules. When
these were subjected to MACS sorting an increase in the fluorescence of the main
body of the class I transfected cells was observed relative to the Ltk" control (Fig
7.3). However, the flouerscence intensity of the positive cells revealed a lower level
of expression on this cDNA transfected cell line. Further characterisation of this
transfected cell line was done with different AlO-specific mAbs.
7.7.1 FACS analysis with AlO-specific mAbs
Three AlO-specific mAbs (IL-A7, IL-A10 and IL-A34) were used to determine
whether the product expressed by the pBoLA-10 transfected cell line had A10
specificity. Only IL-A34 recognised the product expressed on the surface of
transfected cells (Fig 7.3). This suggested that transfected cell line probably encoded
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Fig. 7.3 FACS analysis of the pBoLA-10 transfected cell line with (A) BoLA-AlO
specifc mAb IL-A7, (B) BoLA-AlO specfic mAb IL-A10, (C) a pan-class I mAb
(IL-A88), and the BoLA-AlO specific mAbs and (D) BoLA-AlO specific mAb IL-
A34. Cells were labelled with the class I-specific primary antibody, followed by the




a component of the BoLA-AlO haplotype. However, the fluorescence intensity of the
transfectant stained with IL-A34 mAb was lower than that of staining IL-A88
staining, possibly reflecting a lower affinity of this mAb for the expressed product
encoded by this cDNA clone. In a parallel experiment, the pBoLA-30 transfectant
cells were also analyzed using the same AlO-specific mAbs. None of AlO-specific
mAbs reacted with the pBoLA-1 transfectant. Interestingly, neither the A10 or
pBoLA-1 transfected cell lines were recognised by the anti-HLA mAb W6/32 which
cross-reacts with some bovine class I molecules.
7.8.2 Sequencing of the pBoLA-10 insert cDNA
In order to investigate further the structure of the AlO-encoding cDNA clone, and
also to compare the sequence with that of two All genomic clones (19.1 and 4.2),
sequencing of the cDNA clone was undertaken from its reconstructed clone pBoLA-
10. The exon-specific primers for the sequencing of the 19.1 and 4.2 genes were
used on the A10 cDNA. All these primers were based in sequences conserved in
various published bovine cDNAs. To complete the sequencing of both strands,
further extension primers were designed from the sequence obtained with the initial
primers. The cDNA encoded a polypeptide of an up to position 1019 and had a
150bp of 3'-ut region as shown in (Fig 7.4). This sequence fragment does not
contain the polyadenylation sequence since the primers used for amplification were
based at positions insides these sites.
7.8.3 Features of the pBoLA-10 encoded class I molecule
The predicted amino acid sequence of this BoLA class I cDNA has the features
expected of functional antigen-presenting glycoproteins. It has the four conserved
cysteine residues at positions 101, 164, 203 and 259 in the a2 and a3 domains, for
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Fig. 7.4 The nucleotide sequence of the class I gene from the cDNA clone pBoLA-
10. The translated amino acids sequences of the exons are given in three-letter code































770 exon 2 froward 5' GCTCCCACTCTGAGGTATT 3'
771 exon 2 reverse 5 'CTCGCTCTGGTTA/GTAGTAGCC 3'
N0700 exon 2 forward 5' GAGGGGCYSGAGTATTGG 3'
N0701 exon 2 reverse 5' CCAATACTCSRGCCCCTC 3'
1595 exon 3 forward 5' GGCTGCG/TACGTGGGGCC 3'
1596 exon 3 reverse 5' TCCAGGTATCTGCGGAGC 3'
N0699 exon 3 reverse 5' CCGCGGTCCAGGAGYGAC 3'
N0698 exon 3 forward 5' TGCRCTCCTGGACCGCGG 3'
1597 exon 4 forward 5' CCTCCAAAGGCACATGT 3'
8442 exon 4 reverse 5' CTCCACAAGCTCCATGTC 3'
1599 exon 5 reverse 5' CCTCAGA/CCCTCCTTCCTC 3'
1600 exon 7 reverse 5' AGACACATCAGAGCCC 3'
773 exon 7 forward 5' GGCTCTGATGTGTCTCTCACG 3'
772 exon 8-3'-ut rev 5' GATGMAGCATCACTCAGTCCC 3'
M0700 3'-ut reverse 5'GGGGGCGGCCGTGGGGARGGGCAG
CAGTGGG 3'
Table 7.1: Sequencing primers used for pBoLA-10 and their location on A10 gene.
intra-domain disulphide bond formation. There is a single conserved site for N-linked
glycosylation at position 86 in cq domain and there is also a conserved
phosphorylation site at serine 333 in the cytoplasmic domain (Guild and Strominger,
1984). The transmambrane region of this cDNA class I sequence contained 37
amino acids as seen in published BoLA class I cDNA A10, pBolA-1 and BL3-6
(Bensaid et al. 1991; Brown et al. 1989; Ennis et al. 1988).
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7.9 Discussion
The PCR amplification system to subclone coding sequences from genomic and
cDNA into the expression cassette (pBoLA-21) provides a rapid way of isolating
and characterising functional bovine class I genes. The described approach could
also be very useful for the expression of bovine class I genomic or published cDNA
clones which lack exonl and /or 3'-untranslated regions (Garber et al. 1993, 1994).
Furthermore, different 3'-end primers can be used to select all class I genes, or
genes potentially from different loci. As more bovine class I sequence information
becomes available, it may be possible to identify locus-specific sequences in the
untranslated regions of class I genes. Using such locus-specific regions as primers,
it would be easy to selectively amplify, clone and express the different bovine class
I genes using this system. Selective amplification of class I cDNA sequences for
HLA-C and H-2D or H-2L by using locus specific primers have also been described
previously by (Zemmour and Parham, 1992; Cai and Pease, 1990). Locus specific
substitutions have also been found in 3'-untranslated regions of HLA class I genes
(Koller et al. 1984; Strachan et al. 1984).
Only a single full length 1.2kb cDNA clone was obtained using the 3'-end primer
M0700. This does not however, suggest that there was only one A10 like gene
present in this haplotype. The failure to isolate other A10 -like sequences appeared
to be due to the poor efficiency of TA cloning of the PCR amplified cDNA. It was
not surprising to find two out of three cDNA clones obtained were truncated, which
probably reflects the quality of cDNA template due to inefficient reverse
transcription and also non-specificity of the PCR due to the size of the annealing
regions on both 5' and 3' primers. Although the presence of additional Eag I site
in the insert made the cloning exercise difficult, but it supported the evidence of
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selective amplification of A10 cDNA with 3'-end primer as both the 19.1 and 4.2
sequences lacked Eag I site in the 3.2kb insert fragment.
The characterisation of the pBoLA-10 transfected cell line with three AlO-specific
mAbs revealed that only IL-A34 recognised the expressed product. Further analysis
of pBoLA-10 transfectants revealed that the expressed product from A10 cDNA was
not seen by the anti HLA class I mAb W6/32. Biochemical studies by Joosten et
al. (1992) showed that a class I molecule associated with A10 specificity was
immunoprecipitated by IL-A34 from the A10 haplotype. This molecule was not
recognised with W6/32 in the same experiment. The FACS anaysis data from the
A10 transfected cell line when compared to the findings of Joosten and co-workers
(1992), suggests that A10 cDNA isolated here might encode the molecule which was
immunoprecipitated by IL-A34 in their experiments. Since PBM from this animal
were recognised by IL-A7 and IL-A10. So it is expected that one or more other
genes encoding components of the A10 haplotype are also expressed in this animal.
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Chapter 8
ANALYSIS OF BoLA CLASS I SEQUENCES
8.1 Introduction
The major histocompatibility complex has been the subject of intense investigation
due to the high polymorphism of its genes and its central role in the immune system.
Between different species and even between strains of mice, the number of MHC
genes varies and this is especially true for the class I genes (Rogers, 1985); eg. more
than 60 have been found in rat compared to as few as six in pigs and perhaps only
one in Syrian hamster and Cheetah (Kindt and Singer, 1987; O'Brien et al. 1985).
Although the number of class I genes in man may be as high as 30 (Driesel et al.
1985), there are only three functional class I genes (classical): in humans HLA-A,
B, C; and in mice H-2K, D, L. Amongst these multiple genes however, one can
discern many features shared by classical class I molecules of all species, presumably
because of selection through antigen presentation. Thus, residues important for
maintaining the structure of the heavy chain and its interactions with /32m, TCR,
CD8 and antigenic peptides are conserved in all classical class I molecules. Despite
the potential advantage of expression of multiple MHC genes, the number of class
I genes actually used in antigen presentation appears to be small, usually one to
three, and others factors relating to the establishment of immunological self-tolerance
may act to limit this number (Matzinger et al. 1984).
Most class I genes are composed of eight exons separated by seven introns;
exceptions include the human pi2.4 pseudogene and mouse Q10 and TL genes
(Fisher et al. 1985). The corresponding introns and exons of class I genes are well
conserved (Jordan, 1985), e.g. the lowest homologies found among five HLA genes
were 79% for exon 8 and 64% for intron 7 (Sodoyer et al. 1985). This is in
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contrast to comparisons between species (mouse and man) which have shown that,
while the exons share a substantial degree of homology (75-85%), the introns are
essentially non-homologus. The length of the introns with exception of introns 3 and
5 is similar between class I genes, whether comparisons are being made between
alleles, loci or species. Intron 3 is variable in length amongst the mouse class I
genes, and is longer than its human counterpart, whereas intron 5 is longer in
humans (Lew et al. 1986).
Understanding the polymorphisms of class I genes requires comparison of the allelic
sequences. This simple proposition is complicated by uncertainty as to the total
number of alleles and the presence of many different class I genes and pseudogenes
in the human and murine genomes. Analysis of HLA-A,B,C sequences has shown
that within alleles of a locus, the 5' part of the gene, encompassing exons 1 to 3, is
highly variable and shows few locus-specific substitutions; while the 3' part of the
gene, exons 4 to 8, is relatively conserved and contains many locus-specific
nucleotides (Parham et al. 1989). Most of the substitutions in this region are seen
in the transmembrane and cytoplasmic domain-encoding exons and in the 3'
untranslated region (Coppin et al. 1985; Koller et al. 1984). However, the degree
of allelic variation differs between HLA loci. The HLA-B alleles are highly variable
in the 5' exons and homogenous in the 3' exons. In contrast, HLA-A alleles show
less variability in the 5' exons and less homogeneity in the 3' exons.
In cattle, polymorphism at the BoLA class I loci has been detected primarily by
serological methods (Bernoco et al. 1991; Bull et al. 1989). This has enabled the
identification of 52 serological specificities, most of which behave as alleles of single
highly polymorphic locus (Davies et al. 1994). However, there is limited serological
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evidence for a second locus by reagents (Stear et al. 1982). When biochemical (Al-
Murrani et al. 1993, 1994) and molecular techniques are employed, there is good
evidence for more than one class I locus in cattle (Ennis et al. 1988; Brown et al.
1989; Toye et al. 1990; Bensaid et al. 1991; Ellis et al. 1992; Garber et al. 1993,
1994). These loci are apparently in linkage disequilibrium (Al-Murrani et al. 1993),
making them difficult to distinguish by conventional methods. However, based on
the number of the amino acids in transmembrane region, the published class I cDNA
sequences suggest the presence of three loci. SDS-PAGE, ID-IEF and peptide
mapping analysis of charge heterogeneity of bovine class I molecules have confirmed
at least three BoLA class I loci are expressed at the protein level (Al-Murrani et al.
1994).
In this work three BoLA class I sequences (pBoLA-19, pBoLA-4 and pBoLA-10)
were isolated from a single animal, heterozygous for the BoLA serological
specificities BoLA-AlO and BoLA-All. The sequences were derived from two
genomic and one cDNA class I clone. All three clones expressed a detectable bovine
class I product on mouse L cells in transfection experiments, which suggest that they
represent functional class I genes. The expressed products from the genomic class
I clones pBoLA-19 and pBoLA-4 were typed as All by serological, biochemical and
cellular methods as described in section 4.3. In addition, a cDNA clone, isolated
by PCR amplification using a selective primer based in the 3'-ut, expressed A10
specificity. In order to determine whether these sequences were alleles of same
locus or from different loci, the sequences were compared with each other and with
all of the published BoLA cDNA sequences.
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8.2 Comparison of pBoLA-19 and pBoLA-4 sequences
In order to determine whether the All-encoding pBoLA-19 and pBoLA-4 sequences
were from different loci or were alleles of the same locus, comparative analysis of
the sequences of the two genomic clones was done. The sequences exhibit 92.8%
nucleotide identity in the coding region and 88% identity at the amino acid level.
The length of the transmembrane region of both the sequences was 35 amino acids.
However, the two sequences appeared to be more diverged in the 3' part of the gene
particularly in the transmembrane and cytoplasmic domains. Both these regions of
have been suggested to contain locus-specific residues (Davidson et al. 1985). This
comparison sequence suggested that these two sequences were likely to be different
genes rather than alleles of the same locus. Interestingly, in spite of the differences
between the two sequences, the expressed products from these class I genes were
indistinguishable by IEF analysis. To investigate whether similarity in isoelectric
point of the products of pBoLA-19 and pBoLA-4 was in accord with the predicted
amino acid sequences of the proteins, the pi of the pBoLA-19 and pBoLA-4 encoded
products was calculated. However, the leader peptide was not included for the
calculation of pi.
8.2.1 Determination of isoelectric point ofpBoLA-19 and pBoLA-4.
The PC/GENE program ISOELECTRIC (Intelligenetics) was used to determine the
isoelectric point of the two gene products by computer. This program calculates the
isoelectric point of a protein from its amino acid sequence assuming that no
isoelectrostatic interactions occur that perturb ionisation. ISOELECTRIC then plots
the total positive and negative charges and the net charge of the protein as a function
of pH. When the predicted amino acid sequences from the pBoLA-19 and pBoLA-4
were compared using this program the values were found to be very similar ie 5.26
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for pBoLA-19 and 5.23 for pBoLA-4. This difference of 0.03 pi units between
these two class I molecules would not be differentiated on IEF gel and this is in
accord with the observation that the class I molecules from these two genes
migrated to same position in IEF analysis. Many HLA antigens have
indistinguishable IEF patterns ie HLA-A3 and HLA-B7, B8 and B27.5 (Baur and
Danilovs, 1980; Guttridge and Klouda, 1989). These results indicate that different
locus products can have very similar pi values and that the pBoLA-19 and pBoLA-4
sequences represent different genes encoding components of the All haplotype.
8.3 Comparison of three BoLA class I sequences with other published bovine
class I cDNA
Recent molecular cloning studies involving BoLA class I genes have resulted in the
isolation of a number of bovine class I sequences by various workers. The
identifiers assigned to the sequences by the EMBL database, and names of




Btbolaa BL3-6 Ennis et al. 1988
Btbolab BL3-7 do
Btmhla pBoLA-1 Brown et al .1989
Bimhawa AwlO Bensaid et al. 1991
Bimhbkna Knl04 do




Btl87 BSX Garber et al. 1994
Btla All pBoLA-19 Sawhney et al. 1995
pBoLA-4 unpublished
pBoLA-10 unpublished
This sequence data appears to demonstrate the presence of at least three MHC class
I loci in cattle (Garber et al. 1994). But as yet the total number of cell-surface
expressed class I genes in any haplotype has not been established. Ennis and co¬
workers were first to report bovine cDNA clones (BL3-6 and BL3-7) which were
suggested to be products of different loci. This finding was based upon differences
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in the 3'ut regions and in the length of the transmembrane regions. In another report
(Bensaid et al. 1991), two cDNA clones were isolated from a homozygous animal
expressing the BoLA types W10 and KN104, and these clones showed divergence
at both ends of the gene. When the 3'untranslated regions of W10 and KN104 clones
were used as probes in Southern blots only a single fragment was revealed in each
digested sample, showing these probes had locus specificity. Further evidence for
the presence of at least two class I BoLA loci came from the use of the polymerase
chain reaction to amplify fragments of expressed bovine MHC class I genes from
cDNA (Ellis et al. 1992). The results suggested the presence of four alleles
representing the products of two class I loci. Ellis and co-workers (1992) also found
the presence of alternatively spliced mRNA which results in the removal of exon 7,
predicting a truncated molecules with the cytoplasmic tail 16 amino acids shorter
than usual. Garber et al. (1993, 1994) isolated six different class I cDNAs from a
single heterozygous animal which is strong evidence of three class I loci in the cattle.
However in none of these studies was the transcription of the genes related to surface
expression of class I products.
8.3.1 Three new BoLA class I sequences encode functional antigen presenting
molecule.
Comparison of the predicted amino acid sequences of pBoLA-19, pBoLA-10 and
pBoLA-4 with those of all published BoLA class I cDNAs demonstrated that three
genes have features of functional antigen-presenting molecules. The various
functionally-important amino acid residues have been marked on Fig 8.1. The only
notable difference is that pBoLA-4 sequence has arginine in place of leucine 334 in
the consensus sequence for phosphorylation (Ser-AspZGlu-Xaa-Ser(P)-Leu). This
sites is conserved across species, but has not been shown to be of functional
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significance (Guild and Strominger, 1984). However, since the phosphorylated
residue (Ser 333) is conserved, it is not clear whether this substitution would affect
its phosphorylation.
8.4 Sequence alignment
The alignments presented in this section were generated using the program PILEUP
from the GCG package, version 7.3. This program creates a multiple sequence
alignment using progressive pairwise alignments. The differences between the
various pairwise sequences alignments may then be calculated by the program
DISTANCES from the PILEUP output. On the basis of these genetic distances a
phylogenetic tree was generated using the full length amino acid sequences, which
split the sequences into two groups as shown earlier by Garber et al. (1993). Two
of the cDNAs (pBoLA-4 and KN104), however, were no more closely related to
either of the two branches (Fig 8.2). These data thus suggested the presence of at
least four BoLA class I loci, represented by five cDNAs in cluster A (BL3-6, BSA,
pBoLA-1, A10 and pBoLA-10), four cDNAs in cluster B (BL3-7, pBoLA-19, BSN
and BSF), and a single cDNA each in clusters C (KN104) and E (pBoLA-4). The
clustering in the alignmemnt suggested that genetic distance between the All
sequences (pBoLA-19 and pBoLA-4) was sufficiently large which makes them more
likely to be different genes rather than alleles. These sequences shared 88%
similarity at the nucleotide level and the amino acid differences in the transmembrane
and cytoplasmic regions support the suggestion from alignment data that these two
sequences come from different loci.
The pBoLA-10 sequence was found on the same branch as the A10 cDNA. These
sequences shared 97% identity at the amino acid level. This suggests that pBoLA-10
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Fig. 8.1 Multiple aligmment of the predicted amino acid sequences of 12 BoLA
class I sequences. Dashes indicate residues identical to the consensus. Asterisks
indicated amino acids whose side chains are directed into the peptide binding site.
A conserved site (NQS) for N linked glycosylation at positions 86-88, a conserved
site for phosphorylation (S[DorE] XS{P04} L) at positions 330-334, and sites for
intradomain disulphide bond formation (cysteines 101, 164, 203 and 259) are all
underlined. Amino acids in bold show unique substitution in the pBoLA-4 sequence
in the transmembrane and cytoplasmic domains.
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oq domain 50
BL3-7 y- g --ia e vp
pBoLA-19 y- --ia 1 d vp
BSF --ia 1 e p
BSN 1- --ii nt
pBoLA-4 1- r d --1 n r
BL3-6 --1 q
BSA - -1 q
AwlO --1
PBoLA-10 1- --1 v-
pBoLA-1 --1
BSC y- --is n -e -d--e v-
KN104 1- vr-- --ii 1 gd--v
Consensus GSHSLRYFST AVSRPGLGEP R--EVGYVDD TQFVRFDSDA PNPRMEPRAR
* * * * * *
a2 domain
51 100
BL3-7 -m iy-d- --i d 1 ni-a
pBoLA-19 -m iy-d- --i--a al e
BSF -m 1 iy-d- y s-
BSN k --e--ns-e- a al v-e
pBoLA-4 -q ns-ga d i-a
BL3-G n--gn --s s-
BSA n--gn --s s-
AwlO --e-qr--gn --f s--n s-
pBoLA-10 -qe--k--gn --f s--n 1-s-
pBoLA-1 -qe--k--g- a i al
BSC -m 1 iy-d- d e
KN104 k -ee--r--dh --f--rg--a e
Consensus WVEQEGPEYW DRNTR-AK-T AQTFRVNLNT LRGYYNOSEA GSHTLQWMYG
*** ********** ******* * ** * * * *
101 150
BL3-7 w




BL3-6 a-r 1 g--e-
BSA r 1 g--e-
AwlO -y pp 1 v--m- --S m
pBoLA-10 -y r 1 v--v- --s m
pBoLA-1 r
BSC g--e 1 h-s v
KN104 -y e g-- h --s




BL3-7 -a--tw --e -- --s
pBoLA-19 r --r g --
BSF dn--se --e --
BSN tw --r g a-- -- --s
pBoLA-4 -a--ge --t a-- --
BL3-6 -y --e -- g
BSA -y --e -- a
AwlO --r -- r g
pBolA-10 ~-r --
pBoLA-1 r --t 1 -- --s--gh
BSC rf --r g a-- -- a
KN104 -st-fy --e --
Consensus GEAEVQRNYL EG-CVEWLRR YLENGKDTLL RA DPPKAHVT HHPISDREVT









AwlO n n 1--
pBoLA-10 n n v
BSC h-
KN104 h- v
Consensus LRCWALGFYP EEISLTWQRD GEDQTQDMEL VETRPSGDGT FQKWAALWP
transmembrane domain
251 300
BL3-7 1- --i . . -1-
pBoLA-19 1-
BSN 1-
pBoLA-4 k --i- vpi 1-
BL3-6
BSA





Consensus SGEEQRYTCR VQHEGLQEPL TLRW EPPQPS FLTMGIIVGL VLLWTGAW
cytoplasmic domain
301 339
BL3-7 --a--wr ri-t- -a
PBoLA-19 --a--wr ri-t- -a
BSF --a--wr ri-t- -a 1 a
BSN --a--wr ri-t- -a 1
pBoLA-4 --a--wr--c - qt-t- -a d r
BL3-6 c n




BSC c n --g
KN104 — f—w n a--r--
Consensus AGWI-MKKR S GEKGG-YIQ ASSSDSAOGS DVSLTVPKV
Fig. 8.2 Phylogenetic tree of BoLA class I sequences based upon the alignment of
the complete amino acid sequences in figure 8.1, constructed from the PILEUP
output. The tree was rooted by including human sequences in the alignment.















KN104 ] Cluster C
and A10 class I cDNA are alleles from the same locus. These sequences are identical
in the transmembrane and cytoplasmic domains. In addition, pBoLA-1 (Btmhla) was
always found to be closely associated with both AlO-specific sequences in this
analysis, which suggests this sequence is also from the same locus. The KN104
sequence formed a distant member of this group because of its unique amino acid
substitutions in transmembrane domain it was assigned to cluster C.
In previous studies the characteristics of the cattle A, B, and C cluster cDNAs
suggested that these clusters represented products of three classical class I loci; and
this was based on sequence differences in exons encoding the transmembrane and
cytoplasmic domains which distinguished these clusters (Garber et al. 1993).
Analysis of the pBoLA-19 coding sequence showed 97% identity at the amino acid
level with BL3-7. This suggests that pBoLA-19 is allelic to BL3-7, and this is
supported by the observation that 21 of the 26 amino acid differences between
pBoLA-19 and BL3-7 are in polymorphic the exons 2 and 3. There are only three
substitutions in the exon 4- exon 8 region between these two sequences. Similar
high nucleotide sequence homologies of both coding and non coding regions ie,
94.5% and 97.2%, were seen between HLA-A2 and HLA-A3 alleles.
The pBoLA-10 sequence grouped with the cluster A cDNAs. These cluster A class
I sequences had TM length of 37 amino acid which was two more amino acids than
the cluster B and E sequences. This difference in the length transmembrane region
of BoLA class I cDNAs was also noted by Ennis and co-workers (1988) as
supporting evidence of two loci. Locus-specific differences in the length of the
transmembrane domain also occurs in humans where HLA-C gene products have one
more amino acid than do the HLA-A and HLA-B gene products. This is one of the
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regions which contain locus-specific residues which are apparent when comparing
alleles (Gussow et al. 1987). These results suggests that pBoLA-10 sequence is a
different locus than pBoLA-19 and pBoLA-4. Since pBoLA-19 and pBoLA-4
sequences were also from different loci based on the data in section 8.2.1, all the
three sequences isolated from this animal are likely to be potential candidates to
represent three different loci.
8.4.1 Phylo,genetic analysis
Unlike the exons encoding the ax and a2 domains, where high rates of nucleotide
substitutions are found in the ABS as a result of the selection (Hughes and Nei,
1988), substitutions that occur in the more conserved regions of MHC class I genes
are often locus-specific, and therefore the analysis of such conserved regions may
yield information about relationships among MHC class I sequences where there is
no clear locus-specific assignment by other methods. In order to make the
comparison more locus-specific, and also to include the truncated sequence Btl87
(Garber et al. 1994), the three class I sequences determined here were aligned with
the other BoLA class I sequences using only the region between exon 4 and 8.
Phylogenetic trees based on these alignments were constructed using a number of
methods, all taken from PHYLIP package version 3.5c. In all cases human MHC
sequences were used as outgroups to root the trees. The principle method used for
analysis was the DNADIST program which estimates the genetic distance based on
the nucleotide identity between each pair of sequences. A tree was constructed using
NEIGHBOR program based on DNADIST data on the exon 4 -exon 8 DNA
sequence alignments (Fig 8.3). There are three main branches, one of which
contained only Btl87 and pBoLA-4. Each of these two sequences has numerous
unique nucleotide substitutions which appears to prevent them from being more
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closely grouped with any of the other BoLA cDNAs. These nucleotide differences
also contribute to the long branch length that separates Btl87 from pBoLA-4. These
two sequences were always grouped together in all of the different methods of
analysis used. At the DNA level, Btl87 and pBoLA-4 sequence are 94% identical.
As there was no sequence available from the 3'ut region of Btl87, the comparison
could only be done with the exon 4-exon 8 region. However, there is no strong
evidence from this data that these sequences are from same locus or they are
different loci.
The other two branches of this tree (Fig 8.3) resembles with phylogenetic tree
constructed by using the exon 2-exon 8 peptide sequences (Fig 8.2). Thus, exclusion
of polymorphic exons 2 and exon 3 for the analysis of class I sequences did not
make any significant influence on the topology of the tree. However, KN104 was
exception as it was always found to be associated with the A10- like sequences
(AwlO, pBoLA-10 and pBoLA-1) in all methods of analysis, but based on physical
mapping KN104 and AwlO were shown to be different loci (Bensaid et al. 1991).
8.4.2 Comparison of the intron sequences ofpBoLA-19 and pBoLA-4
To further determine whether pBoLA-19 and pBoLA-4 sequences are likely to be
from different loci, a comparison of the intron sequences was made. The two
complete intron sequences between exons 4 and 5 and between exons 7 and 8, were
compared from the two genomic sequences pBoLA-19 and pBoLA-4. While the size
of the introns between these two genomic clones was generally less well conserved,
the comparison of introns 4 and 7 revealed small insertions or deletions. The intron
sequences were less conserved than the flanking exons and overall identity of the
intron sequences compared was between 88-90%. Since there are no other bovine
158
Fig. 8.3 Phylogenetic tree of BoLA class I DNA sequences exon encoding a3,
transmembrane, and cytoplasmic domains of BoLA class I sequences. The tree was
constructed using the DNADIST and NEIGHBOR programs within the PHYLIP






















genomic class I sequences available it was difficult to conclude from these results
whether this degree of identity in introns was sufficient to assign these two class I
sequences to different loci.
8.4.3 Comparison of the 3'-untranslated region
It has been suggested that the non-coding and flanking sequences are less well
conserved between sequences from different loci compared to alleles from the same
locus. Nucleotide sequence analysis of the 3' untranslated regions of mouse class
I cDNA clones revealed that this region could be divided into subregions NCI and
NC2 (Kress et al. 1984; Lalanne et al. 1985). These regions contained sequences
specific for the various class I loci, including H-2K, D, L but the NC2 region tended
to have a greater proportion of locus- specific residues than NCI. The sequences
in the 3'-ut of bovine class I cDNA clones are more diverged from each other than
the rest of the gene and appear to contain locus-specific motifs. This region is more
prone to insertions/deletions in all species and appears to generally contain AT-rich
stretches of sequence. The 3'ut region of class I genes has also been shown to be
locus specific in man (Lew et al. 1986). In humans and mice the 3'-untranslated
regions of alleles from same locus show a mean homology of 94-98 % whereas the
identity between alleles of different loci in the range of 74 to 95% (Ennis et al.
1988). When the comparisons were made between the available 3'-untranslated
region sequences of pBoLA-19 and pBoLA-4 the degree of the identity was 83.42%,
clearly in the range expected for alleles of different loci. From these comparisons
it appears that pBoLA-19 and pBoLA-4 are two different genes which encode
products with All specificity are components of the All haplotype.
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8.5 Discrimination of intralocus and interlocus alleles on the basis of pairwise
differences
To further support the above analysis, the pairwise differences between all of the
BoLA class I sequences were calculated. For every pairwise combination of
sequences, the number of amino acid differences were calculated and their
frequency distribution was plotted (Fig 8.4). Calculation of similar pairwise amino
acid differences between pairs of HLA-A, B, C sequences generates distinct ranges
of values, depending upon whether comparisons are between alleles of the same
locus or of different loci. The range of differences for alleles of the same locus is
0 to 21 amino acid substitutions compared to 42 or more for alleles of different loci.
(Parham et al. 1995). Pairwise comparison of HLA-B and HLA-C alleles shows
fewer differences than when either HLA-B or HLA-C alleles are compared to HLA-
A. In the bovine class I sequences this comparison resulted into two major groups
as observed from the histogram pattern (Fig 8.4). These groups were represented
by pairs of sequences which had scores of 0-8 and 10-22 repectively. All intralocus
comparisons are likely to be within the range 0-8 whereas sequences pairings which
had differences 10-22 appear to generally come from different loci. Within the 0-8
range the identity between the paris were found more than 90% which is expected
for alleles. This holds true for all the cluster A and B sequence pairs. However,
the sequence pairs which fall in the middle range of 10-12 were not clearly separted
from the either group but based on the previous analysis they were from different
loci. The pairwise differences for these class I sequences are given in table 8.2.
The three sequences KN104, Btl87 and pBoLA-4 when paired with the most of the
other sequences showed differences in the range 17-22 suggesting these sequences
were distinct from the other BoLA class I sequences and each other. This
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Fig. 8.4 Histograms showing the distribution of amino acid differences from the
pairwise comparisons of BoLA class I sequences assigned in Fig 8.1. For every
pairwise combination of sequences, the number of amino acid differences were
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observation is supported from the topology of the phylogenetic tree (Fig 8.3) as these
sequences were found on the outermost branch of the tree.
The pairwise comparisons of pBoLA-10 with pBoLA-4 and pBoLA-19 were in the
range expected for interlocus comparisons as suggested from the earlier results.
Also the difference between pBoLA-4 and pBoLA-19 pair showed a score of 13
which appears to be in the interlocus comparisons. This is also supported by the
earlier analysis of 3'-ut and the differences in transmembrane and cytoplasmic
domains of these sequences.
Pairwise differences in amino acids in number
10 11 12
BL3-6 x pBoLA-19 BSA x pBoLA-19 B13-6 x pBoLA-4
pBoLa-10 x KN104 BSC xpBoLA-19
BL3-7 x Bt 187 KN104 x pBoLA-19
BSN x Bt 187
pBoLA-19 x Bt 187
BSF x Bt 187
Table 8.2 : Comaprison of pairwise differences of amino acids between BoLA class
I sequences in the range of 10-12
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8.6 Conclusion and problems
All of the methods used in the analysis of the three class I sequences suggested that
the differences between the sequences were sufficient to be in the range expected for
genes of different class I loci. The two All sequences (pBoLA-19 and pBoLA-4)
appeared to be different genes encoding components of All haplotype. There may
be variable numbers of expressed classical MHC class I loci in cattle, as is seen in
between mouse strains (Steinmetz et al. 1982b; Weiss et al. 1984). This number
could differ in different haplotypes as well as breeds, possibly as a result of gene
duplication. It has been suggested that the genes of the BoLA class I loci are in
linkage disequilibrium, so that the allo-antisera see the products of multiple genes,
and thus are not gene locus-specific but haplotype specific. This is supported by the
findings that the two genes encoding components of the Al 1 serological specificity
were not differentiated by alloantisera although they were different genetically.
Previous analysis regarding the number of different class I loci in cattle has been
primarily based on the cloning and sequencing of cDNA sequences from individual
animal. This has produced evidence that at least three class I genes are transcribed
in cattle (Garber et al. 1994). But all of the transcribed genes may not necessarily
be expressed at the cell surface, so this approach alone is not sufficient to determine
how many class I products are expressed.
All of the full length bovine sequences transmembrane regions of either 37 or 35
amino acids, with the exception of KN104 where the length is predicted to be 36
amino acids. Garber and co-workers (1994, suggested that these three patterns
represent three different loci, however no published sequence except KN104 has
revealed another 36 amino acid TM region, which suggests that KN104 is an
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diverged allele which belongs in one of the other groups. KN104 was isolated from
Bos indicus and this specificity is only found in African cattle, so it is not clear
whether this is a difference between B. taurus and B. indicus. In addition, when the
number of different sequences identified in individual animals is taken into account,
it is clear that the products of more than one locus have a 35 amino acid TM e.g.,
the two sequences pBoLA-19 and pBoLA-4 have TM regions of 35 amino acids, but
have locus specific features which make them likely to be two different genes on the
same chromosome. These results indicate that assignment of sequences to loci will
not possible using the method of single cDNA isolation, but will require the





In cattle, the BoLA complex is presently defined serologically as a single allelic
series of 52 internationally defined allo-specificities (Davies et al. 1994).
Information regarding the genetic basis of these specificities was limited, until
several class I sequences were published (Ennis et al. 1988; Brown et al. 1989;
Bensaid et al. 1991; Garber et al. 1993, 1994; Sawhney et al. 1995). The number
of expressed loci is important, as the class I gene products act in shaping the
repertoire of T-cells available to the animal, hence partly determining its ability to
respond to pathogens. Although there may be 20 or more genomic class I genes
found in cattle by Southern analysis (Lindberg and Andersson, 1988), the number
of expressed class I products in cattle is unclear. Biochemical (Joosten et al. 1992;
Al-Murrani et al. 1993, 1994) and molecular biological studies (Ennis et al. 1988;
Brown et al. 1989; Bensaid et al. 1991; Ellis et al. 1992; Garber et al. 1993, 1994)
suggest that two or three MHC class I loci are transcribed. However, there has been
no systematic attempt to confirm the number of expressed products. Most of these
workers used a cDNA approach to analyse the number of expressed class I genes.
It has been suggested that all of the genes which are transcribed may not necessarily
be expressed on the cell surface, and thus are not likely to be functional antigen-
presenting molecules (Ellis et al. 1995). The aim of this study was to investigate
the expression and function of individual class I products, by the transfection and
characterisation of bovine class I genomic and cDNA clones isolated from a single
animal serologically typed as BoLA-AlO/All.
This study began with a group of 15 class I genomic clones, of which five
representative clones were transfected into mouse L cells. Of the five different
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clones transfected, only 19.1 and 4.2 showed expression at the L cell surface using
the bovine monoclonal antibody IL-A88 (chapter 4). The transfectants obtained
from both expressing clones were characterised serologically, biochemically and by
cellular assays and both were found to encode the All serological specificity.
Interestingly, the products of the 19.1 and 4.2 transfected class I genes were
indistinguishable by isoelectric focusing, despite having clearly different nucleotide
sequences in both the clones and in the transfected cells. These results suggested
that both class I genes encoded a component of the All haplotype and, thus,
represented the products of two different loci. These observations show that while
serology may be of some use to study class I polymorphism, allo-antisera do not
recognise the products of individual class I loci but instead recognise the products
of multiple loci within a haplotype which further supports the idea that these loci are
in linkage disequilibrium. Indeed, physical mapping studies by Bensaid et al. (1991)
have shown tightly linked, expressed class I loci. From the BoLA workshops it has
been suggested that the allo-antisera recognise allelic products (Spooner et al. 1979b;
Bull et al. 1989; Bernoco et al. 1991). However, the observation that the 19.1 and
4.2 genes encode the same serological specificity, and the work of Al-Murrani and
co-workers (1993) suggest that the allo-antisera are haplotype-specific rather than
allele-specific. In order to extend the panel of allo-antisera and improve the ability
to distinguish between products of different BoLA class I loci, it may be
advantageous to use reciprocal immunizations between animals from genetically
distant breeds. Animals from different geographical locations face distinct selection
pressures, making them carry different allelic combinations, thus increasing the
chance of producing sera that recognise the products of different genes (Kemp et al.
1988). Although it is generally expected that class I MHC molecules encoded by
different loci have different isoelectric points (Yang et al. 1984), some overlap is
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still observed. The predicted isoelectric points of the 4.2 and 19.1 gene products
were very similar, 5.23 and 5.26 respectively. The results support the idea that
bovine class I molecules encoded by different loci can have very similar isoelectric
points. Indeed, similar pi values of 5.24 and 5.26 were predicted for the from
BL3-6 and BL3-7 bovine class I cDNA sequences which have been suggested from
different loci (Ennis et al. 1988).
Sequence data for about 500bp flanking the 5'-end of the class I gene (chapter 5) was
obtained from clone 19.1, and a repetitive DNA element was discovered immediately
upstream of the class I promoter (Sawhney et al. 1995). This clearly defines the
start of the class I gene and may not be conserved of other class I loci. Such
potentially locus-specific sequences will be invaluable for designing primers for
amplification of the adjacent class I genes in a range of haplotypes, which could be
further characterised for functional antigen presentation.
The lack of expression from the three phage clones 1.3, 15.2 and 17.3x suggested
that these clones might contain truncated class I genes or pseudogenes. The three
non-expressing clones did not express, even when subcloned in the expression vector
pBoLA-21, suggesting that they are pseudogenes. However, these class I clones
could be useful as probes to map the genes in and around the MHC region.
Geraghty and co-workers (1992) reported more than twelve HLA class I
pseudogenes. It was suggested that most of these pseudogenes evolved as a result of
gene duplication events. The functional significance of these class I MHC genes
which do not participate in antigen presentation remains unclear. It has been
proposed that these genes may be a source of donor sequences for the generation
of sequence variation in classical class I genes (Lawlor et al. 1990). An alternative
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view is that these loci may represent relics of genes that were once used in antigen
presentation and have been subsequently discarded, or the products of unsuccessful
evolutionary experiments with antigen presenting genes (Klein and Figueroa, 1986;
Howard, 1987). For example, in man HLA-AR alleles closely resemble alleles
encoding HLA-A antigen-presenting molecules, although the presence of one or two
deleterious mutations prevent these alleles being active in antigen presentation
(Zemmour et al. 1990) This line of speculation argues that, depending on the
antigen environment, there can be either positive or negative selective pressure on
particular MHC alleles and loci. This suggests the MHC is a particularly dynamic
system in which different genes and alleles are being brought into play and then
discarded in the course of evolutionary time. This may, in a general sense, explain
some of the unusual variability in the number of MHC genes.
In order to isolate and characterise other functional class I genes from this animal,
a cDNA approach was tried. The amplification of cDNA was achieved by using a
selective primer based in the 3'-ut region of the class I gene and a conserved primer
in the exon 2 area (chapter 7). A 1.2kb (exon 2 - 3'-ut) amplified cDNA was
expressed after subcloning into the pBoLA-21 class I expression vector. Only one
cDNA clone of the right size was isolated in these experiments, and most of the
cDNA clones screened were shorter in length and were not further investigated.
These cDNA clones might be truncated due to alternative splicing of transcripts or
abberant PCR. Ellis and co-workers (1992) have reported that some class I alleles
were more prone to alternative splicing resulting in the removal of exon 7. It has
been suggested that the length of internal exons play a important role in the splice
site selection (Dominski et al. 1991). Internal exons less than 50bp are more likely
to be involved in exon skipping. However, the shorter length transcripts were
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truncated by 100-500bp. The transfectants obtained from the cDNA clone encoded
a product with A10- specificity, which was confirmed by flow cytometry analysis
with the A-10 specific monoclonal antibody IL-A34.
Sequence analysis of the three class I genes (chapter 8) suggested that all the three
sequences are likely to be from different loci. The sequences on pBoLA-19 and
pBoLA-4 encoded the same serological specificity (All), and were very different in
their transmembrane and cytoplasmic domains, and in the 3'-ut regions, strongly
suggesting they are different genes of the All haplotype. The fact that both genes
encode the same specificity also implies that they are different genes of the same
haplotype. These observations suggest both All genes could have evolved by
possible gene duplication mechanism as seen for the presence of multiple DQ genes
in the class II region in some haplotypes of cattle (Marello et al. 1995). But there
is no evidence for this since they are very distinct in sequence. It is also possible
that there could be variation in the number of the expressed class I genes in different
haplotypes as well as breeds. Variation in the number of expressed class I genes
between horse breeds have been reported by (Lew et al. 1986). It was observed that
many thoroughbred horses do not appear to carry a gene for the secreted class I
molecule which is commonly found in most other horses. Variation in the number
of class I genes between haplotypes has also been demonstrated in mice (Wroblewski
et al. 1994), where D region can contain one and five loci. It has been shown that
six distinct cDNA sequences, apparently from three loci, were expressed in
heterozygous bull (Garber et al. 1994), in other haplotypes it appears that one or two
genes may be transcribed (S.A. Ellis, unpublished observations). In this study three
functional class I genes were isolated from the A10 and Al haplotypes, but there
may be more expressed class I genes in this animal. While two expressed All genes
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were found the presence of two or three functional A10 haplotype genes cannot be
ruled out, although only one expressed A10 gene was isolated. These observations
are supported by the evidence that PBM from this animal were seen with all the
three AlO-specific mAbs, but isolated AlO-encoded gene product was recognised by
only IL-A34. So the presence of the other AlO-like genes encoding component of
A10 haplotype are likely to be expected. Also it was not possible to isolate allelic
sequences from the A10 and All haplotypes so there is no evidence that the two
haplotypes carry alleles of the same gene.
The results presented here demonstrate the feasibility ofusing transfection techniques
and DNA sequencing to help define the number of functional class I MHC genes.
Additionally, transfected cells are valuable tools for producing new serological
reagents to MHC molecules, and for studying the role of individual MHC molecules
in the restriction of CTL recognition of foreign antigens. These transfected cell lines
expressing individual class I products could be useful for the determination of allele-
specific class I peptide motifs, which have further application in the determination
of T cell epitope for designing new vaccines. The peptide motifs for the two BoLA
class I molecules A20 and All showed the presence of charged amino acid at the
carboxy-terminus (Bamford et al. 1995; Hegde et al. 1995). This observation
suggests the bovine TAP system is functionally similar to humans. The peptide
motif for the All molecule has been suggested to be from the product of the
pBoLA-19 gene (Hedge et al. 1995). Motifs the same as or similar to, for BoLA-
All have been reported for HLA-B7, HLA-53, HLA-B*5101 and HLA-B*5102
(Rammensee et al. 1995). Sequence comparisons between these molecules and
pBoLA-19 showed that key residues involved in accommodating motif residues P2
and P9 (ie 9, 24, 45, 67, 77 ,116) share similar characteristics. The BoLA-All
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motif is consistent with this molecule assuming a similar conformation as human
class I ABS. Not unexpectedly, therefore, the predictions on the peptide specificity
of BoLA-All sequence is similar to the corresponding peptide motifs from this class
I molecule. Since residue 67 (Tyrosine) in the pBoLA-19 sequence is predicted to
block the B pocket, such that a residue with a small side chain is the most likely to
be found in P2. In the peptide motif position 2 was occupied by Pro, which can
kink the peptide to be accommodated in the B pocket (Hedge et al. 1995).
The expression vector pBoLA-21 successfully expressed both genomic and cDNA
copies of class I genes. This system should also facilitate the functional
characterisation of class I clones lacking exon 1 and 3'-untranslated regions which
would otherwise difficult to express (eg. many of the published cDNAs). In
addition, this system can be used to selectively amplify, clone and express different
bovine class I genes for rapid characterisation of individual genes from a range of
haplotypes.
Future studies
The results presented in this thesis show only the beginning of the correlation of
serological specificities with the molecular characterisation of bovine MHC class I
genes from the BoLA-AlO and All haplotypes. It would have been better if the
genomic counterpart of the BoLA-AlO cDNA had been isolated allowing a clear
comparison of genes from both haplotypes. The isolation of other clones expected
to encode and express the products recognised by two AlO-specific mAbs (IL-A7 and
IL-A10) would help define the number of expressed genes from the A10 haplotype.
Ideally isolation of overlapping genomic clones would help to identify how similar
bovine MHC is that of to mouse and man. Progress in the determination of the
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range of functional bovine class I genes will require the use of homozygous animals,
combining phylogenetic analysis of sequences with the identification and
characterisation of expressed gene products in transfected cell lines. The transfected
cell lines made during this project could be further used for the prediction of class
I Motifs. Construction of pBoLA-21 allows rapid analysis of the other haplotypes
without screening the libraries.
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40ml 0.5 M EDTA pH8
TAE - Stock 50 x TAE
Per liter :
242g Tris
57.1ml glacial acetic acid
100ml 0.5 M EDTA pH8
30% Acrylamide stock solution
Acrylamide 29g
N, N-methylene bisacrylamide lg
made to 100ml with autoclaved distilled water
Phage buffer.
This buffer is used for storage and dilution of bacteriophage X stocks.
10 mM Tris HC1 pH7.5
10 mM MgS04
0.01% gelatin
The phage buffer was autoclaved.
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Cesium chloride solutions for step gradients prepared in phage buffer









Adjust pH to 7.5 with sodium hydroxide and autoclave as 500ml stocks.
LB plates
The LB medium is made up according to the above formula and before autoclaving,
one of the following was added (per liter) :
Bacto-Agar 15g (for plates)
Agarose 7g (for top agarose)







L cell growth medium
i) 10 ml of 10 x RPMI-1640
2 ml sodium bicarbonate 7.5% (to get pH6.8 to 7.2)
2ml L Glutamine
10ml foetal calf serum
0.5ml gentamycin
to 100ml with autoclaved distilled water
ii) Selection medium






made up in distilled water and autoclaved.
Eosin stain (2', 4', 5', 7',- tetrabromofluorescein) (Sigma).
5% eosin in 1 x HBSS




5ml 0.15 M Na2HP04
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Table: The list of mAbs used during this project and their specificity.
mAb Specificity working dilutions Reference
EL-A88 Bovine MHC class I 1:1000 Bensaid et al. 1991
IL-A12 CD4 1:1000 Howard et al. 1991
IL-A51 CD8 1:500 Ellis et al. 1986
EL-A7 BoLA- A10 1:1000 Toye et al. 1990
IL-A10 BoLA-AlO 1:1000 do
IL-A34 BoLA-AlO 1:1000 do
W6/32 HLA class I 1:500 Brodsky and Parham, 1982
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Cattle major histocompatibility complex [(MHC) (BoLA)]
class I molecules are heterodimeric glycoproteins which
present endogenous antigenic peptides to CD8+ T lympho¬
cytes, initiating a cellular immune response. The MHC-
cncoded heavy chains are highly polymorphic and, in cattle,
have been characterized mainly by using allo-antisera
raised by reciprocal calf/dam immunisations (Spooner et
i 1978). This has enabled the identification of about 50
serological specificities, most of which behave as alleles of
a single highly polymorphic class I locus (Davies et al.
1994). However, evidence from biochemical (Joosten et al.
1992; Al-Murrani et al. 1993, 1994) and molecular biolo¬
gical studies (Ennis et al. 1988; Brown et al. 1989; Toye et
al. 1990; Bensaid et al. 1991; Ellis et al. 1992; Garber et al.
1993, 1994) suggest that more than one BoLA class I locus
is expressed. These loci are apparently in linkage disequili¬
brium (Al-Murrani et al. 1993), making them difficult to
distinguish by conventional methods. In order to investigate
fe expression and function of individual class I locus
products, we are correlating BoLA class I gene sequences
with the expressed products by the transfection and char¬
acterization of genomic class I clones. Shotgun transfection
®d expression of BoLA class I molecules has been
described previously, but the genes involved were not
isolated (Toye et al. 1990). In this paper we report the
isolation, DNA sequencing, transfection, and expression of
a genomic clone encoding a BoLA-All determinant from
"ianimal expressing A10 and All serological specificities.
he nucleotide sequence data reported in this paper have been
'Emitted to the EMBL, GenBank, and DDBJ nucleotide sequence
s, and have been assigned the accession numbers
®2671-X82675
^ M. S. Sawhney • N. N. Hasima1 • E. J. Glass • S. W. K. Al-Murrani
J; K- Nichani • R. L. Spooner • J. L. Williams • G. C. Russell (£3)division of Molecular Biology, Roslin Institute, Roslin, Midlothian,
®25 9PS, UK
Resent address:department of Genetics and Cellular Biology, University of Malaya,
100 Kuala Lumpur, Malaysia
A genomic library was prepared in the lambda vector
EMBL3, using peripheral blood mononuclear cell (PBM)
DNA from an animal with A10 and All serotypes. The
library was screened by hybridization with a 32P-labeled
cattle MHC class I cDNA clone, pBoLA-1 (Brown et al.
1989). A total of 15 independent clones were selected from
the library, which hybridized with both 5' and 3' ends of
pBoLA-1 and were considered candidates for full-length
genes. These clones were tested for expression by calcium
phosphate mediated transfection into murine L cells, as
described by Wigler and co-workers (1979), with the
thymidine kinase (tk) gene as a selectable marker (Hasima
1992). Expression was examined by flow cytometry
(FACS), using monoclonal antibody (mAb) IL-A88,
which recognizes a monomorphic, non-conformational
epitope on BoLA class I heavy chains (Toye et al. 1990).
Only one clone, 19.1, showed significant levels of expres¬
sion of a BoLA class I product. Three rounds of FACS
sorting produced a population in which all of the cells
expressed a 19.1 product. This purified population of
transfected cells was characterized by serological, cellu¬
lar, and biochemical methods.
The identity of the expressed antigen was initially
investigated by using a BoLA class I micro-lymphocyto-
toxicity test (Spooner et al. 1978) with allo-antisera routi¬
nely used to define the All specificity (Davies et al. 1994).
The transfected L cells expressing the product from clone
19.1 were lysed by three All-specific allo-antisera: Ed73,
Ed 102, and Ed 110, but were not killed with a fourth All-
specific allo-antiserum, Ed76. Control L cells were not
killed with any of the All sera, and neither the control
nor the transfected L cells were killed with sera defining
other BoLA specificities. The killing of the transfected cells
required the use of higher concentrations of the allo-
antisera than for normal cattle PBM. This may reflect the
degree of expression of the transfected gene, or may
indicate that L cells are more robust than cattle PBM.
Functional analysis of the product expressed by the
clone 19.1-transfected cells was done using anti-All and
anti-AlO allo-reactive cytotoxic T lymphocytes (CTL). The
CTL lines were generated in vitro as described previously







BoLA-Al 1 products — _ - Transfected gene product
5:1 10:1 20:1 40:1 80:1
Effector: Taroet ratio
Rg. 1 BoLA class I-specific 51Cr-release cytotoxicity assay of clone
15.1-transfected cells with: A anti-All specific; and B anti-AlO
specific CTL, performed essentially as described previously by
Spooner and co-workers (1987). Theileria annulata-iniected lympho-
Hastoid cell lines (Ta) were used as target cells for establishing
specificity of effector cells. Transfected and control L cells were
harvested with 0.02% ethylenediaminetetraacetate 16 h before the
say and incubated overnight in DMEM medium in non-adherent
polystyrene petri dishes (Townsend et al. 1984). The panel of target
tells were as follows: A • Ta from the donor animal, BoLA A10/A11;
ATa, BoLA All/-; □ Ta, BoLA A6/A31; A Clone 19.1 transfected
L-cells; O Control L cells. B • Ta from the donor animal, BoLA A10/
Ml. ▲ Ta, BoLA A10/A11; □ Ta, BoLA A3/A13; A Clone 19.1
Pansfected L cells; O Control L cells
(Spooner et al. 1987), except that after four rounds of
'^stimulation, CD4+ cells were depleted by complement
lediated lysis, using the mAb cc8 (Howard et al. 1989) to
enrich cell populations for CD8+ cytotoxic T cells. The cell
'ines produced were 97% CD8+ as assessed with mAb IL-
^51 (Ellis et al. 1986). The All-specific CTL line killed
L cells transfected with clone 19.1 and cells from the donor
lnimal equally well (Fig. 1 A), whereas the transfected cells
ftre not recognized by the AlO-specific CTL line
% IB). Target cells expressing other BoLA class I
Wigens and control L cells were not killed by either
-fL line. Recognition of the transfected cells by the CTL
'™es could be inhibited by treating the target cells with the
''HC class I-specific mAbs IL-A88 and W6/32 (A. K.
"ichani, unpublished data).
-H-2
Fig. 2 Iso-electric focusing of class I antigens. MHC class I antigens
were analyzed by 1D-IEF essentially as described by Joosten and co¬
workers (1988), except that for the control and transfected L cells, 108
cells were labeled for 6 h with 300 pCi of 35S-methionine (Amersham)
for each precipitation. The gel shows 35S-labeled molecules immuno-
precipitated with the allo-antiserum Edl02 which is specific for the
BoLA-All haplotype from: lane 1 PBM from an A10/A11 animal;
lane 2, control L cells; and lane 3, L cells transfected with clone 19.1
Biochemical analysis of the clone 19.1 gene product was
done by 1D-IEF as described by Joosten and co-workers
(1988). The All-specific allo-antiserum Edl02 was used to
immunoprecipitate cell-surface molecules from A11+ PBM,
Ltk~ control cells and the clone 19.1-transfected cells after
metabolic labeling with 35S-methionine. The banding pat¬
tern of the PBM sample contained several charge variants
(Fig. 2, lane 1), as reported previously (Al-Murrani et al.
1993). Although the serum Edl02 cross-reacted with H2
molecules expressed by the control Ltk~ cells (Fig. 2,
lane 2), it immunoprecipitated a single additional molecule
from the transfected L cells (Fig. 2, lane 3). This tranfec-
tant-specific band had the same iso-electric point as one of
the All molecules from PBM. This adds weight to the
serological and cellular identification of the 19.1 gene
product as a component of the All haplotype.
The lambda EMBL3 clone 19.1 contained a 21 kilobase
(kb) DNA insert with all of the pBoLA-1 hybridization
localized to a 1 kb Sal I-Bam HI fragment and the adjacent
7 kb Bam HI fragment (Hasima 1992). These fragments
were gel-purified and subcloned into pBR322 to form
pBoLA-17 and pBoLA-18, respectively, from which the
original arrangement of fragments was reconstructed in
pBoLA-19. To ensure that pBoLA-19 carried the entire
class I gene from phage clone 19.1, it was co-transfected
with the tk gene into Ltk- cells. After HAT selection, over
90% of the surviving transfectants expressed a cattle class I
molecule as detected by FACS analysis, confirming the
integrity of the gene on pBoLA-19.. Both phage- and

















































plasmid-derived transfectants were used in subsequent Fig. 3 The nucleotide sequence of the class I gene from the lambda
analyses, with identical results. clone 19.1. Intron sequences are given in lowercase. The translated
DNA from plasmids pBoLA-17, pBoLA-18, and
amino acid sequences of the exons are given in three-letter code above
the DNA sequence. Two possible translation initiation codons arepBoLA-19 was sequenced by the dideoxy chain-termina- shown in italics. The region equivalent to the class I regulator)'
tion method (Sanger et al. 1977), with modified T7 DNA complex (CRC) sequence in HLA genes is shown in bold type, and
Polymerase (Sequenase; Amersham, Amersham, UK). For promoter sequences are underlined and indicated as follows: CAAl
initial sequencing we used primers designed from con- ccAAT-box; TATA, TATAA box. Predicted polyadenylation sequencese ^ OTP 1 rt fascist 11 st 11 /-• o PflptrmtiAn amT/ma pitan nra imny-J otl/1 I fl Dele
, • i i ■ i j i c , r afe in bold italics. Restriction enzyme sites are overlined and 1served regions of the published cattle class I cDNA as follows. Bam< Bam HI; Pvu yPvu „ The estimated sizes »P
sequences (Ennis et al. 1988; Brown et al. 1989; Bensaid of unsequenced regions are given at their appropriate positions®
et al. 1991; Ellis et al. 1992; Garber et al. 1993) and ellipses (•••)
pBR322-specific primers flanking the cloned fragments.
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Extension primers, based on the sequence data obtained,
«re used to complete the sequences of all of the exons in
the class I gene on clone 19.1, including contiguous
segments of 1034 base pairs (bp) and 886 bp at the 5'
and 3' ends of the gene, respectively (Fig. 3).
The pBoLA-19 exon sequences were combined and used
lo search the EMBL nucleotide sequence database. All of
Ihe similar sequences found were MHC class I genes,
dearly identifying clone 19.1 as a cattle class I clone, the
dosest match being with the cattle cDNA clone BL3-7
(Ennis et al. 1988) with 96% identity over 1451 aligned
liases. Phylogenetic analysis of class I protein coding
sequences, analysis of the length and sequence of the
iransmembrane and cytoplasmic domains, and compari¬
sons of the 3' untranslated (UT) sequences have been
used to classify the BoLA class I sequences. These
methods have assigned the published BoLA class I cDNA
sequences to three putative loci which comprise BL3-6,
BSA, BSC, pBoLA-1 and A10; BL3-7, BSF, BSN and
BSX; and KN104 (Ennis et al. 1988; Ellis et al. 1992;
Garber et al. 1994). Analysis of the pBoLA-19 coding and
3' UT sequences suggest that it is from the same locus as
BL3-7, and this is supported by the observation that 21 of
the 26 amino acid differences between pBoLA-19 and BL3-
7 are in the polymorphic exons 2 and 3.
The pBoLA-19 sequences upstream of exon 1 can be
split into two distinct areas based on similarity to known
sequences. The region from position 1 to about 630 is
similar to the Art2 repetitive element in the cattle lysozyme
gene (Irwin et al. 1993), suggesting that this region may be
part of a related repetitive DNA sequence. The remainder
of the 5' flanking region is homologous with MHC class I
promoters, containing an identifiable class I regulatory
complex (CRC) and promoter elements (Fig. 3). In hu¬
mans, the CRC sequences are highly conserved between
alleles of a single locus (96%-99% identity), but are less
well conserved between loci (78%-89% identity; Cereb
Yang 1994). The degree of identity between the CRC of
pBoLA-19 and the cattle promoter sequences BTMHCI
(!• S. Harms, unpublished data; accession L19193) and
ifoLAenh-9 (Harms and Splitter 1994) is 92% and 86%,
respectively, suggesting that these promoters may be from
different class I loci. Interestingly, the exon 1 sequence of
BTMHCI is identical to that of the cDNA BL3-6, while
pBoLA-19 appears to be allelic with BL3-7.
By transfecting a clone containing a well-characterized
single gene, we were able to assign a sequence to the All
Sene and identify the product it encodes. Importantly, the
integrity of this class I gene product is maintained in the
Iransfectant, as determined by serological, functional, and
biochemical analysis. Iso-electric focusing shows that only
#ne BoLA class I product is immunoprecipitated from the
bansfectant, whereas the All allo-antisera recognize sev-
Jal molecules from PBM. Thus, allo-antisera recognize
!everal gene products associated with individual haplo-
Tpes. Furthermore, the IEF patterns assigned to serologi-
;ally defined haplotypes by family studies are consistent
egardless of breed or origin of the typed cattle (Joosten et
1988; Al-Murrani et al. 1993; Davies et al. 1994),
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implying that the cattle class I loci are in linkage disequili¬
brium. The approach described in this paper will allow the
number of expressed class I loci to be resolved, and will
also facilitate the functional analysis of individual locus
products.
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SUMMARY
A vector is described for the rapid expression of genomic or cDNA copies of bovine
MHC class I genes in transfected mammalian cells. Class I gene fragments are amplified by
the polymerase chain reaction using primers in conserved regions of exon 2 and the 3'-
untranslated region of the gene, and can be subcloned directly into the expression vector
pBoLA-21, which contains the necessary 5'- and 3'- sequences for correct expression. The
vector was tested by subcloning and expressing genomic and cDNA clones, and by selectively
amplifying, cloning and expressing a gene encoding one component of the BoLA-AlO
haplotype from crude cDNA.
INTRODUCTION
The bovine major histocompatibility complex (BoLA) encodes a range of cell surface
glycoproteins which mediate the presentation of antigenic peptides to T cells for immune
surveillance. Serological analysis of BoLA class I molecules has identified about 50
serological specificties, most of which behave as alleles of a single highly polymorphic locus
(Davies et al. 1994). Biochemical and molecular biological analyses, however, have provided
evidence that BoLA class I molecules are the products of three or more genes (Al-murrani et
al, 1994; Ennis et al. 1988; Brown et al. 1989; Bensaid et al. 1991; Garber et al. 1993, 1994;
Sawhney et al. 1995) which may be tightly linked. In order to correlate BoLA class I gene
sequences with their expressed products we are cloning and transfecting class I genes from
an animal which expresses A10/A11 serological specificities. As part of this work, we have
developed a system for the transfection of bovine MHC class I genes based on a novel
plasmid expression vector. The plasmid vector (pBoLA-21) carries the 5'- and 3'-ends of a
characterised genomic class I clone (pBoLA-19; Sawhney et al. 1995), flanking a unique Eag
I site which is used for the subcloning of PCR-amplified class I gene fragments. This system
has been tested by subcloning the coding regions from two expressible genomic phage clones
and one cDNA clone.
RESULTS AND DISCUSSION
(a) Primer selection and amplification of the coding fragment
In order to amplify MHC class I genes from genomic or cDNA, primer sites were
selected in regions conserved in all of the published bovine class I sequences (Ennis et al.
1988; Brown et al. 1989; Bensaid et al. 1991; Garber et al. 1993, 1994; Sawhney et al. 1995).
Since the majority of these sequences represent truncated cDNA clones, the 5'-end primer site
was located at the start of exon 2, while the 3'-end primer was located within the 3'-
untranslated region (Fig. 1). Amplification using these primers yields a fragment of 3.2kb
from genomic class I genes and 1.2kb from cDNA.
(b) Construction of the class I expression vector, pBoLA-21
To allow the PCR-amplified gene fragments to be expressed, a pBR322-derivative vector was
constructed in which the 5'- and 3'-ends of the genomic class I gene on pBoLA-19 (Sawhney
et al. 1995) flanked a unique Eag I restriction site into which the PCR products could be
cloned (Fig. 2). By providing the promoter, exon 1, and polyadenylation sequences on the
expression vector pBoLA-21, it was hoped that this vector could be used to characterise the
products of class I genes amplified from crude genomic or cDNA, or from truncated genomic
or cDNA clones.
(c) Reconstruction of genomic class I clones in pBoLA-21
The PCR primers for amplifying bovine MHC class I gene fragments and the expression
vector pBoLA-21 were tested using two positively-expressing genomic clones (19.1 and 4.2;
Sawhney et al. 1995). The 3.2kb class I gene fragments amplified from the genomic class
I clones with primers A and B were subcloned into the TA cloning vector pCRII (Invitrogen).
This allowed the PCR products to be analysed and subcloned into pBoLA-21 using Eag I sites
in primer A and in the TA vector polylinker. Both reconstructed clones were found to
express a detectable cell-surface class I product after transfection into mouse L cells,
confirming the validity of the approach. Fig. 3 shows histogram FACS analysis of the 19.1
reconstructed clone using the anti-bovine pan-class I mAb IL-A88. About 90% of the
transfected cells expressed bovine class I molecules.
(d) Subcloning and expression of cDNA clones in pBoLA-21
The selection of primers sites in transcribed parts of the gene meant that the primers could
be used to amplify both genomic and cDNA copies of class I genes. To test pBoLA-21 for
cDNA expression, a 1200bp fragment containing was amplified from a truncated bovine class
I cDNA clone (pBoLA-1; Brown et al. 1989), using primers A and E (Fig. 1). These primers
contained terminal Eag I sites for direct cloning of the amplified pBoLA-1 cDNA fragment
into pBoLA-21 to form pBoLA-30, and primer E was based on a potentially locus-specific
segment of the pBoLA-1 3'-untranslated sequence which is conserved in BL3-6, W10 and
KN104, but was absent from pBoLA-19 and BL3-7. The reconstructed pBoLA-30 cDNA
expressed a detectable bovine class I product on transfection, suggesting that the hybrid
transcript was correctly spliced and expressed.
After successfully expressing the pBoLA-1 cDNA, the potentially locus-specific primer
(primer E; Fig. 1) based in the 3'-ut sequence of pBoLA-l-like sequences was used in an
attempt to selectively amplify an A10 class I cDNA from total cellular RNA prepared from
PBM with A10/A11 specificity. The 1.2kb amplified cDNA product was digested with Eag
I and cloned into pBoLA21 to form pBoLA-10. The reconstructed cDNA clone pBoLA-10
expressed a bovine class I molecule on the surface of transfected L cells. The serological
specificity of the product expressed by the pBoLA-10 transfected cell line was examined using
IL-A88 and three AlO-specific mAbs IL-A7, IL-A10 and EL-A34 (Toye et al. 1990). The
transfectant reacted positively with IL-A88 and IL-A34 but not with IL-A7 or IL-A10 (Fig.
4), suggesting that pBoLA-10 encodes a component of the A10 specificity, and that the A10
specificity comprises the products of more than one gene.
(e) Conclusions
The primers and vector described here allows the rapid and direct cloning of class I
genes in expressible form, from genomic or cDNA. They will also facilitate the functional
characterisation of class I clones lacking exon 1 or 3'-untranslated regions which would
otherwise be difficult to express (e.g. many of the published cDNAs). Potentially gene-
specific primers, based in the 3'-untranslated regions of class I genes, may also be used to
selectively amplify, clone and express different bovine class I genes in this system.
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FIGURE LEGENDS
Fig.l. Multiple nucleotide sequence alignments illustrating the selection of primers for
amplification of MHC class I gene fragments. In the alignments residues identical to the
pBoLA-19 sequence are represented by dashes (-), regions of sequence which were not
determined are shown by dots (.), and gaps inserted to maximise similarity in the alignment
are shown by carets (A). The sequence of primer A and the reverse complement of primers
B and E are given beneath the alignments. Sequences in italics in primers A and E are
restriction enzyme sites included to facilitate subcloning of the PCR products, and the
following ambiguity codes represent degenerate positions in the primer sequences: S, G or C;
M, A or C; Y, C or T; and W, A or T. The primers were based on sequences conserved in
exon 2 and in the 3'-untranslated region of the published bovine class I sequences. (A) The
forward primer A included 10 bases of flanking intron sequence, in addition to the conserved
sequences from exon 2, to allow correct splicing of exon 2. (B) Reverse primer B was
designed for amplification of all possible class I sequences whereas primer E contained a 15bp
region which was missing from the pBoLA-19 and BL3-7 sequences, and was expected to
give locus-specific amplification.
Conditions for PCR amplification were as follows: denaturation at 94°C for 30 sec, followed
by 30 cycles of 94°C for 30 sec, 55°C for 30 sec and 72°C for 2 minutes. The last extension
step was for 5 minutes at 72°C. The reaction buffer contained lOmM KC1, lOmM NH2S04
, 20mM Tris-HCl (pH8.8), 2mM MgS04 , 0.1% Triton X-100, 200umM of dNTPs and 20
pmol of each primer. To achieve amplification of fragment size larger than 3kb and also to
ensure the accuracy of replication, addition of vent DNA polymerase to Taq DNA polymerase
at a 1:10 ratio was used.
Fig. 2. The expression vector pBoLA-21 was constructed as follows: (A) a 1.2kb Sal I-
Eag I fragment containing the class I promoter and exon 1 was subcloned from pBoLA-19
into pBR322. Next, a 450bp Pvu II fragment from pBoLA-19 containing most of the 3'-
untranslated region and polyadenylation sequences was added to make pBoLA-20. (B)
Inverse PCR using primers C and D (marked by arrows) was then used to amplify a 4.4kb
receptor fragment from pBoLA-20. Primer C was based on intron 1 sequences flanking the
Eag I site, and primer D was the reverse complement of primer B. Finally, the PCR fragment
amplified from pBoLA-20 was self-ligated to make pBoLA-21.
Restriction enzyme sites, and important features of the sequences are shown as follows: S, Sal
I; E, Eag I; P, Pvu II; Pr, class I promoter region; Exl, pBoLA-19 exon 1; ApR, Ampicillin
resistance gene; TcR, Tetracycline rsistance gene; ori, pBR322 origin of replication.
Fig. 3. Fluorescence-activated cell scan (FACS) analysis of bovine class I molecules
expressed on the surface of transfected cells. Cells were labelled with the anti-bovine class
I monoclonal antibody I1-A88, followed by a fluorescently-labelled anti-mouse IgG secondary
antibody. After washing, the degree of cell fluorescence (ordinate) is plotted against cell
number (abscissa) for both the negative control (untransfected L cells, open curve) and for the
reconstructed pBoLA-19 class I gene in pBolA-21 (closed curve).
Fig. 4. FACS analysis of the pBoLA-10 transfected cell line with ( A) IL-A7, (B) IL-A10,
(C) a murine monoclonal antibody specific for a non-polymorphic determinant on bovine
MHC class I (IL-A88), and the BoLA-AlO specific mAbs and (D) IL-A34. Cells were
labelled with the class I-specific primary antibody, followed by the appropriate fluorescent
secondary antibody, and were analysed an described in Fig. 3.
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pBoLA-19 gtctcaccct cttgccccag GCTCCCACTC CCTGAGG
GAGGTCCGGCCG CTTGCCCCAG GCTCCCACTC SMTGA
Primer A
3'-untranslated region
tgctg cccttcccca c gt t
tgctg cccttcccca c gt--- g ---t
tgctg cccctcccca ccctgac-
tgctg cccctcccca c aaa t t
A A A A A A A A A A A A A A A ^ A A
CCCACaaaaaaaaaaaaaaaC ATGCCaaCCC tccccaccct gacctgtgtt ctcctccc
cccactgctg cccytcccca CGGCCGCCCC
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